Foot orthoses versus hip exercises and the effect of greater foot mobility in the management of patellofemoral pain by Matthews, Mark
1 
 
 
 
Foot orthoses versus hip exercises and the effect of greater 
foot mobility in the management of patellofemoral pain 
 
Mark L G Matthews 
Masters of Physiotherapy (Musculoskeletal) 
Bachelor of Physiotherapy 
 
 
 
 
 
 
 
 
 
A thesis submitted for the degree of Doctor of Philosophy at 
The University of Queensland in 2019 
The School of Health and Rehabilitation Sciences 
 
2 
Abstract 
The patellofemoral joint comprises of an articulation of the patella with the 
trochlear groove of the femur. The patella is tethered distally via the patella 
tendon, proximally via the quadriceps tendon and multiple local structures 
such as medial and lateral patellofemoral ligaments retinaculum. When the 
knee flexes and extends, the patella engages and translates through the 
groove, often under high stress, during complex multidirectional motion. 
Patellofemoral pain (PFP) is a prevalent and recalcitrant knee pain condition 
that can have a significant impact upon a person’s quality of life. 
Patellofemoral pain is defined as anterior, retro and/or periarticular pain 
around the patellofemoral joint that is typically aggravated by weight bearing 
activities with a flexed knee. Patellofemoral pain is considered to be a 
multifactorial condition with various biomechanical, neurological and/or 
psychological contributors proposed in its aetiology. Due to its multifactorial 
nature, PFP can be an enigmatic condition for clinicians to treat. Various 
approaches targeting structures and areas local, distal and proximal to the 
patellofemoral joint have been proposed. As such, clinicians can become 
confused about what interventions are most effective for particular patient. 
Two evidence-based recommended treatment approaches for PFP are foot 
orthoses and hip exercises. Foot orthoses and hip exercises have been 
investigated in clinical trials with each treatment having a proposed 
biomechanical mechanism of effect at the patellofemoral joint. However, these 
two treatments have not been compared head to head, to determine if either 
treatment is superior. Whilst the treatments have been shown to be effective, 
they are not a one-size-fits-all approach with results from clinical trials 
suggesting the presence of subgroups that reported a more favourable 
outcome to a particular treatment. Clinical guidelines recommend using 
evidence-based treatments that are tailored to the individual patient, however 
there is a dearth of guidance on how to tailor the treatments. Furthermore, 
there is a paucity of evidence on how to identify the unique subgroups that 
might benefit most from a specific treatment. There was a need for further 
research to (i) determine if and what patient characteristics identify those with 
PFP who would benefit most from a specific treatment, and (ii) compare the 
clinical superiority of foot orthoses versus hip exercises.  
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The chapters within this thesis explore the evidence and describe the design, 
implementation and results of a randomized clinical trial. Study one was a 
systematic review of the literature. Preliminary evidence suggested greater 
midfoot width mobility (at least 11mm change in the width of the midfoot 
moving from non-weight bearing to weight bearing) was associated with 
greater global improvements with foot orthoses treatment. Crucially, the 
evidence was limited by studies lacking a comparator treatment and over-
fitting of variables for the statistical models. Review indicated that further 
research was needed to explore the potential treatment effect modification 
midfoot width mobility may have with regards to foot orthoses.  
 
Based on this preliminary evidence, study two was the design of a two-arm 
parallel; superiority randomised clinical trial in Australia and Denmark to 
address two aims. The aims were to test (i) the potential treatment effect 
modification of greater midfoot width mobility for foot orthoses treatment over 
hip exercises, and (ii) the clinical superiority of foot orthoses versus hip 
exercise treatments for managing PFP. The trial required the recruitment of 
220 participants (18-40years) who reported an insidious onset of knee pain 
(≥6 weeks duration); that was aggravated by activities (e.g. stairs, squatting, 
running), and at least three out of ten pain on the numerical rating scale (ten 
being worst imaginable pain). Participants were stratified by their midfoot 
width mobility (high ≥11mm change in midfoot width) and site, and then 
randomised to foot orthoses or hip exercises. The primary outcome was a 
patient-perceived global rating of improvement at 12 weeks. 
 
Study three was the implementation of the randomised clinical trial. Of the 218 
participants recruited and enrolled from June 2014 to April 2017, 192 
completed follow up at 12 weeks. We found no difference in success rates 
between foot orthoses versus hip exercises in those with high midfoot width 
mobility (6/21 v 9/20; 29% v 45% respectively) or low midfoot width mobility 
(42/79 v 37/72; 53% v 51%). There was no association between midfoot width 
mobility and treatment outcome (Interaction effect P=0.19). This study found 
no difference in success rate between foot orthoses versus hip exercises 
4 
(48/100 v 46/92; 48% v 50% respectively). The discovery that those with 
patellofemoral pain and greater foot mobility did not have superior benefits 
using foot orthoses, compared to hip exercises contradict common clinical 
assumptions. We found that foot orthoses and hip exercises offer similar 
global outcomes in the management of patellofemoral pain. These results 
suggest that clinicians should not use midfoot width mobility to decide which 
patients would benefit from foot orthoses, versus hip exercises. Given both 
foot orthoses and hip exercises offer similar global benefits, clinicians and 
patients can consider either in managing patellofemoral pain.  
 
Study four highlights a clinical case of a person with PFP. The person met the 
exclusion criteria for the trial as she had done briefly hip exercises as part of a 
fitness program in the last 12months. The case provides a clinical exemplar of 
the evidence, and reasoning, in the management of someone with PFP which 
may be clinically useful for similar case presentations. The case demonstrates 
the research in action and explores one avenue of tailoring treatment to the 
individual. Whilst the limitations of a case study are acknowledged, it offers 
hypotheses about relationships between physical, psychological, social and 
behavioural variables which remain to be investigated for PFP. Overall, the 
research in this thesis, and published studies, adds to the evolution of 
knowledge and clinical management of PFP. A potent outcome from this 
study showed both foot orthoses and hip exercises offer comparable benefits 
and needn’t select patient characteristics for one or the other on current 
evidence. This research opens path for foundations on future research on the 
beneficial effects of combining foot orthoses and hip exercises, cost-benefit 
analysis of interventions for PFP, and consideration for a stepped-approach to 
the management of PFP that includes an educational and activity modification 
aspect.  
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Chapter 1. Introduction   
The knee is the largest, and one of the most complex joints in the human 
body. The knee must withstand high multidirectional forces all the while 
performing complex tasks to move the lower limb, transmit forces, absorb 
shock and maintain an upright body position during physical activity. The knee 
is the most commonly injured joint with an estimated 2.5 million sports-related 
injuries presenting to emergency departments in the United States annually 
[1]. Adolescent athletes (15-24 years) had the highest injury rate (3.43 per 
1,000), with most injuries occurring during sports and recreational activities 
(49.3%) [1]. The knee has a complex interplay between the tibiofemoral joint 
and patellofemoral joint that allow for flexion, extension and rotation motions 
of the lower limb whilst generating and transmitting large forces [2]. The 
patellofemoral joint plays a vital role in allowing large forces to transmit across 
the anterior aspect of the knee, through a large range of motion. It does this 
via complex and dynamic interplay between articulation of the patella bone 
within the trochlear groove of the femur, ligamentous attachments and 
muscular tissues [3]. Due to the high multidirectional forces exerted across 
the knee, and the complex interplay of biomechanical and psychosocial 
factors, insidious conditions such patellofemoral pain (PFP) are prevalent [4].  
 
Patellofemoral pain is a common musculoskeletal condition of the knee that 
presents to health practitioners [5, 6]. Studies on adolescents and young 
active adults have investigated the incidence of PFP [7-10]. In a prospective 
study of 145 adolescent female basketball players, 14 (11%) players 
developed PFP during the season [7]. In a 2 year prospective study of 282 
students aged 17-21years (mean age 18.6) enrolled in physical education 
classes, 24 (9%) were diagnosed with PFP. [9] In military cohorts of new 
infantry recruits undertaking basic training, incidence has been reported to 
range from 3 to 32% [8, 10-12]. Current evidence indicates that the incidence 
of PFP in young active adults are around 10-15%, while in military population, 
the rates are more varied (range 3-32%).  
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Evidence is indicating PFP is not self-limiting for a substantial proportion of 
people with PFP [13, 14]. A recent prognostic study reported 40% of 310 PFP 
participants involved in treatment trials reported an unfavourable recovery at 
12 months follow-up [15]. Factors such as duration of symptoms greater than 
2 months, higher age [16] and greater pain severity at baseline have been 
associated with a poor outcome. Moreover, PFP has been suggested as a 
precursor in the cascade of degenerative changes in the patellofemoral joint . 
In summary, for a substantial proportion of those with prolonged PFP 
symptoms, the prognosis is poor with possible degenerative longer-term 
consequences.  
 
Chapter 2. Background  
This chapter covers the broad aspects of patellofemoral pain aetiology and 
the local, proximal and distant contributing factors. It highlights broad 
considerations towards the management of patellofemoral pain and a 
appreciation of the biopsychosocial aspects of patellofemoral pain.  	
Patellofemoral pain is described as a pain originating in the anterior, retro or 
peri-patellar region of the knee. [17] It is theorised to be an overuse tissue-
stress injury around the patellofemoral joint related to local, proximal and/or 
distal factors [5, 18, 19]. Diagnosis of PFP is based on around the clinical 
presentation, and the exclusion of other structural pathologies that may 
manifest similar anterior knee pain symptoms. [20, 21] Characteristic 
symptoms of PFP arise from activities that load the patellofemoral joint  in the 
flexed knee position, such as running, squatting, climbing or descending stairs 
or sitting for a prolonged period of time. [22] 
 
Recent studies have investigated the quality of life impact of PFP. 
Adolescents with PFP reported lower quality of life scores and higher pain 
catastrophizing scores compared to pain free controls and that their 
symptoms had a significant impact on their quality of life (P<0.0001) [23, 24] 
Fear-avoidance beliefs about physical activity were identified as a strong 
predictor of function and pain outcome in those with PFP. [25] This growing 
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body of evidence from studies of adolescent participants has identified the 
profound detrimental impact of PFP on psychological and physical wellbeing. 
There is a need for more research in adolescent and adult populations to 
determine i) the impact of PFP on the quality of life, ii) longitudinal follow-up 
and iii) intervention studies to minimise the persistence of symptoms and 
optimise the person’s quality of life.  	
2.1 Aetiology of Patellofemoral Pain 
The aetiology of PFP, its causes and contributing factors are an area of 
ongoing research [26]. There are conceptual theories that PFP symptoms are 
a result of elevated stresses on the patellofemoral joint and surrounding 
tissues [26, 27]. One theory is that PFP results from mal-tracking of the 
patella; that is, the patella laterally deviates in the trochlea groove of the 
femur, resulting in elevated contact pressure between the lateral facet of the 
patella and the lateral femoral condyle elevating patellofemoral joint  stress 
[28]. Theories have been proposed that patella mal-tracking may adversely 
stress the lateral patellofemoral structures, contributing to processes such as 
ischemia, inflammation of the synovial lining, stress patella retinaculum and 
fat pad tissues, overload of the sub-chondral bone and increase osseous 
metabolic activity [29-31]. Studies have reported a decrease in patellofemoral 
joint contact area and subsequent increased lateral patellofemoral joint  stress 
during fast walking [32] and squatting activities [33] in individuals with PFP 
when compared to pain-free controls. However, these are studies on small 
samples with methodological limitations such as the unknown limits in 
accuracy of surface tracking measures to infer dynamic changes in relative 
position of the patella and femoral condyles. Whilst evidence has suggested 
an association between elevated patellofemoral joint  stress and incidence of 
PFP, it is also possible that people with PFP may modify their movement 
strategies to normalise the magnitude of force at the patellofemoral joint [32]. 
Additionally, cross-sectional studies are unable to draw conclusions on the 
causality of elevated patellofemoral joint stresses and PFP. It is hoped that 
methodological limitations for calculations of joint contact pressures can be 
overcome in the future, and the relationship of this variable to patient 
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symptoms and disability better understood. It would be ideal if prospective 
studies could investigate longitudinal changes in motion of the patella and 
patellofemoral joint stresses in the development of PFP, to infer directions of 
causality between changes in mechanics and symptoms.   
 
Extensive research has focused into biomechanical and physiological 
aetiology of PFP. In particular, abnormalities of the retro-patellar structures 
and overload of subchondral structures may play a role in the pathogenesis of 
PFP [2]. These structural abnormalities are proposed to be a precursor to the 
cascade of developing patellofemoral joint  osteoarthritis [34]. As such, 
research has investigated patellofemoral cartilage composition and 
surrounding structures to gain a better understanding in the pathogenesis of 
PFP. Despite the recent advancement of high-resolution magnetic resonance 
imaging, structural abnormalities of the patellofemoral joint and diminished 
patellofemoral cartilage composition are not associated with PFP [35, 36]. 
Thus, research and clinicians alike are warranted in considering other 
possible causes for pain and disability, aside from just tissue injury models. 
 
Pain is the predominate symptom reported by those with PFP. The processing 
of information to create the perception of pain results from interplay of factors 
ranging from peripheral tissue pathology to the mind and immune system. 
Biological, psychological and social contextual factors can each profoundly 
modulate symptoms and motivate behaviour [37]. Some factors are 
modifiable, such as tissue robustness, beliefs and behaviours. Others are 
non-modifiable with health interventions, such as genetics, age, 
socioeconomic [38]. The neurophysiological processing of information to 
create pain perception has been described as a neuromatrix, that 
encompasses the peripheral nociceptive input that informs about location of 
physical or chemical danger to the tissues. Thoughts and feelings based on 
past experiences and current interpretation of the environment modulate pain  
[39]. An example of the plasticity between stimulus and perception is that 
people with PFP demonstrate lower mechanical pressure pain thresholds than 
those without PFP [40]. A decrease in mechanical threshold for pain 
perception has been associated with a poor outcome. [41-43] A recent review 
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reported linear correlations with pain and physical function with mental health 
and cognitive factors such as anxiety and depression, pain catastrophizing 
and fear-avoidance beliefs. [44] Thus, although the behaviour of patient’s pain 
may appear to follow the magnitude of mechanical load at the knee, the 
complexity of interacting factors at the nervous system, with ascending and 
descending modulation must be acknowledged. Onset or persistence of PFP 
can be modulated by neurophysiological, psychological and social factors.  
This project focusses on specific, modifiable biological interventions, but if an 
effect is observed with these, it should still be considered that the 
mechanism(s) for any individual participant might have involved a wide range 
biological, psychological and social factors in combination.   
 
A recent concept of neurotags suggests the brain is an complex array and 
interaction of neural representations whose output act on particular systems, 
such as motor system to create movement or consciousness to create a pain 
output [45]. This highly complex matrix of factors is suggested to subserve a 
regulatory i.e. control and protection purpose for the body on both a 
physiological and perceptual level [45]. It is plausible clinical interventions for 
PFP may address this complex neuromatrix indirectly through altering 
physiological processes, with neuro-motor techniques and appropriate activity 
management, and perceptual through patient education and behaviours. In 
summary whilst extensive research has gone into investigating 
anthropometric, anatomic and neuromuscular factors in PFP, any 
improvement in pain symptoms to clinical interventions with a biomechanical 
and pathoanatomical approach may only be one component of the recovery 
process. [39, 45-48] 
 
2.2 Local factors for Patellofemoral Pain aetiology 
A variety of anthropometric measurements locally at the knee have been 
investigated in relation to mal-tracking of the patella in people with PFP. The 
Q-angle is the angle formed at the knee by a line connecting three points on 
the lower limb; the anterior superior iliac spine at the pelvis, the patella, and 
the tibial tubercle. It has been reported that more patients with PFP had a Q-
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angle > 20° (73%) in static stance compared to control participants (46%) 
[49]. Other radiographical studies have reported a shallow trochlear groove 
(sulcus angle) as a predictor of patellar displacement at 0-9 degrees of knee 
flexion [50], with greater lateral patella displacement and patella tilt being 
demonstrated in those with PFP when compared to a control group [51]. 
However, two radiographic studies of sulcus angle and patella tilt failed to 
identify any difference in these parameters between people with PFP and pain 
free control groups [52, 53]. A point worth consideration is that the multi-
planar motion of patella during physical activity may not be well represented 
by any morphological measure in a single plane. The role of these 
morphological measures in contributing to PFP remains unclear. 
 
A potential cause of patellofemoral mal-tracking is deficits of neuromuscular 
functioning of the quadriceps muscles [54, 55]. Deficits in neuromuscular 
control may alter coordination of the medial and lateral quadricep muscles 
that insert on the patella, exposing the patellofemoral joint to elevated 
stresses. Deficits reported include delays in onset timing of vastus medialis 
obliquus (VMO), delayed co-ordination of VMO relative to vastus lateralis and 
an overall reduced strength of the quadriceps muscle group [55, 56]. Delays 
in the timing of muscle activation onset of VMO relative to vastus lateralis has 
been reported as a risk factor in development of PFP [11]. Additionally results 
suggest that timing of VMO onset of activation is delayed in participants with 
PFP, compared to control participants [57, 58]. However there is conflicting 
evidence from one prospective study, which reported that a delay in onset 
timing of VMO, relative to vastus lateralis, was not a significant risk factor for 
development of PFP [9]. Contrasting results from prospective studies could be 
due to the differences in study cohorts, with military personnel undergoing 
greater rigorous physical activity [11] than student cohorts [9]. In conclusion, 
while deficits have been identified in neuromuscular function of VMO, results 
from cross-sectional study design are unable to determine whether these 
deficits are causative factors for PFP, or an effect of PFP symptoms. The role 
of VMO timing in PFP symptoms should be investigated with prospective 
studies of adult cohorts that are representative of the wider population.  
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Patellofemoral pain has historically been viewed as a local problem at the 
knee, however research and clinical trials focused on PFP have investigated 
regions outside of the knee. The lower limb comprises of multiple multi-axial 
joints to form an interdependent kinetic chain. Studies have recently shifted 
focus to investigate and report on a myriad of proximal and distal factors to 
the knee to propose hypotheses that may influence PFP and identify potential 
predictors of onset and resolution of symptoms.  
2.3 Proximal factors for Patellofemoral Pain aetiology 
A pathomechanical model has been suggested of a proximal influence on 
patellofemoral joint stress. The model proposes that aberrant deviation of the 
femur into hip adduction and internal rotation during weight bearing activity 
would medially deviate the femur under the patella, resulting in patella mal-
tracking and place excessive stress on the patellofemoral joint  [28, 59, 60]. A 
prospective study of 400 female runners reported that those who developed 
PFP (n=15) exhibited greater hip adduction during running [61]. In a cross-
sectional study of 32 female runners (16 with PFP, 16 healthy controls), it was 
reported those with PFP had greater peak hip adduction, hip internal rotation 
and shank internal rotation than healthy controls [62]. Aberrant hip adduction 
and internal rotation during weight bearing tasks has also been associated 
with strength deficits of the gluteal muscles, particularly the hip abductors and 
external rotators [61, 63, 64]. When compared to pain-free controls, those with 
PFP exhibit 15-20% less isometric strength for hip abduction and external 
rotation (expressed as percentage of body weight) [65]. Conflicting this 
hypothesis, a prospective military cohort of 1597 new recruits found increased 
hip external rotation strength as a risk factor in those that develop PFP [63]. 
So too, a prospective trial reported no differences in isometric strength of any 
hip muscle groups (flexors, extensors, abductors, adductors, external and 
internal rotators) between the runners who did or did not develop PFP [66]. A 
case-control study reported no differences in the isometric muscle strength of 
the hip abductors or external rotators in those with PFP compared to gender 
matched controls [67]. In a kinematic analysis, females with PFP exhibited 
similar hip and knee kinematics during a step-down task to matched pain free 
control participants, despite the fact that participants with PFP had a 
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significant hip muscle weakness [68]. The pathomechanical model suggests a 
biomechanical relationship between neuromuscular systems and hip 
kinematics, however there is conflicting evidence. The variation in results for 
gluteal muscle function and kinematics in people with PFP could be due to the 
specific cohort variables or methodological differences in challenging the 
neuromuscular system. These conflicting results could suggest that people 
with PFP recruit compensatory strategies during activity to normalise the load 
on the patellofemoral joint.  
 
Research has investigated the effect of loading and the neuromuscular 
system in those with PFP. In a cross-sectional study, subjects with PFP have 
demonstrated a deficiency in neuromuscular control with delay in activation of 
both anterior and posterior fibres of gluteus medius, when compared to 
asymptomatic controls [69, 70]. Delayed activation in gluteus medius could 
impair control of the hip position in weight bearing, and contribute to hip 
adduction and internal rotation, predisposing individuals to patellofemoral joint 
stress and subsequent development of PFP. In a military cohort, increased 
hip internal rotation during a drop jump landing task was identified as a risk 
factor for the development of PFP [63]. The drop jump landing task required 
participants to drop down from a box set at 50% of their body height, land on 
a force platform and jump vertically for maximum height [63], challenging the 
neuromuscular system much more than a step-down task [68]. In a study of 
running and PFP, the PFP group exhibiting decreased hip abduction and 
external rotation strength (P<0.0125) but no changes to hip internal rotation or 
adduction kinematics (p>0.05)[71] relative to pain free control participants. In 
another running kinematic study, the PFP cohort demonstrated three distinct 
kinematic strategies, and all three of the strategies demonstrated less overall 
motion compared to healthy controls [72]. Whilst both studies were designed 
to push participants to the point of exhaustion, PFP cohorts in both studies 
experienced pain during testing. Therefore, it cannot be determined whether 
pain and/or exhaustion induced the group differences that were observed. 
These findings from more demanding activities suggest that people with PFP 
could have insufficient neuromuscular capacity to tolerate the loading 
demands upon the lower limb during a pre-selected physical activity. 
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Prospective and cross-sectional studies are required that look at the activation 
timing of the gluteal muscles and the effects of loading on a spectrum of PFP 
and pain-free populations to test these hypotheses. Additionally, interventional 
studies need to examine whether neuromuscular training of the hip muscles, 
such as strength, movement retaining and endurance capacity, can have an 
effect on PFP symptoms.   
 
2.4 Hypothesised Distal factors for Patellofemoral Pain aetiology 
A distal model to bottom-to-top lower limb biomechanics has proposed that 
excessive foot pronation or prolonged phases of foot pronation during gait 
could indirectly increase patellofemoral joint  stress [73]. This dynamic 
coupling model hypothesized that aberrant foot pronation induced greater 
tibial internal rotation during the mid-stance phase of gait, restricting 
tibiofemoral joint extension (normal gait mechanics would require the tibia to 
externally rotate as the tibiofemoral joint extends). Due to the foot being 
grounded, a proposed compensatory mechanism is for the femur to internally 
rotate on the tibia, to achieve full extension of the tibiofemoral joint. This 
compensatory mechanism results in lateral displacement of the patella 
relative to the femur, and is hypothesised to elevate stress at the 
patellofemoral joint  [73].  
 
Studies have investigated the distal pathomechanical model of excessive or 
prolonged foot pronation during gait proposed. [73] Various anthropometric 
measurements and scales have been developed to quantify the degree of foot 
pronation, or to define excessive motion in the foot. The navicular drop was 
described as a sagittal plane representation of foot pronation, calculating the 
change in the navicular tuberosity height off the ground, from a weight-bearing 
subtalar joint neutral position to a relaxed foot posture. Normative values for 
navicular drop have been reported as 10-15mm [74]. The foot posture index is 
a 6-item scale assessment tool that evaluates multiple segment and multiple 
plane static foot posture [75]. Another published measure of foot mobility at 
the midfoot calculated the difference in mediolateral midfoot width (midfoot 
defined as 50% of total foot length), between a non-weight bearing to weight 
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bearing posture (Figure 2.1) [76]. In a normative study of 345 participants (left 
and right feet of asymptomatic individuals), average midfoot width mobility 
was reported to be of 9.6 mm on the left and 9.3 mm on the right [76].  
   
Figure 2.1. Measurement of midfoot width  
in weight bearing (left image) and non-weight bearing (right image) (from 
McPoil et al. [76]). 
 
One point of contention has been the use of static measurements and scales 
to represent motions of the foot that are implicated in PFP. A recent 
development of dynamic foot kinematics analysis has investigated rearfoot 
eversion with three-dimensional motion-analysis system, to quantify foot 
pronation (Figure 2.2) [77].  
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Figure 2.2. Reflective marker placement to measure dynamic rearfoot motion  
(from Barton et al. [77]).   
 
Studies have reported excessive foot pronation, measured statically by the 
foot posture index [78] and greater peak rearfoot eversion within PFP cohorts 
[77] . In a prospective study of a military cohort, an increased navicular drop 
was reported as a risk factor for developing PFP [63]. Those who displayed a 
navicular drop of 10.67 mm or more (90th percentile) were reported to be 3.4 
times more likely to develop PFP than those who had a navicular drop 
measurement of 4 mm or less (10th percentile) [63]. In a kinematic gait study, 
the PFP group demonstrated peak rearfoot eversion, relative to the tibia, to 
occur 7% later in stance compared to the control group indicating a prolonged 
foot pronation phase associated with PFP [79]. However prospective evidence 
from three studies has contradicted a model of excessive or prolonged 
pronation in stance phase. In a study of 400 female runners, there was no 
statistically significant difference in rearfoot eversion between those who 
developed PFP and those who didn’t [61]. Likewise, in a study of military 
recruits who were initially pain free, those who developed PFP demonstrated 
significantly more laterally directed pressure distribution; with the authors 
suggesting this indicating a less pronated foot posture [80]. Lastly, in a study 
of novice runners, there was no association between an excessively pronated 
or supinated foot posture and the development of PFP [81]. Furthermore, 
cross-sectional studies have also reported no difference in peak rearfoot 
eversion between PFP and control groups during physical activities. [82-84]. 
Reports suggest that the PFP group may have a more rigid landing, thus 
higher impact forces, which could contribute more to PFP development than 
foot posture [81, 85]. A contributor to these conflicting results could be the 
methodological challenges of motion analysis. It is questionable if foot 
pressure distribution can accurately determine foot motion. Likewise, it is 
debateable whether reflective surface markers can truly represent motion of 
the underlying bones during motion analysis of foot and lower limb during gait. 
Overall, evidence is inconclusive about the relevance of a distal 
pathomechanical model causing PFP, with a need for prospective and cross-
sectional studies using robust motion analysis on a wider population.  
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Most current evidence on aetiology has been drawn from retrospective 
studies with research paradigms isolated to a biomechanical and 
physiological focus. A key focus needs to be to determine where correlation 
and associations may actually represent causality. A strong focus needs to 
consider co-existence of multiple mechanisms around PFP. Current theories 
representing a strong biomechanical paradigm to PFP and do not consider 
the influence on central and peripheral pain processes. It is plausible altered 
pain processing mechanisms may have a stronger influence on the aetiology 
and persistence of PFP in some individuals than others with PFP. Overall 
there is a need for prospective designs that consider co-existence of multiple 
mechanisms behind PFP symptoms for higher levels of evidence and to 
support theorised aetiologies.  
 
In summary, the local, proximal and distal theories to aetiology of PFP have 
supporting evidence from specific cohorts, demonstrating that PFP is indeed 
multifactorial. Contradictory results between studies highlight the 
heterogeneity of the aetiology of PFP and indicate the need further 
investigations on a for a variety of cohorts need to be undertaken before solid 
conclusions can be drawn. Notwithstanding these limitations, it is plausible 
that the aetiology of PFP arises from an individual-dependent combination of 
local, proximal and distal factors combined with extrinsic factors, such as 
loading forces from activity, may have an overloading influence on the patella 
kinematics and results in PFP symptoms. It is highly probable that a 
biomechanical approach to managing PFP will have vectors of effect on the 
nervous system functioning, whether sensory or motor and the central pain 
processing mechanisms. This area of research is outside the scope of this 
thesis, but also warrants consideration. 
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Chapter 3. Non-surgical management of patellofemoral pain 
This chapter broadly explores the evidence behind the management of 
patellofemoral pain. In particular, it draws on considerations for tailoring 
treatment towards the individual and potential treatment effect modification.  
 
The multifactorial nature of PFP and various identified associated local, 
proximal and distal factors involved is reflected in the broad options of 
management strategies proposed for PFP. Various options regarding 
conservative (non-surgical) and surgical methods have been proposed [86] 
[87]. Conservative interventions are regarded as the cornerstone of PFP 
management over surgical interventions in the management of PFP. Surgical 
intervention is rarely indicated for PFP and is reserved only when a clearly 
defined abnormality that the operation can specifically target is present (e.g., 
identifiable lesion or structural instability) [88, 89] Surgical options usually 
considered are patellar realignment, resurfacing, patellofemoral trochleoplasty 
and arthroplasty. [87] The benefits gained from surgery remain inconclusive 
though as most surgical studies have been single arm in design. One 
randomised controlled trial has compared arthroscopic surgery plus an 8-
week exercise programme to an exercise program alone [90]. At nine month, 
24 month and 5 year follow-up both intervention groups showed equally 
marked improvement across all outcome measures [90, 91] suggesting 
arthroscopy gave no added benefit to a home exercise program. These 
findings strengthen the evidence that conservative interventions as the 
forefront mainstay initial management of PFP.  
3.1 Evidence for conservative interventions for patellofemoral pain 
Research into managing patients with conservative interventions has been an 
evolution of knowledge with wide variability and controversial approaches. 
Intervention options have historically included wait-and-see, bracing, 
electrotherapy, manual therapy, foot orthoses, taping, open and/or closed 
chain exercises, strength training, flexibility training and acupuncture. This 
multitude of therapy options adds to heterogeneity of managing a 
multifactorial condition.  
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Current best practice guidelines for optimising management of PFP propose 
four key over-arching principles to ensure effective management of this 
multifactorial condition, including (1) individually tailored approach with 
treatment, (2) focusing on an immediate pain relief to gain patient trust, (3) a 
strong emphasis on active over passive interventions to empower the patient 
and (4) thorough patient education and relative activity modification. [86] 
 
Randomised controlled trials investigating conservative interventions for PFP 
have reported heterogeneity in patient outcomes to specific interventions, 
from successful to worsening. [92-94] This spectrum of results is difficult to 
interpret in part due to the nature of PFP, the outcome measures used and 
the potential effect an intervention has to alter, or modify, the prognosis of the 
condition. Studies have looked to compare an intervention against a control 
group. Previous clinical trials have shown foot orthoses to be effective 
compared to a wait-and-see (9/19 versus 1/20; p = 0.008, relative risk 
reduction = 8.47%, numbers needed to treat = 2) or flat inserts (relative risk 
reduction 0.66, 99% confidence interval 0.05 to 1.17; NNT 4 (99% confidence 
interval 2 to 51). [92] In another trial comparing hip exercises to a usual-care 
approach, at 3 months the hip exercise group showed better outcomes than 
the usual care group with regard to pain at rest (adjusted difference −1.07, 
95% confidence interval −1.92 to −0.22; effect size 0.47), pain on activity 
(−1.00, −1.91 to −0.08; 0.45), and function (4.92, 0.14 to 9.72; 0.34).[93]  
Whilst evidence indicates a difference in response rate, differences in 
outcome alone (i.e. successful to worsening) do not automatically suggest the 
direct effect of an intervention response and should be interpreted with a 
degree of caution.  
 
Research has suggested the presence of more homogenous subgroups 
within the PFP population who have a favourable outcome to a specific 
intervention [77, 95]. Patient outcome could be optimised if clinicians could 
identify the homogeneous treatment and target the treatment to their 
presenting local, proximal and/or distal presenting characteristics. Whilst PFP 
is acknowledged as a local condition to the knee and patellofemoral joint, the 
knee is only part of an integral kinetic chain of the lower limb. During daily 
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activities, the lower limb is exposed regularly to cyclic load bearing tasks, 
such as walk, up very high load tasks, such as running, squatting with 
weights. The lower limb must have sufficient compliance and capacity to 
absorb these loads and optimally transfer the forces without overloading 
certain tissues. In those with PFP, evidence from clinical trials addressing 
these deficits (i.e. proximally at the hip with exercises, and distally with foot 
orthoses) is highlight the significant improvement in symptoms. While the 
mechanism of effect of these treatments remains inconclusive with different 
theories proposed [96], the ultimate mechanisms of effect may still be local at 
the patellofemoral joint. The importance of addressing proximal factors at the 
hip, and distal at the foot still remains pertinent. 
 
One limitation of the guidelines is advice on how to individually tailor treatment 
to the patient. In summary, whilst these results from interventional studies 
highlight the benefits that prefabricated foot orthoses can have on reducing 
PFP, not all patients reported a successful outcome. Whilst exercise is now 
considered an efficacious approach for most with PFP [4], considerable 
debate continues on in regards to the type of specific exercises (i.e., strength, 
endurance, motor-patterning), target muscles, and duration of an ideal 
exercise program for patients with PFP. 
3.2 Evidence for targeting interventions proximal to the knee 
Studies have investigated interventions for hip muscle strength for treatment 
of PFP. Hip muscle weakness, particularly the hip abductors and external 
rotators, is a modifiable factor in those with PFP [26, 62, 97]. Clinical trials 
investigated the outcomes of hip strengthening treatment for PFP, with many 
participants showing improvement [98-101]. In one trial, a 4-week isolated 
open-chain hip strengthening protocol was compared to a 4-week quadriceps 
strengthening protocol, prior to weight-bearing exercises. Results indicated 
the initial hip strengthening protocol was more effective in reducing PFP 
symptoms than quadriceps strengthening [102]. Trials also investigated the 
comparison of a knee strength and stretching program versus a knee strength 
and stretching program, supplemented with hip strengthening exercises [101, 
103]. The hip exercises targeted the hip abductor, external rotator and 
40 
extensor muscle groups. Results reported improved single leg hop, stair tasks 
and reduced pain in the supplemented programme compared to the program 
for knee strength / flexibility [101, 103]. Additional clinical trials have targeted 
hip abductor and external rotator muscle groups in those with PFP, reporting 
significantly reduced pain, increasing hip strength and improved health status 
over control groups [104, 105]. Furthermore, improvements in hip abductor 
and external rotator strength can change lower extremity kinematics [106]. 
This growing body of evidence from randomised clinical trials has highlighted 
the efficacy of hip strengthening programmes in the PFP population. 
However, a substantial proportion of clinical trials have been conducted on 
only female cohorts [99-101, 103]. While these results are promising, it is 
unknown whether hip strength for males is as important a factor as it is for 
females with PFP. Further clinical trials are required that investigate the 
effects of hip strengthening on a mixed cohort, that is generalizable to the 
wider clinical population. 
 
3.3 Evidence for targeting interventions distal to the knee 
Another form treatment alternative for PFP is foot orthoses. Foot orthoses are 
specially designed shoe inserts. Notable features of therapeutic orthoses 
include contouring and intrinsic medial posting, a variety sizes, shapes and 
hardness, that are either custom-made or prefabricated, and fitted based on 
patient comfort and performance improvement [107]. Foot orthoses are 
fundamentally designed to realign and correct an aberrant motion of the foot 
[108]; however this traditional notion of skeletal realignment is questionable 
[109]. Foot orthoses have also been proposed to enhanced activation of the 
quadriceps and gluteal musculature and reduced lower limb muscle activity 
and joint moments by enhancing footwear comfort and [110, 111]. A recent 
systematic review and meta-analysis on the mechanisms of foot orthoses 
reported that foot orthoses could cause a reduction in rearfoot eversion and 
tibial internal rotation in non-injured cohorts [96]. A significant finding reported 
was the shock attenuating effect of a posted molded orthosis compared with a 
posted non-molded orthosis in uninjured participants [96]. These findings infer 
that the benefit of foot orthoses results from the modification of loading rate 
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and force through the foot and lower limb. However, this is based off evidence 
with small effect size from non-injured cohorts. There is a need for further 
studies investigating the exact mechanism of foot orthoses, particularly in 
injured cohorts. A greater understanding of this mechanism could influence 
the management of PFP with foot orthoses and help to optimize treatment 
outcomes. 
 
Whilst there is a paucity of mechanistic evidence of foot orthoses, 
interventional studies have investigated clinical outcomes from foot orthoses 
treatment for PFP. Evidence has highlighted the efficacy of prefabricated foot 
orthoses in those with PFP [92, 112, 113]. A case-series reported foot 
orthoses had an immediate impact to reduce pain and improve function in 
step-down, single leg raise and squat tasks for people with PFP [113]. Foot 
orthoses provide greater improvements in patient-specific function and patient 
perceived global improvement in a 6 and 12 week intervention period 
compared with flat shoe inserts [92]. A high quality clinical trial randomly 
allocated 179 participants with PFP to four treatment arms, comparing the 
treatment efficacy of flat inserts, foot orthoses, a proven multimodal 
physiotherapy program [114], and combination of foot orthoses plus 
physiotherapy [92]. No significant difference was reported on global 
improvement between foot orthoses and physiotherapy, or between 
physiotherapy and foot orthoses plus physiotherapy, whether considered at 6, 
12 or 52 weeks follow-up [92]. Collins et al. (2008) identified that the number 
needed to treat with orthoses for PFP was 4 [92].  However, the 99% 
confidence interval ranged from 2 to 51, and should be interpreted with 
caution.  
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Chapter 4. Can we predict the outcome for people with 
patellofemoral pain? A systematic review on prognostic 
factors and treatment effect modifiers. 
 
 
This chapter is a systematic review of the literature for patient characteristics 
that provide prognostic benefit or modified treatment effect. In summary, the 
review identified a number of studies that had report prognostic findings or 
clinical prediction rules, however the lack of a comparator treatment, and 
over-fitting statistical models, greatly restricted the findings.  
 
4.1 Introduction 
Patellofemoral pain is a prevalent and persistent knee condition [115, 116] 
that affects approximately 1 in 20 teenagers and 1 in 10 adult women. [6, 117-
120] Despite receiving evidence-based treatments that are initially effective, 
more than one third of patients’ still report persistent symptoms 12 months 
later [116] with approximately 25% reporting symptoms up to 20 years 
later.[121] It might be helpful clinically to know whether certain prognostic 
factors can identify patients with PFP who are at risk for a poor outcome. 
[122]  A review identified a number of prognostic factors for outcomes in those 
with PFP (e.g., age, pain severity, foot posture/motion), [121]  only presented 
differences between groups at baseline, which are not helpful to the clinician 
wanting to determine the prognosis of a specific patient. 
 
The complex and multifactorial nature of PFP leads to a heterogeneous 
clinical presentation.[48] A recent best practice guide recommended that 
treatment be tailored to each patient’s presentation, but it did not provide 
direction for the clinician on how to individually tailor treatment.[86] Prognostic 
factors are patient characteristics that help to determine a clinical outcome, 
positive or negative, within a certain time period. [123, 124] Treatment effect 
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modifiers are patient characteristics that predict a response or clinical 
outcome, or lack of response, from a specific treatment. An evidence-based 
approach to individually tailor treatment requires the identification of treatment 
effect modifiers, because although prognostic factors help predict the 
likelihood of an outcome within a certain time period, they cannot predict the 
likelihood of an outcome after a specific treatment. [125]  
 
To inform clinical practice and research related to PFP, the purpose of this 
systematic review was to determine which baseline patient characteristics 
were: (i) associated with a poor outcome (prognostic factors); or (ii) 
associated with a successful outcome after a specific treatment (treatment 
effect modifiers).  
 
4.2 Methods 
4.2.1 Search Strategy 
The systematic review was conducted following the PRISMA guideline. [126] 
Electronic databases (Medline, Scopus, Embase, CINAHL, SPORTDiscus 
and Web of Science) were searched up to July 2016 for studies investigating 
conservative (non-surgical) treatments for PFP. Key search terms relating to 
PFP and other such synonyms used in all databases were adapted from 
similar search strategies. [48, 127, 128] Keywords used to narrow the search 
to the aim of the review were success*, factor*, predict*, charact*, prognos*. 
Searches were limited to human studies with no language restrictions 
(appendix 1). The protocol for the systematic review was not registered.    
4.2.2 Eligibility 
Studies were included if they had investigated: (a) participants diagnosed with 
PFP determined by clinicians based on the report of retro or peripatellar pain 
that was provoked by either a partial squat, stair ascent or descent and pain 
reported during palpation of peri-articular structures, and (b) an association 
between patient characteristics that were measured at the outset of the study 
and the outcome (status of the condition) at a later time (minimum period of 1 
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week). If an included study had used an intervention, only conservative (non-
surgical) interventions were included. Studies were excluded if they included 
pain from structures other than the patellofemoral joint, and other knee 
pathologies such as internal derangement, knee ligament insufficiency or 
patellar tendinopathy. Case reports or reviews of the literature were also 
excluded.  
4.2.3 Review process 
All identified studies were imported into Endnote X6 (Thomson Reuters, 
Carlsbad, California, USA) and duplicates removed. Two reviewers (MM & 
MSR) independently assessed study titles and abstracts for eligibility with a 
third reviewer (BV) available if necessary, to resolve discrepancies. Where 
there was duplication or pooling of data from different trials, only the primary 
publication (the study of the highest relevancy to the purposes of this review 
as determined by all three reviewers) was included. Reference lists of all 
publications considered for inclusion were hand-searched recursively until no 
additional eligible publications were identified.  
4.2.4 Quality assessment 
Two reviewers (MM and MSR) independently assessed papers for quality. 
Any discrepancies were discussed to reach consensus, and if discrepancies 
remained, a third reviewer was consulted (BV). Study quality of all included 
studies was assessed using the Epidemiological Appraisal Instrument (EAI) 
[129] in a method used in previous reviews. [130, 131] Items were scored as 
Yes (score = 2), Partial (score = 1), No (score = 0), Unable to determine 
(score = 0) of the applicable items. An average score was then calculated 
across all applicable items for each study (range 0-2). The EAI is a valid and 
reliable appraisal instrument for systematic reviews [132]  
Studies that aimed to investigate predictors of outcome after a specific 
treatment were further evaluated for quality using a checklist for prescriptive, 
derivation-based clinical prediction rules (QUADCPR). [133] The QUADCPR 
was designed and developed using a 3-round Delphi process involving 
physicians, epidemiologists and physical therapists. It includes 23 items 
across 4 sections – (i) sample and participants (ii) outcome measure (iii) 
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quality of tests and measures and (iv) statistical assumptions. Each item is 
scored yes, no, or unclear without generating a quantitative score. Two 
modifications were made to the QUADCPR for the purposes of this review. 
First, in accordance with the statement on Transparent Reporting of a 
multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) 
[134], an adequately powered study required at least 10 participants in the 
limiting sample size (group with least frequent outcome) for each variable 
analyzed as a potential predictor (Question 18). Second, in discussion with 
the corresponding author of the QUADCPR, a fifth section was added to 
assess whether outcomes are treatment effect modifiers - (v) quality of 
treatment approach. This section addressed the quality of the treatment 
approach using published recommendations on the preferred study methods 
for identifying treatment effect modifiers and subgroup effects.[125, 135, 136] 
An additional 4 questions were inserted into the checklist (Questions 24 -27) 
that addressed treatment explanation and implementation of the target 
treatment and comparator treatment.  
4.2.5 Data Extraction and Analysis 
Study details were extracted by MM and checked by MSR. Details extracted 
were: publication details, sample characteristics, participant demographics, 
study methods including study design, outcome measures, any 
intervention(s), and the baseline factors studied. Study results were extracted 
by following the definitions for a successful outcome or poor outcome applied 
by each individual study. Outcome measures used per study are detailed in 
Table 4.2 (col. 4) and Table 4.3 (col. 3). Relationships between baseline 
predictors and a poor outcome (i.e., prognosis) were expressed as R2, 
whereas baseline predictors and a successful outcome after a specific 
treatment were quantified by extracting positive likelihood ratios (LR+) and 
odds ratios (OR). Positive likelihood ratios indicate the change in probability of 
a successful outcome if the identified predictor is present. Shifts in probability 
of a successful outcome are categorized as small and rarely important (LR+ 
1-2), small but sometimes important (LR+ 2-5), moderate shift (LR+ 5-10) or 
large and often conclusive (LR+ >10). [137] Odds ratios measure the 
association between the exposure and an outcome (OR >1 higher odds; OR 
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<1 lower odds). For studies that did not report OR, LR+ or post-test probability 
scores, authors were contacted, and those indices were calculated from 
available data. Meta-analyses were performed where appropriate. 
4.3 Results  
4.3.1 Search results and critical appraisal of methods 
The search retrieved 11629 citations, of which 7339 unique titles and 
abstracts were reviewed, with 59 papers identified for full text examination. 
Twenty-four studies met the eligibility criteria for quality assessment and data 
extraction, (figure 4.1) which evaluated 180 participant characteristics 
(appendix 2). The most frequently evaluated characteristics were age and sex 
(n=14 studies), knee pain duration (n=13), Q angle, body mass index, weight 
and height (n=8), sports participation (n=6) and navicular drop (n=5 studies). 
Twelve studies investigated patient characteristics associated with a poor 
outcome, and the remaining 12 studies investigated patient characteristics 
associated with successful outcome after a specific treatment.  
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Figure 4.1 PRISMA flow diagram 
4.3.2 Quality assessment  
Overall across all 24 studies, there was good conformity of the study aims, 
treatments, assessments and main findings on the EAI checklist. Very few 
studies reported adequate adjustment for covariates in the statistical 
analyses, blinding of observers or reporting of adverse events. There was 
also a lack of reporting reliability and validity of the main outcome measures 
used (appendix 3). Twelve studies investigated prognostic factors for a poor 
outcome (three randomized controlled trials, eight case series and one had no 
treatment), only one of the randomized trials [138] adjusted for treatment and 
reported it was not a confounder.  
 
In addition to being evaluated for quality on the EAI, studies that investigated 
patient characteristics associated with successful outcome after a specific 
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treatment were appraised under the QUADCPR checklist (n=12). Overall on 
the QUADCPR quality checklist, significant methodological limitations were 
identified with only one study using a control group. Only one study [139] had 
adequate statistical power with at least 10 participants in the limiting sample 
size (group with least frequent outcome) for each potential predictor included 
in the statistical analysis. Even if a lower threshold of 5 participants in the 
limiting sample size for each potential predictor is used, [140] this was still the 
only study that had adequate statistical power. An issue with potential 
reporting bias was identified with only four [95, 139, 141, 142] of the twelve 
studies administered outcome measures in a blinded fashion and in only three 
studies were the examining [95, 139, 143] or treating [95, 142, 144] clinicians 
blind to the outcome measures (appendix 4).  
 
4.3.3 Patient characteristics associated with a poor outcome (prognosis)  	
Sixteen patient-reported and anatomical characteristics were associated with 
a poor outcome, with degree of association (e.g., R2) ranging from 27 to 46% 
(appendix 5). The patient-reported characteristics were duration of PFP 
symptoms [138, 145, 146] bilateral symptoms, [147] higher frequency of pain 
occurrence, [148] older age, [149] female gender, [146] lower baseline Kujala 
knee pain score and function (Kujala scale and functional index questionnaire 
in [138]), poor health and low/middle education level. [147] 
Anatomical characteristics associated with a poor outcome were swelling of 
the knee (self-reported by the participant in [147]), patellar hypermobility, 
[146] slower vastus medialis obliquus reflex response, [145] larger side to side 
differences in isometric quadriceps muscle strength, [150] smaller quadriceps 
cross sectional area on MRI and lower eccentric knee strength, [148] 
evidence of chondromalacia patella on MRI and a tibial tubercle lateral 
deviation > 14.6 mm relative to the trochlear groove. [151]  
4.3.4 Patient characteristics associated with a successful outcome after a 
specific treatment  	
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Six different specific treatments were investigated; foot orthoses, [77, 95, 142, 
143, 152, 153] lumbopelvic manipulation, [144, 154] patellar taping, [141] 
femoral nerve mobilization, [155] leg press exercise and stretching [139] and 
exercise therapy (consisting of static and dynamic exercises for the 
quadriceps muscles, flexibility and balance exercises) [156] (appendix 6). 
Twenty-two patient characteristics were reported to be associated with a 
successful outcome after a specific treatment. Studies defined a successful 
outcome using a predetermined amount of improvement in pain scores, 
questionnaire and/or a rating on a global rating of changes scale to stratify 
respondents into successful or unsuccessful outcomes.  
4.4.1 Foot orthoses  
Fourteen predictors were univariately associated with a successful outcome 
after foot orthoses treatment across six studies. [77, 95, 142, 143, 152, 153] 
Four predictors were static measures of the foot; these were 2° or more of 
valgus forefoot alignment, 78° or less great toe extension, 3mm or less 
navicular drop [152] and two studies reporting a mid-foot width difference 
between weight bearing and non-weight bearing greater than 10.96mm. [95, 
142] Two studies investigated foot movements during functional tasks. One 
study used 3-D kinematic analysis during gait to show those who had a 
successful outcome had a mean difference of 2.3° greater rearfoot eversion 
relative to the ground than those who reported an unsuccessful outcome. [77] 
The other study of a drop jump task reported those who had an immediate 
decrease in the medial-to-lateral peak foot loading went on to report 
improvements in pain and function after wearing foot orthoses for 12 
weeks.[153] Two studies found baseline pain scores of usual pain less than 
22.0 mm [143] and worst pain less than 53.25 mm [95] on a 100mm visual 
analogue scale predicted a successful outcome. One functional performance 
predictor was reduced pain during a single leg squat whilst wearing foot 
orthoses. [143] Ankle dorsiflexion range less than 41.3°, relative to the 
vertical, (measured as tibial inclination using a digital inclinometer placed 
anteriorly mid-tibia) during weight bearing ankle dorsiflexion with a bent knee 
also predicted a positive outcome. [143] Other demographic predictors 
reported were height less than 165 cm and age over 25 years. [95] In addition 
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to the patient centric factors, those participants who wore footwear with 
reduced motion control properties, assessed using a footwear assessment 
tool, [157] were more likely to report a successful outcome when wearing an 
orthosis. [143] Three predictors (height, forefoot valgus alignment, great toe 
extension) had a reported LR+ range of 4.0 - 4.9 [95, 152] but the 95% 
confidence intervals for these predictors were large raising greater uncertainty 
on the precision of these relationships. Three predictors of success had LR+ 
range between 2.5 to 3.9 and narrow confidence intervals; with two studies 
identifying midfoot width difference from weight bearing to non-weight bearing 
foot posture of >10.96mm [95] and >11.26mm, [142] reduced pain during 
single leg squat while wearing a foot orthosis and usual pain <22/100mm 
visual analogue scale.   
Two studies used multivariate analysis to evaluate a combination of predictors 
for clinical prediction rules for success after treatment by foot orthoses 
(appendix 7). Each study reported a different combination of four predictors, 
with a LR+ of 8.8 (95%CI 1.2-66.9) [95] and 11.1 (95%CI 2.7-46.9) [143] when 
three or more predictors were present, raising post-test probability of success 
to 85.4% and 78% respectively. These LR+ suggest a moderate to large and 
often conclusive shifts in probability of a successful outcome after foot 
orthoses treatment. No participants in either of the two studies presented with 
all four of the respective predictors (appendix 7). 
4.4.2 Lumbopelvic manipulation  
Five predictors were identified using multivariate analysis and reported to be 
associated with a successful outcome after lumbopelvic manipulation. [154] A 
follow up study [144] on a different but similar sized PFP cohort failed to 
replicate the same five predictors reported by Iverson et al. [154] 
 
4.4.3 Patellar taping  
One study [141] reported three predictors of a successful outcome with 
patellar taping as described by McConnell. [158] After multivariate analysis, 
smaller lateral patellofemoral angle (an angle formed by the line between the 
femoral condyles and another line between the margins of the lateral facet of 
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the patella) measured with radiographs in 30° of knee flexion, larger Q angle 
and a lower body mass index [141] were reported to be associated with a 
successful outcome. Larger Q angle was the only one of three reported 
predictors have an OR >1 (OR 1.14 95%CI 1.03-1.26).  
 
4.4.4 Femoral nerve mobilization 
One study [155] reported two predictors to be associated with a successful 
outcome after six sessions of femoral nerve mobilization. After multivariate 
analysis, significant immediate improvement after a femoral nerve 
mobilization and a bilateral difference of at least 3° in hip extension angle of 
the femoral slump test, which had a LR+ 5.1 (1.3-20.3), suggests a moderate 
shift in probability of successful outcome after femoral nerve mobilization.  
 
4.4.5 Exercise  
Two studies investigated predictors of successful outcome after exercise. One 
study compared exercise therapy to usual care and found no significant 
predictors of a successful outcome to exercise therapy. [156] One study 
evaluated a leg press training and lower limb muscle stretching exercise 
program. [139] Patellar tilt angle difference (PTA-d), which is the difference in 
patellar tilt angle in a quadriceps contracted (Qc) and a quadriceps relaxed 
(Qr) position measured on axial computed tomography, was associated with a 
successful outcome after a leg press strengthening and lower limb stretching 
program. [139] Those who had greater PTA-d (i.e greater realignment of the 
patella with quadriceps contraction) before beginning exercise treatment had 
greater reductions in pain after treatment. [139] The optimal cut-off value was 
−1.5° PTA-d (Qc−Qr) for the clinical discrimination of treatment success 
based on a minimum pain reduction of 1.5-cm on the VAS (sensitivity = 0.74, 
specificity = 0.71, LR+ 2.5). 
4.5 Discussion 
Our systematic review on PFP investigated baseline patient characteristics 
that were associated with a: (a) poor outcome (prognosis), or (b) successful 
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outcome after a specific treatment after more than one week. The review 
highlighted a large amount of non-significant association with a total of 180 
patient characteristics being investigated by 24 studies. Twelve prognosis 
studies investigated 104 characteristics and identified 16 prognostic factors 
associated with a poor outcome. Twelve studies reported that only 22 out of 
100 potential treatment effect modifiers were associated with a successful 
outcome after a specific treatment. However, the review identified significant 
methodological limitations in all studies appraised with the EAI and modified 
QUADCPR tools. Of the 12 studies that investigated prognostic factors, only 
one study, a randomized controlled trial, [34] controlled for treatment and 
showed it was not a confounder. Of the 12 studies that investigated potential 
treatment effect modifiers, 11 did not have a control condition or a comparator 
treatment. Due to this methodological limitation, it is unclear whether the 22 
baseline patient characteristics identified in these studies actually predict 
success following a specific treatment or are just non-specific prognostic 
factors. As a result of these limitations, pooling and meta-analyses of the data 
were not warranted. Although definitive conclusions cannot be drawn until 
these methodological limitations are addressed, in order to make the best use 
of available evidence, our discussion will focus first on studies investigating 
prognostic factors for a poor outcome followed by studies that investigated 
potential treatment effect modifiers.  
 
Prognostic factors are important in the decision making process and 
managing patient expectations. [159] Persistent PFP symptoms could have a 
negative impact on the physiological and psychological well-being of an 
individual with PFP. [115, 160, 161] Of the 12 studies that evaluated 
prognostic factors for a poor outcome, 16 characteristics were reported, but 
only five were investigated by more than three studies. Longer duration of 
knee pain, [138, 145, 146] older age, [149] greater usual pain severity and 
lower baseline anterior knee pain score [138] were factors of an unsuccessful 
outcome (appendix 8). Three of the five studies that evaluated duration of 
knee pain, one a large prospective study, reported a consistent finding of 
longer duration of pain (>4 months [35]) as an indicator of a poor outcome. 
Longer duration of symptoms as a poor prognostic indicator seems to be 
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consistent across musculoskeletal conditions, [162] even in adolescents with 
knee pain.[115] It is important to consider that all identified prognostic factors 
were collected once a baseline, a final score. It is possible that a change in 
score, or lack of change, (i.e. collecting a score again after a certain time 
period) may prove to be a stronger prognostic factor (e.g. minimal change in 
reported worst pain or anterior knee pain score over 6-week period). It would 
appear prudent for clinicians to keep duration of symptoms in mind when 
consulting a patient with PFP. This prognostic factor should also be 
considered in guidelines and future research for the effective 
management/prevention of persistent PFP.  
 
Twelve studies evaluated potential treatment effect modifiers associated with 
a successful outcome after a specific treatment with four conducting 
multivariate analyses to report clinical prediction rules for either foot orthoses, 
[95, 143] or lumbopelvic manipulation. [144, 154] A limitation of these single 
group studies identified in the QUADCPR appraisal was (a) the absence of an 
appropriate comparator intervention, [163] and (b) inadequate statistical 
power because limiting sample sizes were too small. Of the 12 studies that 
investigated potential treatment effect modifiers, 11 did not have a control 
condition or a comparator treatment. Lack of a control condition or a 
comparator treatment means there is no way to know that the outcome was 
necessarily due to the specific treatment. It is unclear whether the baseline 
patient characteristics identified in these studies actually predict success 
following a specific treatment or are just non-specific prognostic factors. The 
risk of spurious findings when overfitting or underfitting data to the limiting 
sample size was highlighted in a replication study of lumbopelvic manipulation 
for PFP [144] which used the same methods as the original study [154] but 
achieved contrasting results. Replication studies play an important role in 
predictive performance in a second, independent sample, especially when 
there are concerns about overfitting/underfitting data in the original study 
because of a relatively small limiting sample size. These studies need careful 
consideration in design that allow for an analysis of the interaction between 
treatment group and status on the prediction rule. 
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Foot orthoses were the most common treatment in studies that attempted to 
identify potential treatment effect modifiers (6 studies). One factor that was 
identified by two studies [95, 142] and formed part of a multivariate clinical 
prediction rule, was midfoot width difference of greater than 11mm, reported 
by Mills et al. [142] This study was the only one of the 13 studies looking at 
treatment effect modifiers to use a control group (wait-and-see approach). 
[142] Mills et al [142] provide preliminary evidence that midfoot width 
difference might be useful at identifying those who might benefit from a foot 
orthosis, beyond natural history of the condition in the short term. This 
provides the clinician some useful information/evidence beyond any 
prognostic value of this foot characteristic.  
 
Whilst single group studies cannot distinguish between treatment effect 
modifiers and non-specific prognostic factors, they can identify prognostic 
factors that could potentially be treatment effect modifiers. Rather 
appropriately the bulk of identified factors that might predict success with foot 
orthoses, were based at or around the foot. The two studies reporting clinical 
prediction rules for prescribing foot orthoses reported likelihood ratios that 
could signify a moderate to large and often conclusive shift in probability of a 
successful treatment. [137] The factors that are most likely to be clinically 
modifiable are ankle dorsiflexion (tibial inclination <41.3° from the 
vertical),[143] mid-foot width difference (>11mm) [95, 142] and footwear 
motion control properties (weighted mean >5). [143] An interesting clinical 
examination finding that contributed to one of these clinical prediction rules 
was a positive treatment direction test, [164] which is essentially the 
immediate reduction in pain with a single leg squat on initial wearing of a foot 
orthosis. [143] Somewhat consistent with the report of a positive treatment 
direction test [143] is the finding of an immediate decrease in medial-to-lateral 
peak foot force with fitting a foot orthosis being associated with a successful 
outcome. [153] In another laboratory study, kinematic analysis found those 
with greater rearfoot eversion relative to the floor, would also successfully 
respond to foot orthoses. [77] Taking the findings collectively, there appears 
to be a body of exploratory results from single group studies that suggests the 
ability of the reported clinically measurable and modifiable prognostic factors 
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to be potential treatment effect modifiers to identify those who would be 
successful with foot orthoses (appendix 8). Further research is necessary to 
investigate clinically relevant and plausible prognostic factors from single 
group studies in appropriately designed clinical trials to test for their ability to 
be treatment effect modifiers. In particular, midfoot width difference should be 
further explored as a treatment effect modifier for foot orthoses compared to 
other treatments because it has been shown to predict success with foot 
orthoses when compared to no intervention. 
 
In clinical practice, a positive finding of reproduction of symptoms with a 
femoral slump test, that reduced with neck extension, would reasonably direct 
the clinician to consider using femoral nerve mobilisations in patients who 
have PFP. Only one study reported clinical features that predicted success 
after femoral nerve mobilization treatment. [155]. In addition to the limitations 
of the single-group design, the authors used a modified testing protocol for the 
femoral slump test that is not easy to replicate in a timely manner in clinical 
practice. It is questionable the degree of confidence with which a clinician 
could determine a 3° difference from side to side as the authors did not report 
the error of this test measurement, so it is difficult to know if 3° exceeds 
measurement error. Nevertheless, further investigation of this treatment 
approach is warranted.  
 
Patellar taping, strengthening and stretching exercises of the thigh and lower 
limb muscles are often recommended to treat PFP. [158] A study by Lan et al 
[141] reported that success following patellar taping was associated with 
lateral patellofemoral angle and Q angle. Peng et al [139] measured the 
difference in patellar tilt angle between relaxed and contracted states of the 
quadriceps, noting a greater difference i.e., greater realignment of the patella 
with a contracted quads with treatment success. Notably though, all these 
measures from single studies of patellar position were made with radiological 
imaging, which is not readily accessible in a typical clinical setting (appendix 
8).  
A series of important methodological issues were identified in the reviewed 
studies. Prognostic studies should ideally be prospective in design, [123] but 
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in order to review all available studies that reported prognostic factors, 
weaker-designed retrospective studies were also included in this in review. 
Studies investigating predictors of a successful outcome after a specific 
treatment usually analyzed too many potential predictors for the limiting 
sample size. This increases the risk of over-fitting (or under-fitting) the data 
which can lead to the identification of predictors that are implausible and likely 
to perform poorly in new samples of patients [140] The absence of 
comparator interventions in studies investigating outcomes after a specific 
treatment make it difficult to differentiate between treatment effect modifiers 
and non-specific prognostic factors. Future studies should determine a 
sufficient limiting sample size to order to guide recruitment of an appropriate 
sample size. [136] Lastly, studies need to apply appropriate blinding where 
possible for participants and treating clinicians, but it is critical to blind 
investigators assessing the outcome to minimize false positives, or negatives, 
and potential biases. 
4.6 Conclusion 
This review of relationships between patient characteristics and treatment 
outcomes for PFP identified that methodological limitations such as the 
absence of a control/comparator group, or too many predictors for the limiting 
sample size, make it unclear whether the predictors reported actually modify 
treatment effects. Despite the limitations inherent in current research evidence 
we identified modifiable and measurable factors that have been studied so as 
inform hypotheses that may help in the clinical decision-making process 
(appendix 8). Three prognostic studies of patient characteristics identified that 
persistence of PFP beyond 4 months should alert clinicians to increased risk 
of a poor outcome. Greater change in midfoot width from non-weight bearing 
to weight bearing was the only characteristic that had sufficient evidence for 
being a potential treatment effect modifier for a successful outcome after foot 
orthoses treatment. The LR+ suggested a small but sometimes important shift 
in probability of a successful outcome, and this characteristic did not predict 
short-term improvement in a control group who received no intervention. 
Adequately powered randomized trials that compare relevant treatments are 
needed so that treatment can be tailored to the individual patient. 
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Chapter 5. The Foot Orthoses versus Hip eXercises (FOHX) 
trial for patellofemoral pain: A protocol for a randomized 
clinical trial to determine if foot mobility is associated with 
better outcomes from foot orthoses 
 
Preliminary findings from the systematic review suggested midfoot width 
mobility as a potential treatment effect modifier for foot orthoses. Limitations in 
the methodology of the identified studies, primarily the lack of a comparator 
treatment, restrict the clinical utility of reported findings. This chapter outlines 
the protocol for a randomsied controlled trial with two aims; to determine: (i) if 
greater midfoot width mobility will be associated with greater success with foot 
orthoses, when compared to hip exercises, and (ii) the superiorty of hip 
exercises versus foot orthoses, irrespective foot mobility.   
 
5.1 Background 
Patellofemoral pain (PFP) is a prevalent knee condition throughout the 
lifespan [7, 119, 165, 166], with a propensity to become persistent. [116, 121] 
Patellofemoral pain classically presents as anterior knee pain aggravated by 
activities that load the patellofemoral joint, such as climbing or descending 
stairs, running, squatting or sitting for prolonged periods. [4] Diagnosis is 
based on the clinical presentation of PFP, in the absence of other pathologies 
that might manifest as anterior knee pain. [4]  
 
Patellofemoral pain is also a multifactorial condition with guidelines 
suggesting optimal treatment should confer early pain relief and be targeted to 
the individual. [4, 86] Physical and exercise interventions for PFP are often 
targeted at the foot, knee and hip joints, or combinations thereof, with 
combined interventions proving superior. [167] Combined interventions for 
PFP often involve both active (e.g., progressive resistance exercise) and 
passive (e.g., orthoses, manual therapy, tape) therapies applied to the knee 
as well as the foot, thigh and hip regions. Selecting a tailored treatment plan 
for an individual patient from this range of interventions will potentially 
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enhance treatment outcomes and minimise exposing patients to non-essential 
treatments. 
 
Clinical trials have shown that exercising the hip muscles or using foot 
orthoses are efficacious in managing PFP, [92, 142, 168] but no studies have 
compared which is superior. Kinematic data suggests that the position and 
movement of the femoral bone, which is largely governed by hip joint 
movement under control of hip muscles, is the main contributor to 
patellofemoral joint loads [169, 170]. Exercise of the hip muscles would then 
plausibly have more effect on PFP through reduction of patellofemoral joint 
load, when compared to interventions targeting the foot (e.g., foot orthoses). 
We propose undertaking a comparison between hip exercise and foot 
orthoses, as it will address a common point of contention regarding whether 
proximal or distal approaches to PFP are more beneficial. [171] 
 
The recommendation to target treatments to the individual [86] has not been 
researched. One method of matching treatments to individual patients is to 
identify patient characteristics that can predict success after a specific 
treatment, known as treatment effect modifiers. [125] There are currently no 
valid treatment effect modifiers for treatment of PFP, but preliminary data 
suggest that further investigation of midfoot width mobility is warranted. Two 
studies have reported that greater midfoot width mobility [76] (defined as a 
change of 11mm or more moving from a weight bearing to non-weight bearing 
posture) was present in greater proportions of participants reporting 
improvement in their condition when treated with foot orthoses. [95, 142]  
These preliminary studies are limited in terms of the methods required to 
prove treatment effect modification. [172] Such limitations include failure to 
compare the specific intervention of interest against another relevant 
treatment and testing too many potential predictor variables for the sample 
size studied.  
 
We will undertake a randomized clinical trial that will investigate the role of 
midfoot width mobility as a treatment effect modifier for treatment of PFP with 
foot orthoses. It will also evaluate the clinical efficacy of foot orthoses against 
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progressive resisted hip exercises. The prospective trial will stratify 
participants based on their midfoot width mobility and randomly allocate them 
to be treated with foot orthoses or hip exercises.  
 
5.1.1 Objective 
The objective of this trial is to determine if those individuals with PFP and 
greater midfoot width mobility will report better outcomes from foot orthoses 
when compared to hip exercises. The trial will also conduct a direct 
comparison between foot orthoses and hip exercises in the treatment of PFP.  
 
5.1.2.Hypotheses 
1. High midfoot width mobility is a treatment effect modifier for foot 
orthoses compared to progressive resisted hip exercises at 12 weeks. 
This means that beneficial effects of foot orthoses compared to hip 
exercises will be greater for patients with PFP who have high midfoot 
width mobility than in those who have low midfoot width mobility. 
2. Hip exercises will be associated with better outcomes after 12 weeks, 
when compared to treatment with foot orthoses 
 
5.2 Method 
This study protocol follows the Standard Protocol Items: Recommendations 
for Interventional Trials (SPIRIT) guidelines. [173] The study report will follow 
the CONSORT guidelines for randomized trials [174] with the extension for 
non-pharmacological treatments and TIDieR for intervention description. [175, 
176]  
 
5.2.1 Trial design 
A two-arm prospective randomised superiority clinical trial in a multicentre 
setting with stratification on midfoot width mobility will evaluate if midfoot width 
mobility is a treatment effect modifier for foot orthoses compared to 
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progressive resisted hip exercises. An independent off-site body will generate 
a randomisation schedule for all participants for both trial sites. Participants 
will be allocated into either foot orthoses or progressive resisted hip exercises 
in a 1: 1 ratio using permuted block randomisation stratified by site and by the 
mid foot mobility measure. The primary end point will be 12 weeks.  
 
5.2.2. Study setting 
The trial will be conducted in Brisbane, Australia and Aalborg, Denmark. To 
reflect the common treatment settings in these countries, participants in 
Brisbane will attend private physiotherapy practices in the community while 
those is Aalborg will attend physiotherapy sessions in a hospital 
musculoskeletal outpatient department. [177]   
 
5.2.3 Ethics 
This study has been granted ethical approval by the University of Queensland 
Medical Research Ethics Committee (2013000981) and by the local ethics 
committee in the North Denmark Region (N-20140022). All participants will 
provide informed consent prior to being enrolled in the study.   
 
5.2.4 Eligibility criteria 
Volunteers will range from 18 – 40 years of age, report a history of anterior, 
retro or peri-patellar knee pain of non-traumatic origin that has persisted for 
more than six weeks. Self-reported worst pain over the previous week will be 
required to be greater than 3/10 on a numerical pain scale (0 = no pain, 10 = 
worst pain imaginable) with symptoms provoked by at least two or more of the 
following activities: squatting, running, prolonged sitting, stair ascending or 
descending. On physical examination, pain should be provoked by clinical 
palpation of the patellar borders, stepping down from a 25 cm step, during a 
double-leg squat and present on clinical compression of the patella into the 
trochlear groove. Eligible participants will be required to have basic 
comprehension of written and spoken English (Brisbane, Australia) or Danish 
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(Aalborg, Denmark) because of the descriptive nature of pain and behavioral 
outcome measures applied in this study.  
 
Volunteers will be excluded if they have any of the following: concomitant 
injuries or pathologies affecting other knee structures (e.g. ligament, meniscal, 
tendon, iliotibial band, pes anserinus), a history of knee or other significant 
lower limb surgery, patellofemoral dislocation or subluxation, Osgood-
Schlatter’s disease, Siding-Larsen-Johanssen syndrome, a positive patellar 
apprehension test or evidence of knee joint effusion. Volunteers will be 
excluded if they present with any foot condition that may preclude the use of 
foot orthoses, pain in and/or referred from the hip, pelvis or lumbar spine, 
current use of anti-inflammatory or corticosteroid medication including 
injections, or any previous treatment for PFP or other conditions that included 
hip exercises or foot orthoses.  
 
5.2.5 Stratification criterion 
An investigator at each trial site, different to the investigator responsible for 
enrolment, baseline and follow up outcome measures and blind to those 
outcome measures, will measure each participant’s midfoot width prior to 
treatment allocation. Midfoot width mobility is calculated as the difference in 
midfoot width between weight bearing and non-weight bearing postures and 
shown to be reliable. [76] The investigators taking the midfoot width mobility 
measurement will be trained to ensure they can reliably measure midfoot 
mobility. To test for midfoot width mobility as a treatment effect modifier for 
foot orthoses, we determined prior to the study that the stratification cutoff for 
midfoot width mobility will be 11 mm. [95, 142] Those who present with ≥11 
mm midfoot width mobility will be defined as being ‘high mobility’ and those 
with <11 mm as ‘low mobility’.  
 
5.2.6 Interventions 
Eligible participants will be randomly assigned to one of two interventions; (a) 
foot orthoses intervention or (b) a progressive resisted hip exercise 
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intervention. Registered/licenced physiotherapists who regularly treat 
musculoskeletal conditions will deliver both interventions. Treating 
physiotherapists at both sites will be trained by the same investigators (BV, 
MM & MSR) in the intervention protocols for both foot orthoses fitting and hip 
exercises prior to trial commencement to ensure consistent implementation of 
the interventions. Although the treatments are standard physiotherapy 
interventions, to ensure fidelity of treatment application all clinicians will be 
provided with extensive documentation including images of treatments, have 
an option to attend a refresher workshop, and access to a senior investigator 
for any queries or issues that arise during the trial. Treating physiotherapists 
will be blind to the participant’s midfoot width mobility measurements and 
baseline and follow-up outcome measurements. At the start of the study all 
participants will receive education to facilitate a basic understanding of their 
PFP condition and advice on physical activity. Participants will be encouraged 
to remain physically active provided that their chosen activities do not provoke 
pain that persists after ceasing their activities, and there is no general 
deterioration of symptoms during or after the cessation of activity.  
 
5.2.6.1 Foot orthoses 
Prescription of foot orthoses will follow the protocol utilised in a previous 
randomised control trial. [92] Physiotherapists will be provided with a range of 
commercially available prefabricated foot orthoses (Vasyli International, 
Labrador, Australia) (Figure 5.1). The orthoses are manufactured and 
designed from ethylene-vinyl acetate with an inbuilt arch support and a 
manufacturer specified 6° varus wedge. The orthoses are constructed in 3 
different levels of hardness [high (Shore A 75°), medium (Shore A 60°) or low 
(Shore A 52°)]. Prior to fitting the orthoses, the participant will perform a 
nominated aggravating task (e.g., step-ups). Physiotherapists will then follow 
a standardised fitting procedure (Figure 5.2). The physiotherapist has the 
scope within the fitting procedure to review the size, length, and hardness of 
the orthoses, that prioritises comfort as this is a key determinant of participant 
compliance. [178] To maximise comfort of the orthoses, physiotherapists can 
make modifications including heat molding and/or trialing various medial 
66 
wedges to the rear foot (2° or 4° inclination) and/or forefoot (4° or 6° 
inclination) and/or heel raise (4, 6 or 8 mm in height). Once the participant is 
satisfied with the comfort of the orthoses, the participant will perform the 
previously nominated aggravating task. An improved performance will be 
determined by the participant reporting a reduction in pain score or improved 
performance (e.g. more repetitions of an aggravating activity) before the onset 
of their pain. 
 
 
Figure 5.1 Orthoses types 
(From front) Full length, three-quarter length, easy fit & contoured sandal 
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Figure 5.2 Flowchart of orthoses fitting procedure 
 
The prescribing physiotherapist will have 3 attempts to modify the foot 
orthoses to primarily be comfortable and then improve performance of the 
participant selected task. In the unlikely event that the foot orthosis cannot be 
modified sufficiently to the participant’s satisfaction by the third session, then 
the participant will be deemed unsuitable for foot orthoses.. That is, no 
participant will be asked to wear orthoses that they perceive is uncomfortable. 
Previous trials of the same population using the same fitting procedure 
reported that no participants were unsuitable for this intervention. [92, 142]  
 
To encourage wearing of the orthoses, participants will be prescribed up to 
four pairs to fit a wide range of footwear as well as contoured (in the form of 
the orthoses) sandals for everyday use. Participants will be encouraged to 
wear the orthosis or contoured sandal whenever weight bearing. The sandal 
and orthoses have been shown to similarly increase arch height in healthy 
participants. [179]  
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Participants receiving orthoses will also be asked to perform a home foot and 
ankle exercise program twice per day (Figure 5.3). The program will include (i) 
stretches for the triceps surae/tendo-Achilles complex (3 x 30 sec weight-
bearing), and (ii) anti-pronation postural foot exercises. The anti-pronation foot 
exercises aim to improve the participant’s awareness from a relaxed pronated 
posture to a more supinated posture. Therapists will initiate training of the foot 
exercises with participants seated with the knees flexed and bare feet on the 
ground. Training consists of verbal and manual facilitation of participants to 
supinate the rear foot (manual facilitation: therapist upward pressure under 
the navicular as well as palpating the talocrural joint space for medio-lateral 
symmetry), while maintaining the first metatarsal head firmly on the floor and 
the toes relaxed. This foot posture will be held for 5 x 10 s. The exercises will 
be performed on each foot separately. Participants will attend a total of six 
sessions over six weeks. 
 
 
Figure 5.3. Foot and ankle exercises 
(Left): Anti-pronation exercise: The rearfoot is supinated (with tactile 
feedback) whilst maintaining first metatarsal head in ground contact. The 
white non-elastic tape is placed under the distal first metatarsal and the 
participant asked to prevent it from being removed (i.e., through plantarflexion 
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of the first ray) by the clinician who exerts traction on the tape. (Right) Calf 
stretch exercise, which is performed with the foot in netural position and the 
midline of the foot and the mid-point of the patella kept perpendicular to the 
wall 
 
5.2.6.2 Hip exercises 
The progressive resisted hip exercise protocol is modified from a protocol 
successfully used to improve outcomes at 12 months in women with PFP. 
[180] Exercise therapy focused on hip muscle groups, in particular hip 
abductor, external rotator, and extensor muscle groups, as well as a knee 
strengthening and stretching program targeting quadriceps, hamstrings and 
triceps surae muscle groups [180]. Results from intervention studies [94, 98, 
102, 105, 168, 180] support that exercises targeting the postero-lateral hip 
musculature can improve long-term function and reduce PFP when compared 
to no exercises or knee exercises alone. [181]   
 
Participants in the progressive resisted hip exercise group will attend three 
sessions per week for four weeks (12 sessions) [180] to perform exercises 
focused on the hip abductor, extensor and external rotator muscles groups. 
The exercises will be performed alternately on both sides and are described in 
appendix 9. [182] Elastic bands will provide resistance for the exercises and 
will be standardized to allow the participant to achieve a maximum of 10 
repetitions. Resistance (denoted by band colour) and length (50, 60, 70 cm 
loops) of the band (Theraband™) (Figure 5.4A-D) will be selected by the 
physiotherapist to suit individual participant capacity, re-evaluated at each 
treatment session and progressed accordingly. Using an 11-point scale of 
perceived exertion, participants will be encouraged to exercise at a rate of 5-7 
(‘Hard’ to ‘very hard’) (Figure 5.5). The contraction phase for each repetition 
will be 2 s concentric, 1 s isometric, 2 s eccentric and 1 s rest; with 
approximately a 90 s rest between each set of 10 repetitions, while training 
the contralateral side.  
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Figure 5.4A Hip abduction exercise in side lying 
 
 
Figure 5.4B Hip external rotation exercise in supine and with the hip in 30° 
flexion 
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Figure 5.4C Hip abduction exercise in standing 
 
 
Figure 5.4D Hip extension exercise in standing 
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Figure 5.5 Borg scale of perceived exertion 
 
For each of the twelve sessions, the treating physiotherapist will record 
attendance, strength (colour) and length of band used for each exercise, 
number of sets and repetitions completed as well as any adverse effects. At 
the completion of the program, participants will be instructed to continue with 
normal activities of daily living with no instructions to continue on with a home 
exercise program.  
 
5.3 Outcome measures 
The outcome measures will be a range of self-reported questionnaires, 
including psychological and quality of life measures as these are often 
involved in persistent musculoskeletal pain conditions, and functional tasks 
that load the patellofemoral joint. Participants will not be made aware of the 
specific study aim to evaluate midfoot width mobility as a treatment effect 
modifier so as to minimise the impact of participant expectation of treatment 
response on the basis of their foot type (or their allocated treatment group). 
Baseline and follow up (6 and 12 weeks after the commencement of 
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intervention) outcome measures will be administered by an assessor at each 
trial site who will be blind to the participant’s midfoot width mobility 
measurement and intervention allocation. 
 
5.3.1 Primary outcome measurement (6 & 12 weeks) 
The global rate of change scale (GROC) is the primary outcome measure with 
the primary endpoint at 12 weeks. The GROC is a participant rating of the 
direction and magnitude of overall change in symptoms. [183] Participants will 
be asked: “How would you describe your knee pain now, compared to before 
you began the treatment.” They will answer this question by selecting a 
descriptor on a 7-point Likert scale that best represents any change in their 
symptoms (much better, better, a little better, no change, a little worse, worse, 
much worse). Global rating of change scales have been frequently used in 
studies investigating treatment outcome in those with PFP and shown to be a 
flexible, simple and sensitive method for measuring meaningful individual 
improvement. [92, 93, 142, 184, 185] For analysis purposes, the GROC will 
be dichotomized so that ‘much better’ and ‘better’ represent success with 
treatment. 
 
5.3.2 Secondary outcome measures 
Single assessment numeric evaluation (SANE)   
Single assessment numeric evaluation questions have been used previously 
in participants with neck pain [186], shoulder surgery [187] and anterior 
cruciate ligament reconstruction [188] and been shown to correlate well with 
other outcome measures. Participants will be asked: 
1. “How would you rate your knee today as a percentage of normal on a 
scale of 0% to 100%?” with 100% being defined as having no problems 
at all with the knee. (at 0, 6 and 12 weeks) 
2. “On a scale of 0 (not at all) to 100% (totally recovered), how well do 
you feel you have recovered from your knee pain?” (at 6 and 12 
weeks) 
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Patient acceptable symptom state (6 & 12 weeks) 
Patient acceptable symptom state is defined as the highest level of symptom 
beyond which patients consider themselves well. [189] Patient acceptable 
symptom state has been used in musculoskeletal and rheumatic conditions 
and shown to provide information about a patient’s improvement exceeding 
the minimally clinically important improvement. [189-191] Participants will be 
asked to answer yes or no to a structured question: “Is your current condition 
satisfactory, when you take your general functioning and your current pain 
into consideration?” 
 
Perception of success and willingness to recommend the treatment (6 & 12 
weeks) 
Participants will be asked to answer yes or no to two questions in regard to 
their perception of the success of their treatment 
1. “Overall, would you agree that the treatment you have received has 
been successful for your knee pain?” 
2. “If a good friend has the same knee pain as you, would you 
recommend the same treatment you received?” 
 
Patient satisfaction (6 & 12 weeks) 
Participants will be asked two questions in regard to the satisfaction of their 
treatment with a selection of five possible responses (very satisfied, 
somewhat satisfied, neither satisfied not dissatisfied, somewhat dissatisfied, 
very dissatisfied). The questions will be: 
1. “Over the course of treatment for your knee pain, how satisfied were 
you with your overall treatment?” 
2. “If you had to live with the symptoms you have right now, how would 
you feel about it?” 
 
Numerical pain rating scale (0, 6 & 12 weeks) 
The numerical pain rating scale (NPRS) can be a verbal or visual scale to 
grade the intensity of pain experienced by the participant and is 
recommended for research purposes. [192] Participants will be asked to 
indicate a score that best represents the intensity of their knee pain on an 11-
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point scale where 0 represents no pain and 10 represents worst pain 
imaginable. Participants will provide two ratings; their average pain over the 
previous seven days and their worst pain over the previous seven days. An 
improvement of ≥ 2 on the NPRS indicates clinically meaningful change. [193, 
194]  
 
Patient specific functional scale (0, 6 & 12 weeks) 
Participants will self-select up to five tasks or activities that are impaired due 
to their symptoms. Participants will then rate the level of impairment of each 
task/activity on an 11-point scale from 0 (“unable to perform activity”) to 10 
(“able to perform activity at same level as before the injury or problem”).  The 
patient specific functional scale is a reliable and valid tool that is sensitive to 
changes in patient’s symptoms. [195] [196] It has been reported that a change 
of three or more on an individual patient-nominated activity indicates a true 
change in functional capacity. [196]  
 
Kujala Patellofemoral Scale (0, 6 & 12 weeks) 
This questionnaire comprises 13 items designed specifically for PFP. 
Categories within the questionnaire cover a range of knee functions under 
varying loads. Participants select a response to each of the 13 items that best 
depicts their symptoms. Each item is weighted separately and then summed 
overall, with the highest possible score of 100 points representing pain free 
full function and 0 representing total incapacity. This questionnaire has been 
recommended for knee pain because it is reliable and sensitive to changes in 
symptoms. [197-199] A change of 10 points is considered as the minimum 
clinically important difference [198] in patients with PFP. 
 
Knee injury and osteoarthritis outcome scale (KOOS) (0, 6 & 12 weeks) 
This questionnaire is comprised of five separate subscales that assess the 
patient’s opinion of their knee and symptoms. The subscales cover pain, 
symptoms, activities of daily living function, sporting and recreation function 
and quality of life. Each subscale consists of standardized answers (five Likert 
boxes), with each question scored 0-4 separately. The questionnaire will be 
scored according to the 2012 KOOS scoring manual. Participants select a 
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response to each question in each subscale that best depicts their symptoms. 
Each subscale will be normalised to a scale of 0-100 (0 = extreme problems, 
100= no problems). A change of 8-10 points is suggested to represent a 
clinically significant change in symptoms. [200] 
 
Hospital anxiety and depression scale (HADS) (0, 6 & 12 weeks) 
This 14-item scale will be used to investigate emotional states of those with 
PFP. It has been found to be a reliable instrument for detection of anxiety and 
depression in an outpatient setting and a valid indicator of severity. [201, 202] 
Participants are required to select the best of four responses to questions 
pertaining to either anxiety or depression (seven questions each), which are 
scored from 0–3. The scores for the anxiety and depression questions are 
summed separately to give total scores for each component, where 0–7 
represents no anxiety or depression, 8–10 is borderline, and 11–21 indicates 
the presence of an anxious or depressive state.  
 
Euro-Qol™ (EQ-5D 3L version) (0, 6 & 12 weeks) 
This validated questionnaire is used as a measure of health outcome and 
provides a simple descriptive profile and a single index value for health status. 
It compromises of five domains about mobility, usual activities, selfcare, pain 
and discomfort, and anxiety or depression. [203] Participants will be asked to 
rate their impairment on each domain (none, moderate or severe problems). 
Each health state is scored (1-3) and transformed into an index score. This 
score is used to derive quality-adjusted life years as an outcome measure and 
is one of the most commonly used economic evaluations used to inform 
decisions in health care. [204] The participant scores their overall health on a 
0 to 100 scale, where 100 represents complete health and well-being. [203] 
 
Tampa scale for kinesophobia (TSK) (0, 6 & 12 weeks) 
The TSK is a 17-item questionnaire aimed at assessing fear of reinjury due to 
physical movement. [205] Each item is scored on a 4-point Likert scale that 
ranges from strongly disagree (1) to strongly agree (4). The inverse scores 
from items 4, 8, 12, and 16 are used to calculate the total score. Total TSK 
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scores range between 17 and 68, with higher scores suggestive of higher 
levels of fear of physical movement and vulnerability. 
 
Pain Catastrophising Scale (PCS) (0, 6 & 12 weeks) 
The PCS is a 13-item valid and reliable questionnaire that evaluates a 
participant’s level of pain catastrophic thinking, and classifying this into levels 
of rumination, magnification and helplessness. [206] Participants are asked to 
reflect on past painful experiences, and to indicate the degree to which they 
experienced certain thoughts or feelings when experiencing pain, on 5-point 
scales from not at all (0) to all the time (4). The PCS yields a total score and 
three subscale scores for rumination, magnification and helplessness 
respectively. The total score ranges from 0 – 52, with higher scores indicating 
higher levels of pain catastrophization.  
 
Functional tests: Step down, step up and squat (0, 6 & 12 weeks) 
These functional tests are commonly reported as aggravating activities by 
patients with PFP because they load the patellofemoral joint and have been 
previously used in clinical trials. [92] Repeated step testing will be performed 
on a single 25 cm step in time with a metronome set at 96 beats per minute 
(e.g., stepping up/ down on each beat). Repeated squats will be performed in 
time with a metronome set to 96 beats per minutes feet shoulder width apart, 
squatting down in two beats, until the participant can touch both lateral 
malleoli with their fingers, and standing up over two beats.  Activities will be 
stopped when either a) onset of symptoms occurs, or b) there is an increase 
in existing symptoms or c) when a maximum of 25 repetitions has been 
reached without the onset of pain. 
 
5.3.3 Physical measurements 
An examiner at each trial site, who is blinded to treatment allocation and 
midfoot width mobility stratification, will collect self-reported questionnaires 
(i.e., pain scores, Kujala Patellofemoral Scale, etc.), physical measurements 
and demographic data prior to commencement of the intervention and at 
follow-up. Physical measurements will include foot posture measurements, 
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ankle, hip and first metatarsophalangeal range of motion measurements and 
maximal isometric hip strength testing. These measures will be used in post-
hoc analyses of prognostication and identification of other possible candidates 
for treatment effect modifiers. 
 
Midfoot width and height mobility: 
Measurement of the width and height at the midfoot (i.e. 50% of total foot 
length) has been previously described and demonstrated to be reliable. [76] In 
brief, these measurements are performed on a foot measurement platform 
that can standardize foot position by placing heels 15.24 cm apart with the 
first metatarsal heads against a guide with body weight equally distributed on 
both feet.  
 
Midfoot width in weight bearing is measured using a digital caliper with extend 
arms, which are positioned perpendicular to the sole of foot and adjacent to 
lateral and medial aspect of the foot at the 50% length (Figure 5.6A). This is 
repeated in non-weight bearing with the patient seated on a height adjustable 
table and legs hanging freely (Figure 5.6B). Midfoot height (dorsal arch 
height) measurements at 50% of the total foot length in weight bearing 
(bipedal stance) and minimal weight bearing postures will also be taken 
(Figure 5.7). [76] To measure the arch height in a minimal weight bearing 
posture, the participant sits on a height adjustable plinth with their feet 
hanging freely. The assessment platform is positioned under both feet and the 
plinth is lowered until the point of the heel being assessed just contacts the 
platform. The vertical height of the arch is then measured. 
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Figure 5.6A Midfoot width measured in weight bearing 
 
 
Figure 5.6B Midfoot width measured in non-weight bearing 
 
 
Figure 5.7 Midfoot arch height measurement 
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The height and width measurements of each foot in weight bearing and non 
(or minimal) weight bearing will be recorded separately three times and then 
averaged to give a single value for the analysis. The change in midfoot height 
and width is calculated by subtracting the measures in the two weight bearing 
conditions.  
 
Navicular drop: 
The participant stands barefoot with equal weight on both feet. The navicular 
tuberosity will be identified using palpation and the most prominent point 
marked using a water-soluble ink pen. With the patient standing in subtalar 
joint neutral position (defined by palpation of the talus in the mortise and 
scored ‘0’ on the foot posture index [207]), the height of the navicular 
tuberosity will be measured using a clear angle ruler. The participant is 
instructed to relax their feet and the navicular tuberosity height is re-
measured. The difference in height measurements between a subtalar joint 
neutral and relaxed foot position will be calculated to determine the amount of 
navicular drop. [74, 152, 208, 209] 
 
The Foot Posture Index (FPI-6)  
Relaxed foot posture will be assessed using the FPI-6, which consists of six 
criteria: 1) talar head palpation, 2) curves above and below the lateral 
malleoli, 3) inversion/eversion of the calcaneus, 4) bulge in the region of the 
talonavicular joint, 5) congruence of the medial longitudinal arch and 6) 
abduction/adduction of the forefoot on the rearfoot [207]. Each criterion is 
examined and scored on a 5-point scale between –2 and +2, which are then 
totaled to categorize the foot as being highly pronated, pronated, normal, 
supinated, or highly supinated. [207] Intrarater reliability has been reported to 
be very good with interrater reliability being only moderate between three 
raters. [210] [211] 
 
Weight bearing bent knee ankle dorsiflexion (Lunge Ankle Dorsiflexion Device 
- LAD) 
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Bent knee ankle dorsiflexion will be measured using a bespoke device, the 
Lunge Ankle Dorsiflexion measurement device (LAD). The LAD device has 
been previously described. [212] In brief, the LAD was designed with only one 
degree of freedom of motion in the sagittal plane. The patient’s foot is aligned 
in a sagittal plane with a line that bisects the 2nd and 3rd phalanges and the 
midline of the posterior calcaneus. Whilst maintaining the toe in light contact 
with the front of the reference block, the participant slowly lunges forward, 
with the knee in contact with a mobile measurement indicator. The therapist 
focuses on ensuring that the three points remain in the sagittal plane by 
watching for heel drift (usually medially) and heel lift, which indicates that full 
dorsiflexion has been reached. The linear measurement of horizontal distance 
between anterior knee and the fixed reference block at the longest toe is read 
from a ruler (mm). 
 
Hip Strength 
Strength of the hip abductors, adductors and external rotators will be 
measured at baseline, 6 and 12 weeks as dysfunction in these muscle groups 
has been identified as a common impairment within the PFP population, [213-
215] and will be used in post hoc exploratory prognostic analyses. Force 
produced during a maximal voluntary isometric contraction (MVIC) will be 
measured with a hand held dynamometer (Nicholas, Lafayette, IN47903, 
USA) Measurements will take place in supine to minimize the effect of gravity 
during testing and compensatory contractions. [216] Each participant will 
complete two practice contractions (50% MVIC followed by 100% MVIC) 
followed by three experimental MVICs where the participant will be asked to 
contract maximally for 5 s. Participants will have a 30 s rest between each 
contraction. The peak force (Newtons) will be recorded for each contraction 
and converted to torque (using the distance between the point or rotation and 
placement of dynamometer as the lever arm) standardized to body mass 
(Nm/kg). Hip abductor and hip adductor muscle strength will be tested using a 
dynamometer 5 cm proximal to the lateral and medial malleolus respectively, 
and stabilised by a rigid belt. The test leg will be extended in 0° abduction and 
0° flexion, with the non-test hip and knee flexed (Figure 5.8). Hip external 
rotation will be measured in supine with the hips in 30° of flexion with the 
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dynamometer 5 cm proximal to the medial malleolus, stabilised in a solid 
bracket, fixated to the testing device (Figure 5.9). This testing position was 
chosen because it: corresponds to biomechanical data on muscular actions of 
the external rotators in various degrees of hip flexion (i.e., piriformis being an 
external rotator muscle at 0° flexion and functionally switch rotation action to 
internal rotation at >60° hip flexion); [217, 218] replicates the position of 
exercise in the hip intervention protocol [180]; and approximates the degrees 
of hip flexion relative to the pelvis during foot contact/ limb loading in the initial 
stance phase of gait. [219-221]  
 
Figure 5.8 Hip abduction strength testing 
 
 
Figure 5.9 Hip external rotation strength testing in 30° hip flexion 
 
Limb length for the hip abductor and adductor measurements, will be 
measured from the participant’s anterior superior iliac spine to a mark 5 cm 
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proximal from the lateral and medial malleolus, respectively. For hip external 
rotation, distance will be measured from the medial joint line to a mark 5 cm 
proximal to the medial malleoli. Participants will be instructed to hold the sides 
of the plinth for stabilization and receive a standard verbal encouragement 
with consistent level of volume and enthusiasm. 
 
Hip Range of Motion 
Passive hip internal and external rotation range of motion will be measured in 
upright sitting, arms crossed, knees flexed to 90° over the edge of the plinth 
and the non-test leg stabilised by a rigid belt. The hip will be passively rotated 
to the point of resistance with no compensatory pelvic motion. Range will be 
measured using a plurimeter placed 5 cm proximal to the tip of the tibial 
malleoli on the medial border of the tibia for external rotation, and 5 cm 
proximal to the tip of the lateral malleoli to measure internal rotation (Figure 
5.10). 
 
 
Figure 5.10 Hip internal and external range of motion measuring 
 
5.4 Demographic and other information 
Other baseline measurements to be collected will include age, sex, height, 
weight, body mass index (BMI), unilateral and bilateral symptoms, duration of 
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symptoms, use of medications, physical activity levels, joint mobility using the 
Beighton and Horan Joint Mobility Index [207, 210] and reported crepitus 
during daily living activities.  
 
5.5 Participant timeline 
Volunteers will be recruited into the study through a structured process 
involving a comprehensive advertising campaign followed by verbal and 
physical examination screening of eligibility by a registered physiotherapist. 
Participants who meet the eligibility criteria will be offered enrolment into the 
study, complete consent forms then undergo baseline measurements and 
randomly allocated to an intervention (Figure 5.11). Participants with bilateral 
symptoms will nominate their most symptomatic knee to be used in analysis. 
The timeline for events (e.g., outcome measure timepoints and close out) are 
shown in appendix 10. 
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Figure 5.11 Proposed flowchart of participants through trial (CONSORT) 
 
5.6 Sample size 
Sample size was based on proportions of patients rating themselves as 
“better” or “much better” on the Global Rating of Change (GROC) score in the 
foot orthoses and hip exercise treatment groups. The primary aim of the study 
is to determine whether midfoot width mobility is a treatment effect modifier for 
foot orthoses when compared to progressive resisted hip exercises. This 
requires testing for an interaction between midfoot width mobility, 
dichotomised as high (≥11 mm) or low (<11 mm), and treatment group. Based 
on previous findings, which indicated a strong effect of foot orthoses in 
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patients with PFP who had a midfoot mobility ≥11mm, [142] we wanted to be 
able to detect an interaction effect of 50 percentage points. This means that 
the difference between the foot orthoses and hip exercise groups in the 
proportions of participants who are improved at 12 weeks will be 50 
percentage points higher (favoring foot orthoses) in participants with high 
midfoot width mobility than in those with low midfoot width mobility. A sample 
of 30 participants (15 per group) who have high midfoot width mobility 
provides 80% power using a two-sided significance level of 0.05 to detect a 
difference between the proportions of participants with improvement of 30% in 
the hip exercises group compared to 80% in the foot orthoses group. 
Assuming that 20% of participants will be in the high midfoot width mobility 
group, we inflated the sample size to 188 participants (94 per group) to 
ensure adequate power to detect this interaction effect of 50 percentage 
points. [222] To allow loss to follow-up of up to 15%, the final sample size was 
220 participants (110 per group).  
 
5.7 Recruitment 
A comprehensive recruitment strategy, successfully utilized in previous clinical 
trials [95, 142] will be used in regions of Brisbane, Australia and Aalborg, 
Denmark. The recruitment strategy involves paid advertisements in local and 
regional newspapers, supplemented by advertisements on university, 
gymnasium and community websites, online social media, electronic and 
paper noticeboards within the catchment area at regular intervals during the 
recruitment period. Further referrals may come from physiotherapists involved 
in the study and general practitioners, through the provision of information and 
advertising packages at their practices. Volunteers who express interest in 
participating will be screened through the previously described two-stage 
screening process to determine eligibility. 
 
5.8 Allocation  
Once informed consent and baseline measurements have been obtained, 
each participant will be randomly allocated to one of two intervention groups 
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via concealed allocation and assigned a participant code. An independent off-
site body will generate a randomization schedule for all participants at both 
the Australian and Danish sites. The randomization schedule will be 
generated by computer and allocate on a 1:1 basis to each of the treatments 
with stratification on the midfoot width mobility measure. 
 
5.9 Data collection and management 
All data will be collected in paper format and subsequently entered into an 
electronic study database. A number of strategies have been employed to 
ensure fidelity of data entry, such as entries will be screened at random by a 
second investigator to ensure entry is correct. The study database has been 
developed in a regulatory approved electronic medical records platform 
(OpenClinica®) by the Clinical Trials and Biostatistics Unit. This database will 
be used to comprehensively collect all safety and efficacy related data, along 
with additional information for possible exploratory analyses. The database 
development, testing, validation and management strictly follow the regulatory 
guidelines for clinical trial data management. All participant data will be 
analysed on an intention-to-treat basis. Once a participant is enrolled, every 
reasonable effort will be made through paper and electronic media to maintain 
contact and follow the participant for the duration of the trial period. It is 
anticipated that the rate of loss-to-follow-up will be at most 10%. Participants 
will be informed they may withdraw from the study at any time, for any reason 
without any consequences. Participants may be withdrawn from the study in 
order to protect their safety (e.g., the foot orthoses intervention is unable to be 
made comfortable to wear) after consulting with the senior investigator (BV)  
 
5.10 Statistical Methods 
A biostatistician who is blind to treatment group allocation and midfoot width 
mobility will conduct analysis. All participants who have missing data and did 
not fully comply with the treatment protocol will be included in analyses. 
Demographic characteristics will be inspected to assess baseline 
comparability of treatment groups and compare those participants who remain 
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in the study and those who withdraw. If the proportion of missing data for 
endpoints exceeds 5%, multiple imputation methodology will be applied. To 
test the hypothesis of interaction between randomised group and foot mobility, 
terms for randomised group and foot mobility group, together with an 
interaction between the two, will be included in models. For the primary 
outcome (dichotomised GROC) and other binary secondary outcomes, binary 
regression models with a logarithmic link will be fit. For other outcomes, linear 
regression models will be fitted, and assumptions will be assessed using 
standard diagnostic plots. To test for an overall treatment effect, regression 
models for outcomes will include terms for randomised group and foot mobility 
(as foot mobility is a stratifying variable). 
 
We will also undertake a secondary analysis to further explore the relationship 
between midfoot width mobility and the outcome, whereby midfoot width 
mobility will be included in the model as a continuous variable, together with 
an interaction term with randomised group. Relationships will be investigated 
using fractional polynomials. [223] We elected to perform this secondary 
analysis because previous studies that identified midfoot width mobility as a 
potential predictor of outcome after foot orthoses used data-dependent 
techniques in relatively small samples to establish a cut-off value for “high” 
midfoot width mobility. The concern with establishing cut-off values with data-
dependent techniques is that, while the cut-off value may have been “optimal” 
for the original sample, this same cut-off value may not be optimal in the 
larger population. [134, 224] 
 
5.11 Monitoring 
A safety committee will be established when the need arises. It is not 
anticipated that a safety committee will need to convene much or at all, 
because the treatments have been previously studied with no reported 
serious adverse events, are common to everyday practice for this condition 
and there is low perceived risk to participants. Participants and the treating 
physiotherapists are instructed to report any adverse effects. Adverse effects 
reported by participants or documented by the physiotherapists during the 
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treatment phases of the trial will be managed and reported (to ethics and 
relevant institutional unit) as per appropriate policies and procedures at the 
relevant site.  
 
5.12 Adverse events 
Participants will be instructed to report any adverse events to the treating 
physiotherapists, and/or the trial investigators. Adverse effects reported by 
participants or treating physiotherapists during the treatment phases of the 
trial will be recorded, managed and reported (to ethics and relevant 
institutional unit) as per appropriate policies and procedures at the relevant 
site immediately. Appropriate follow up health and medical care will be 
recommended should it be required for any adverse event. All cases of 
adverse events will be followed up to ensure resolution. 
 
5.13 Discussion 
The primary aim of this trial is to determine whether midfoot width mobility is a 
treatment effect modifier for foot orthoses compared to hip exercises. The 
ability to confidently predict a preferential response to any physical treatment 
for PFP, such as foot orthoses, has proven elusive to date and has at times 
been somewhat contentious. [164, 172, 225] Follow up analyses of previous 
work in our research unit [95, 142] on two different samples of participants 
with PFP has revealed that a reliable and easily administered measure of 
midfoot width mobility might predict those who will report a successful 
outcome after receiving foot orthoses. For example, a randomized clinical trial 
reported a success rate of 78% (7 of 9 cases) with foot orthoses in patients 
with PFP who had high midfoot width mobility compared to only a 20% 
success rate (2 of 10 cases) in those who had low midfoot width mobility. 
[142] Methods for defining a successful outcome and categorizing midfoot 
width mobility were similar to those being used in this current protocol. A 
successful outcome was unlikely to be related to natural history because only 
5% (1/20) of the participants in the wait-and-see group had a successful 
outcome. A significant limitation of these data is that single group analyses 
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were used. [172] Absence of a comparison group in the analysis means it is 
not possible to differentiate predictors of the general course of the condition 
regardless of treatment (i.e. prognostic factors) from predictors of outcome to 
a specific treatment (i.e. treatment effect modifiers). [125] 
 
The design of the FOHX trial allows for robust testing of midfoot width mobility 
as a treatment effect modifier for foot orthoses compared to progressive 
resisted hip exercises in individuals who have PFP. It will first test if midfoot 
width mobility of ≥11 mm, which was defined on the basis of our previous 
work [142] will predict a preferential response to foot orthoses versus hip 
exercises. Given that this previous work was based on small sample sizes, we 
will also conduct a secondary analysis, in which midfoot width mobility will be 
treated as a continuous level measure to ensure that we have fully evaluated 
the hypothesis that midfoot width mobility is a treatment effect modifier. If the 
hypothesis is confirmed, then midfoot width mobility could help clinicians tailor 
treatment for patients who have PFP. 
 
Apart from our previous research suggesting that midfoot width mobility may 
be predictive of a success following treatment with foot orthoses, there is 
prima facie evidence to support that foot orthoses will be more successful 
when the patient has a mobile foot. Distal to the knee, abnormal foot 
pronation has been hypothesised to induce adverse lower limb kinematic 
motions, which are associated with excessive load at the patellofemoral joint 
[226, 227]. Foot orthoses have a mechanical effect on foot pronation [96], so it 
is plausible that foot orthoses might have a mechanical effect on the 
patellofemoral joint [228-230] Interestingly, a modeling study of foot orthoses 
on patellofemoral joint load indicated that while there was a significant effect, 
there was considerable inter-individual variation in the response [228] which 
further underpins the need to determine whether midfoot width mobility is a 
treatment effect modifier for foot orthoses. There is also a growing body of 
evidence that supports the efficacy of foot orthoses for people with PFP [92, 
142, 231] but these clinical trials did not specifically examine if the foot 
orthoses were most useful in patients with mobile feet. 
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The head-to-head comparison between treatments that target regions distal 
and proximal to the patellofemoral joint has not been done, making the clinical 
trial outlined in this protocol novel. Proximal to the knee, neuromuscular 
dysfunctions at the hip and pelvis have been hypothesised to impact upon the 
patellofemoral joint kinematics. [227, 232, 233] Evidence suggests weakness 
of the postero-lateral hip musculature in primarily the hip abductor and 
external rotator muscle groups as a common impairment in those with PFP. 
[213, 214, 234, 235] Clinical trials that have compared isolated postero-lateral 
hip musculature exercises to no exercises or as part of a rehabilitative 
program have reported beneficial outcomes for patients who have PFP. [94, 
98, 102, 105, 168, 180] This evidence supports exercises targeting the 
posterolateral hip musculature as a viable treatment option for those with 
PFP, and an appropriate comparator treatment option in this trial. 
 
This trial protocol aims to minimise potential biases, optimise methodological 
quality and report pragmatic clinical findings by addressing key 
methodological limitations of previous studies that have aimed to investigate 
treatment effect modifiers for PFP. Key strengths of the trial include: (i) 
randomization of participants according to a schedule that will be generated 
by an independent body, (ii) enrollment based on pre-determined criteria by 
registered physiotherapists and independent of treatment allocation, (iii) 
participant stratification into pre-determined subgroups based on preliminary 
data, (iv) blinding of participants, assessors and therapists to critical 
information (e.g., trial hypothesis, stratification status, treatment allocation, 
baseline and follow-up outcome measures), (v) head-to-head comparison of 
two efficacious treatments for PFP, (vi) sufficiently powered sample size to 
detect a significant and substantial effect of midfoot width mobility as a 
treatment effect modifier for foot orthoses, (vii) blinded analysis using a pre-
determined statistical analysis plan, and (viii) conducting a pre-specified 
secondary analysis to further evaluate midfoot width mobility as a treatment 
effect modifier for foot orthoses when it is a continuous variable. The findings 
from this trial will be reported in accordance to the CONSORT statement [174] 
and widely disseminated. 
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5.14 Conclusion 
In conclusion, this trial sets out to address two contentious issues that 
confront clinicians who treat patients with PFP. One looks to assist the 
clinician in determining who is likely to have a preferential response to foot 
orthoses treatment, compared to hip exercises, by testing if a simple, clinically 
applicable measurement of midfoot width mobility can be used to predict a 
better outcome. The second is to assist in optimising the management of PFP 
by comparing hip exercises to the use of foot orthoses.  
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Chapter 6. Management of patellofemoral pain: A randomised 
clinical trial comparing foot orthoses versus hip exercises to 
determine if greater foot mobility is associated with a better 
outcome to foot orthoses  
 
The results from the systematic review (chapter 4) provided preliminary 
evidence for the research aims and design of the randomised clinical trial 
(chapter 5). This chapter covers the implementation and results of the trial to 
address the previously mentioned aims. Those aims were to: (i) evaluate 
midfoot width mobility as a treatment effect modifier for foot orthoses 
treatment, when compared to hip exercises, and (ii) compare the treatment 
superiority between foot orthoses and hip exercises at 12 weeks, irrespective 
of midfoot mobility.  
 
6.1 Introduction  
Persistent pain affects approximately 126 million people in the United States, 
costs over $560 billion annually and severely affects the quality of life of the 
individual [236, 237]. One such recalcitrant pain condition is patellofemoral 
pain (PFP). The prevalence of PFP is between 23 and 29% in the population 
[238]. It is associated with a high risk of long-term pain, as one in two will 
continue to suffer after 5-8 years [239]. Evidence suggests PFP could be one 
of the earliest manifestations of patellofemoral joint osteoarthritis [240]. The 
aetiology of PFP remains unknown, but is considered multifactorial with a 
combination of underlying biomechanical, neuromuscular and/or 
psychological contributors [44, 241, 242]. Patellofemoral pain is a clinical 
diagnosis based on a typical presentation of pain around or behind the patella 
during daily activities such as negotiating stairs, squatting or sitting [4].  
 
Systematic reviews [243, 244] and international consensus [181] recommend 
foot orthoses [92, 245] and hip exercises [94, 180] in the management of 
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PFP, yet the quandary is how to best match these treatments to individual 
patients to ensure optimal outcomes [86]. Evidence suggests that greater 
mobility of the midfoot (defined as a change of 11mm or more in midfoot width 
when moving from non-weight bearing to weight bearing [76]), is associated 
with better outcomes following foot orthoses [95, 142]. Crucially, lack of a 
comparator treatment and potential over-fitting of models for outcomes may 
have created spurious findings, compromising their clinical applicability [125, 
243]. Further investigation is needed to examine if a simple clinical 
measurement of the foot [76] can be used to determine which treatment, (e.g. 
foot orthoses or hip exercises) the patient will benefit from the most. 
 
The aims of this trial were to: (i) evaluate if greater midfoot width mobility is 
associated with a better outcome following treatment with foot orthoses when 
compared to hip exercises, and (ii) compare the treatment effectiveness 
between foot orthoses and hip exercises at 12 weeks, irrespective of midfoot 
mobility, in the management those with PFP. The hypotheses were that (i) 
those with greater midfoot width mobility will have greater benefit with foot 
orthoses, compared to hip exercises, and (ii) those that receive hip exercises 
will report greater successful outcomes, than those who receive foot orthoses.   
 
6.2 Methods 
6.2.1 Study Design 
A two-arm parallel, multi-centre randomised superiority clinical trial was 
conducted in a community setting in Brisbane, Australia, and hospital 
outpatient department in Aalborg, Denmark. The trial was prospectively 
registered (ACTRN12614000260628) and the protocol published elsewhere 
[246]. The trial adhered to the principles of the Declaration of Helsinki [247] 
with ethical approval granted by the University of Queensland Medical 
Research Ethics Committee (2013000981) (appendix 11) and the ethics 
committee in the North Denmark Region (N-20140022). The trial was 
conducted in agreement with the registration and more specifically the 
published protocol [246], with the exception that the patient specific functional 
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scale and international physical activity questionnaire were not analyzed. The 
reporting of this clinical trial follows the CONSORT statement and TIDieR for 
describing interventions [174-176]. 
 
6.2.2 Participants  
Volunteers from Brisbane, Australia and Aalborg, Denmark responded to 
advertisements or were referred by health care practitioners. Inclusion criteria 
were: age 18-40 years; insidious onset of anterior, retro or peri-patellar pain 
aggravated by at least two activities (e.g. stair ambulation, squatting, 
jogging/running); reported worst pain of at least 3 out of 10 on a numerical 
pain rating scale (10 representing worse pain imaginable) over the last 7 
days; greater than six weeks’ duration and tenderness on palpation of the 
patellar borders with reproduction of pain completing a step down or double 
leg squat. Participants were excluded if they reported traumatic onset of 
symptoms; concomitant injuries or pain from the hip, lumbar spine, or other 
knee structures that manifested with similar symptoms; patellar dislocation or 
instability; previous knee surgery; evidence of knee joint effusion; any foot 
condition that precluded use of foot orthoses; the use of anti-inflammatory 
drugs or corticosteroid medication; or previous treatment for PFP that 
included foot orthoses or hip exercises. Eligible participants were required to 
have comprehension of written and spoken English (Brisbane, Australia) or 
Danish (Aalborg, Denmark). 
 
6.2.3 Stratification  
Midfoot width mobility at baseline was defined as the difference between non-
weight bearing and weight bearing measurements of the width of the 
participant’s midfoot (defined as 50% of total foot length) [76]. This 
measurement is highly reliable (inter-rater ICC>0.83, intra-rater ICC >0.97) 
[76]. Stratification occurred using a pre-determined cutoff for midfoot width 
mobility of 11mm [95, 142]; those who presented with equal to, or greater than 
11mm midfoot width mobility were defined as ‘high mobility’ and those with 
less than 11mm as ‘low mobility’ [246].  
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6.2.4 Randomisation and blinding 
An independent off-site body generated a randomisation schedule by 
computer for all participants at both the Australian and Danish sites before 
trial initiation. They were sent to the two study sites and kept in a locked 
cabinet. Allocation to each treatment via sealed and opaque envelopes was 
done in a 1:1 ratio using random permuted blocks of sizes 8 to 16; with 
stratification by midfoot width mobility and site (Brisbane or Aalborg). A 
researcher determined eligibility and collected all baseline measurements, 
except midfoot width mobility status. A separate researcher, blind to all 
baseline information, measured each participant’s midfoot width prior to 
allocation to one of the treatments. Randomisation occurred once participants 
were stratified on midfoot width mobility. A separate researcher 
communicated with the randomisation centre, trial participants, and 
physiotherapists and sites. The outcome assessor was blind to treatment 
allocation and midfoot width mobility status. Physiotherapists were kept blind 
to the participant’s stratification and study hypothesis. Participants were 
informed the study involved two evidence-based treatments (foot orthoses or 
hip exercises) but were kept blind to midfoot width mobility status and study 
hypothesis. 
 
6.2.5 Interventions 
Registered physiotherapists completed pre-trial familiarisation sessions prior 
to applying both interventions [246]. Prescription of foot orthoses followed the 
protocol utilised in a previous randomised clinical trial [92].The hip exercises 
replicated those from a previous randomised clinical trial [180], and their 
efficacy has been supported in subsequent trials [94, 180]. 
 
6.2.5.1 Foot orthoses 
Physiotherapists fitted commercially available prefabricated foot orthoses 
(Vionics International, Australia) and a pair of orthosis-like contoured sandals 
[179]. Physiotherapists followed a standardised fitting process that prioritised 
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comfort [178], with scope to review size, length and hardness [246]. 
Participants performed a home exercise program twice per day, consisting of 
calf stretches and anti-pronation foot exercises, aimed to improve foot 
awareness. No instructions were given with regards to continuing or 
discontinuing foot orthoses after the six sessions. 
 
6.2.5.2 Hip exercises  
The hip exercise protocol followed recommended guidelines [182]. Full details 
of the exercise protocol are previously published [246]. Progressive, resisted 
hip exercises were performed bilaterally and focused on the hip abductor, 
external rotator, and hip extensor muscle groups in side lying, supine and 
standing. Participants attended a physiotherapist-supervised one-on-one 
exercise session, three times per week for four weeks (12 sessions total). 
Physiotherapists selected predetermined lengths and grade of elasticated 
band at each session, which provided sufficient resistance for participants to 
achieve a maximum of 10 repetitions and perceived exertion of 5 to 7/10 
(Hard to Very hard) per exercise. No instructions were given with regards to 
continuing or discontinuing hip exercises after the 12 sessions.  
 
6.2.6 Primary outcome 
The primary outcome measure was a 7-point Likert global rating of change 
(GROC) scale with categories of much better, better, a little better, no change, 
a little worse, worse or much worse. This measure has been previously 
utilised in similar trials on PFP [92, 93]. A successful outcome was a-priori 
defined as being much better or better at the primary time point of interest at 
12 weeks. 
6.2.7 Secondary outcomes  
Secondary participant rated outcomes included the single assessment 
numeric evaluation (SANE) to rate the normality of their knee and their 
recovery out of 100% (100% being defined as having no problems at all and 
fully recovered respectively), patient acceptable symptom state (PASS) by 
answering if their current condition was satisfactory (yes/no), perception of 
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success by answering if they agreed their treatment was successful (yes/no) 
Kujala anterior knee pain scale, knee injury and osteoarthritis outcome scale 
(KOOS) , numerical rating of pain severity over the last seven days, hospital 
anxiety and depression scale , Euro-Qol™ (EQ-5D) , kinesiophobia , and pain 
catastrophising [246]. Physical performance tests included hip strength 
measures and a step up and step down task (25cm step), and squatting to a 
metronome set to 96 beats per minute [246]. 
 
6.2.8 Statistical analysis 
Sample size calculations were based on proportions of patients in each group 
rating themselves as “much better” or “better” on the GROC score. The 
primary aim was to detect an interaction effect of 50 percentage points 
between midfoot mobility stratum and treatment group. This would mean that 
a treatment effect favoring foot orthoses (the difference between the foot 
orthoses and hip exercise groups in the proportions of participants who had 
successful outcomes at 12 weeks) was 50 percentage points higher in 
participants with high mobility than in those with low mobility. Assuming that: 
(i) in participants with high mobility, 80% would have successful outcomes 
with foot orthoses compared to 30% with hip exercises, (ii) 20% of participants 
would have high mobility (based on previous data [142]), and (iii) loss to 
follow-up would be up to 15%, 220 participants (110 per group) were required 
to have 80% power to detect the aforementioned interaction effect using a 
two-sided significance level of 0.05 [222, 246].  
 
A statistical analysis plan was published prior to analysis and is available on 
request (https://espace.library.uq.edu.au/view/UQ:623536) (appendix 14). A 
biostatistician blinded to group allocation conducted all analyses. 
Characteristics of treatment groups were summarised as mean (standard 
deviation) for continuous variables and as count (percentage) for categorical 
variables. Data were analysed on an intention to treat basis using Stata v14.1 
(StataCorp), including all randomised participants in their assigned group. 
Missing baseline variables were imputed using single mean imputation [248]. 
Estimates from 20 imputed datasets were combined using Rubin’s rules [249]. 
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Datasets were imputed using chained equations, with predictive mean 
matching from the three nearest neighbours for continuous outcomes and 
logistic regression for binary outcomes. Imputation was done separately for 
each treatment arm, including a range of variables in the imputation models. 
For dichotomous outcomes, binary regression models with a logarithmic link 
were fitted using generalised estimating equations with an exchangeable 
working correlation matrix to account for the two follow-up measurements per 
participant (at 6 and 12 weeks). That is, baseline measures were not included 
as outcomes in the models. Models included a three-way interaction between 
treatment group, midfoot mobility stratum, and follow-up visit number (1 or 2), 
all two-way interactions, main effects, and a term for country (Australia or 
Denmark). The relative risk (RR) comparing treatment groups in each midfoot 
mobility by time stratum was calculated with 95% confidence intervals. To 
compare outcomes between treatment groups, similar models including only a 
main effect for midfoot mobility were fitted. Similar models for continuous 
outcomes were fitted, again using generalised estimating equations, 
additionally including a term for the baseline level of the outcome.  
 
6.2.9 Patient involvement 
Patient representatives were engaged in the development stages of the study. 
Prior to providing consent, all participants were informed of the study 
requirements, asked if they were willing to undergo their allocated 
intervention, and informed they will be emailed the final results. 
 
6.3 Results 
6.3.1 Participants 
Between June 2014 to April 2017, 220 participants enrolled in the study. Two 
non-randomised cases were erroneously included and were removed when 
identified as such after close out, resulting in 218 participants (138 in 
Australia, 80 in Denmark). Forty-nine (22%) participants were classified as 
high mobility and 169 (78%) as low mobility (Figure 6.1). Treatment groups 
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and treatment-by-mobility groups were well matched at baseline (appendix 
15). One participant in the low mobility foot orthoses group received hip 
exercises incorrectly. Participants who did not provide a GROC score were 
deemed to have been lost to follow-up. There were 197 (90%) participants 
followed up at 6 weeks and 192 (88%) at 12 weeks.  
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 Figure 6.1 CONSORT Flow of participants through the study 
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6.3.2 Adherence: 
Ten participants did not attend any of their allocated treatment sessions (n=3 
foot orthoses, n=7 hip exercises). Participants allocated to foot orthoses 
attended on average 5.5/6 (92%, (1-6)) of the sessions and reported to have 
worn their foot orthoses for 74% of waking hours. Participants allocated to hip 
exercises attended on average 10.1/12 (84%, (1-12)) of their sessions.  
 
6.3.3 Effect of midfoot width on success rates 
There was no difference in success rates following foot orthoses or hip 
exercises in either the high (29% v 45% respectively) or low midfoot mobility 
(53% v 51% respectively) strata at 12 weeks (interaction P=0.19) (Figure 6.2, 
Table 6.1). A secondary analysis including midfoot width mobility as a 
continuous interval measure showed similar results (P-value 0.66, Appendix 
16). There was no evidence of any significant interactions between treatments 
and midfoot mobility strata in any of the secondary outcome measures 
(Appendix 16).   
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Figure 6.2 Percentage and number of participants rating perceived global change across categories from much better to much 
worse  
Figure	2:	Percentage	(and	number)	of	participants	rating	perceived	global	change	across	categories	from	much	better	to	much	worse	
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Table 6.1 Treatment outcomes for hip exercises versus foot orthoses at 12 
weeks, grouped according to midfoot width mobility stratification  
(treatment by foot mobility strata interaction p value = 0.19). 
 
Midfoot Width 
Mobility 
Hip Exercises 
(successful+/total 
(%))* 
Foot orthoses 
(successful+/total 
(%))* 
Foot orthoses vs Hip exercises^ 
Relative Risk 
(95% CI) 
P-value 
High (≥11 mm) 9/20 (45.00) 6/21 (28.57) 0.58 (0.26, 1.32) 0.20 
Low (<11 mm) 37/72 (51.39) 42/79 (53.16) 1.02 (0.76, 1.36) 0.91 
All 46/92 (50.00) 48/100 (48.00) 0.94 (0.72, 1.24) 0.67 
 
+ successful defined as much better or better on GROC, * frequency counts 
are complete-cases, ^ point estimates (Relative Risk) are based on multiply 
imputed data  
 
6.3.4 Foot orthoses versus hip exercises   
There was no difference in success rates between patients randomised to foot 
orthoses (48%) or hip exercises (50%) (RR 0.94, 95% CI (0.72 to 1.24)) Table 
6.1). Although there appeared to be small p-values favoring hip exercises 
versus foot orthoses at 12 weeks on three KOOS subscales (symptoms (75.8 
vs. 71.7, coefficient -2.92 (-5.52 to -0.32), p=0.028), pain (80.7 vs. 76.4, 
coefficient -4.09 (-7.63 to -0.55), p=0.023) and daily living (88.6 vs. 84.9, 
coefficient -3.37 (-6.54 to -0.20), p=0.037)), the clinical significance of these 
findings are questionable. There was no evidence of any differences between 
groups with respect to the other 22 secondary outcome measures (Appendix 
17). 
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6.3.5 Co-interventions 
Two participants reported undertaking additional treatments. One participant 
from the low mobility-foot orthoses group commenced yoga between the 6 
and 12-week follow-up sessions, and another used knee wraps while 
exercising with heavy weights.  
 
6.3.6 Adverse events  
Fourteen participants allocated to foot orthoses (14/109, 13%) reported 
temporary toe and/or foot discomfort (n=7) or rubbing/ blistering (n=7) of the 
skin. Five participants allocated to hip exercises (5/109, 5%) reported 
increased discomfort in the hip region after exercises. No adverse events 
prevented participants from continuing treatment.   
 
6.4 Discussion  
There was no moderating effect of foot mobility on treatment effects 
The results do not support the hypothesis that greater midfoot width mobility, 
as a cut-off (≥11mm) or as a continuous measurement, as a treatment effect 
modifier for prescribing foot orthoses over hip exercises. There was no 
evidence to indicate hip exercises or foot orthoses were more effective than 
the other in improving PFP outcomes. 	
 
Previous clinical trials have shown foot orthoses to be effective compared to a 
wait-and-see or flat inserts [92, 142]. Theoretical and preliminary evidence 
[95, 142, 241] suggested that individuals with greater foot pronation 
(measured as midfoot width mobility) would benefit most from foot orthoses 
intervention. Our study contradicts these preliminary findings and suggests 
midfoot mobility should not be used primarily as a deciding factor in their 
prescription. 	
 
There was no difference between foot orthoses and hip exercise: is this 
because there was no response to treatment in both groups?	
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Our finding that there was no interaction or treatment effects could stem from 
both treatments producing no response. When we compare the response to 
foot orthoses using a similar success criterion (i.e. global rating of change), 
our study observed similar responses to a previous one (48% vs 47% [142]). 
Likewise, when we use similar success criteria for exercise programs that 
included hip exercises (i.e. change in self-reported pain and/or anterior knee 
pain scales), we similar response profiles (71% vs 80% [94]). Overall the 
response to the foot orthoses or hip exercise treatments is similar across a 
number of studies and various self-reported outcome measures [16, 20, 30] 
which increases our confidence that the results are reproducible in clinic. 	
 
Is four weeks of exercise sufficient?	
Whilst our study did not compare different durations of exercise interventions, 
the response to four weeks of exercise was sufficient to induced comparable 
strength changes and success rates to previous trials [94]. Exercise therapy is 
recommended for those with PFP [181] but exercise protocols vary between 
trials, [94, 180] and generally lack specific exercise descriptors [182]. A study 
with the highest success rates (80%) after six weeks of hip and core exercises 
[94], reported a notable increase in hip external rotator and abductor muscle 
strength (8% and 11% increases respectively) . Their six-week exercise 
protocol consisted of a supervised and home-based program (6 days/week) 
that targeted hip abductor, extensor, internal and external rotator muscle 
groups (three-sets of 10 repetitions), and a balance air-pad exercise (three-
sets of 30-60seconds). We observed a similar success rate (71%) and 
change in muscle strength of the same muscle groups, 11% and 6% 
respectively, with our four-week physiotherapist-supervised program (3 days/ 
week). The exercises targeted the hip abductor, external rotator and extensor 
muscles, performed at a hard to very hard perceived level of exertion with 
each repetition having a five second time-under-tension cycle (three-sets of 
10 repetitions). Adherence was high (84%). We noted that hip strength 
improvements were maintained between week 6 and 12, despite the 
cessation of exercises after four weeks (Appendix 17). Despite some 
differences in exercise parameters between studies, there were comparable 
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success rates and increases in muscle strength suggesting improvements can 
be gained by doing simple exercises. 
 
6.4.1 Limitations  
Several limitations need to be considered when inferring from our results. One 
is the imbalance in the number of sessions between the hip exercise group 
(12) and the foot orthoses groups (6). Whilst regular visits to the clinician 
would assure adherence and fidelity to the treatment, this would plausibly be 
more resource intensive. Resource and cost implications of the imbalance in 
treatment sessions between groups was not collected. Another consideration 
is the use of only one form of prefabricated foot orthoses, and while it was 
previously shown to be effective, this might well be a limitation. Other foot 
orthoses may be more or less effective and their outcome predictable from 
basic foot measures. This study focused on only hip exercises as an 
intervention, whilst international consensus recommends the use of both hip 
and quadricep exercises in the management of PFP. Future studies may look 
to incorporate quadricep exercises into their interventions.  Sample size 
calculations were based on one follow-up visit per participant, however, in our 
analyses we analysed both outcomes for each participant simultaneously 
using generalised estimating equations. Our sample size calculations thus did 
not account for multiple measurements per participant: doing so would have 
reduced the required number of participants. Due to the presence of 
nonadherence to assigned treatments, the estimated effects in this study must 
be interpreted as estimating the effect of assignment to either foot orthoses or 
hip exercises, rather than the effect of actually engaging with the assigned 
treatments [250, 251]. However, in this study there were relatively high levels 
of adherence to foot orthoses and hip exercise programs, implying that 
estimates from an analysis of the effect of hypothetical full adherence are 
likely to be similar to those obtained here. 
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6.4.2 Clinical implications  
In the management of individuals with PFP, hip exercises or foot orthoses are 
equally effective as treatment choices. In the absence of any differences 
between those with greater midfoot width mobility and between the 
treatments, other determinants ought to be considered in clinical decisions 
when managing PFP. For example, patient preference, resource 
requirements, and time required for each intervention should guide treatment 
selection.  
 
6.5 Conclusion 
Greater midfoot width mobility was not associated with greater patient-
perceived improvement with foot orthoses versus hip exercises. Both hip 
exercises and foot orthoses offer similar outcomes in reducing pain, improving 
function and hip muscle strength. 
 
6.6 Contributors 
MM contributed to the study conception and design, recruitment of 
participants, management of study proceedings, data collection, and drafting 
and revision of the manuscript. AC, TM, RN, and KC contributed to the study 
conception and design, and drafting and revision of the manuscript. MR 
contributed to the study design, recruitment of participants, management of 
study proceedings, data collection, and reviewed the manuscript. JK 
contributed to the statistical analysis and reviewed the manuscript. BV 
contributed to the study conception and design, recruitment of participants, 
data management, and the drafting and revision of the manuscript. BV and 
MM act as guarantors to affirm that this manuscript is an honest, accurate, 
and transparent account of the study being reported; that no important 
aspects of the study have been omitted; and that any discrepancies from the 
study as planned (and, if relevant, registered) have been explained. The 
corresponding author attests that all listed authors meet authorship criteria 
and that no others meeting the criteria have been omitted. 
111 
6.7 Declaration of interest 
BV reports grants from Commonwealth of Australia National Health and 
Medical Research Council (Ref: 631717) and from Vionics International for 
this research. MM was the recipient of an Australian Postgraduate Award 
scholarship (No 351663). BV and TM are voluntary (non-compensated) 
members by invitation on the Vasyli Think Tank. The funders of the study had 
no role in design and conduct of the study; collection, management, analysis, 
and interpretation of the data; and preparation, review or approval of the 
manuscript. The corresponding author had full access to all the data in the 
study and had final responsibility for the decision to submit for publication.  
 
6.8 Acknowledgements 
We thank those who enabled the study to be conducted, the participants who 
volunteered into the study and the physiotherapists that carried out 
treatments. 
 
112 
Chapter 7 is adapted from a publication, as a book chapter: 
 
Matthews, M., Vicenzino, B., Rivett, D. (2019) Targeting treatment distally at 
the foot for bilateral persistent patellofemoral pain in a 23-year-old: a new 
answer to an old problem. Clinical Reasoning in Musculoskeletal Practice 
2ed. Chapter 10, 164-178 Elsevier Health Sciences. 
 
 
Contributor Statement of contribution 
M. Matthews 
(Candidate) 
Conception and design (50%), Analysis and 
interpretation (50%), Drafting and production (50%) 
B. Vicenzino  Conception and design (35%), Analysis and 
interpretation (35%), Drafting and production (30%) 
D. Rivett Conception and design (15%), Analysis and 
interpretation (15%), Drafting and production (20%)  
 
 
  
113 
 
Chapter 7. Targeting treatment distally at the foot for bilateral 
persistent patellofemoral pain in a 23-year-old: a new answer 
to an old problem? 
 
This (book) chapter presents a clinical case, along with reasoning questions 
put forward by one the book authors (DR), our answers to the reasoning 
questions (MM, BV), and a closing clinical commentary for each section (DR). 
 
7.1 Patient interview  
 
Ellie is a 23year old female who recently commenced working in a hospitality 
job that involved prolonged hours of standing and walking. She presented to 
the University of Queensland clinical Sports Injury Rehabilitation and 
Prevention for Health (SIRPH) research unit with a 10year history of non-
traumatic bilateral anterior knee pain symptoms, with the left knee symptoms 
more severe than the right (Figure 7.1). Ellie had previously been a gymnast 
from the age of six, training up to 25-35 hours per week, until the age of 12 
years. She then commenced trampolining activities, training up to 6-12 hours 
per week, until the age of 16 years. Now Ellie worked as a bartender doing 
shift work for 15-20 hours per week. Outside of work she led a sedentary 
lifestyle, with her hobbies including photography and laptop computer work. 
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Figure 7.1 Body chart depicting Ellie’s anterior knee pain 
 
7.1.1 Symptom behaviour  
 
Since commencing the new job three months earlier, her knee symptoms had 
deteriorated to the extent that she now reported a dull ache at the beginning 
of the shift which progressed to a tense, cramping, buzzing-like feeling by the 
end of the shift. Her worst symptoms occurred when ascending stairs, 
especially after work, with pain increasing after one to two steps, up to an 
intensity of 5/10 on a pain numerical rating scale (NRS, 0 = no pain; 10 = 
worst pain imaginable) after one flight. In the previous seven days, Ellie rated 
her worst pain as being 8/10 after working more than eight hours. Her 
symptoms were also aggravated when sitting for longer than 90 minutes 
(4/10) or driving a manual car for longer than 30 minutes, which resulted in an 
uncomfortable ache. Colder weather caused an increase in the knee 
symptoms, as did a rapid change in room temperature (for example, when 
walking in/out of a large refrigerator at work). Throughout the day, Ellie’s 
symptoms were only aggravated by activity or being in positions of knee 
flexion for a prolonged period of time. 
 
Symptoms were relieved with avoidance of aggravating activities, ice for 20 
minutes after working and by modifying resting knee positions. Ellie wore an 
elastic knee support to assist in symptom management during work. She 
reported audible crepitus in the left knee and to a lesser extent in the right 
knee, with a relieving ‘crack’ felt in the left knee at times after moving out of 
flexion from prolonged sitting.  
 
7.1.2 Self-report forms  
 
During the assessment, Ellie completed the Kujala Anterior Knee Pain Scale 
[252] scoring 68/100, which indicated a severe restriction in functional abilities 
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due to knee pain. She also completed a Patient Specific Functional Scale 
(PSFS) to evaluate her ability to perform individually selected activities 
(scored from 0 = ‘able to do for as long as I wish’, to 10 = ‘unable to do’) [195], 
for which she nominated the activities of walking up/down stairs (3/10), 
working for greater than eight hours (5/10) and sitting for more than one hour 
(3/10).  
 
Ellie reported she had seen her local general practitioner for her knee pain 
and had not undergone any investigations. This medical practitioner 
essentially advised that the pain would ‘go away’. She had not consulted any 
other health care professionals.  
 
7.1.3 Reasoning Questions  
 
1. Following the patient interview, and considering the chronicity of 
symptoms, what is your hypothesis regarding the most likely ‘Pain 
Type’ (nociceptive, peripheral neuropathic, maladaptive central 
nervous system sensitisation)? What is your reasoning process behind 
your decision? 
 
Answer to Reasoning Question:  
It was hypothesized that Ellie’s pain was most likely to be predominantly of 
nociceptive origin. Her pain only came on with loading activities of the knee, 
such as negotiating stairs and with sustained knee flexion in sitting and 
driving, suggesting a mechanical load-related cause for her pain. These 
physical activities are known to particularly increase stress at the 
patellofemoral joint. Ellie’s report of a long history of persistent symptoms, 
recent deterioration with increased workloads, and moderate level of symptom 
irritability could also suggest the presence of secondary peripheral sensitivity. 
 
2. Can you please discuss which features of Ellie’s reported history led 
you to your primary and secondary diagnostic hypotheses?  
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Answer to Reasoning Question:  
The impression following the patient interview was of a primary hypothesis of 
persistent patellofemoral pain, with a secondary hypothesis of fat pad 
irritation. The primary hypothesis of persistent patellofemoral pain was 
supported by the exclusion of findings in Ellie’s history which may be 
indicative of other pathologies. That is, there was no history of trauma, no 
mention of symptoms suggestive of ligamentous instability and little likelihood 
of referral of symptoms from the lumbar spine or hip. Patellofemoral pain is 
typically aggravated by activities that load the patellofemoral joint (e.g., 
squatting/crouching, stair ambulation and running) or which involve sustained 
knee flexion (e.g., prolonged sitting), consistent with the activities that Ellie 
reported to be painful. Further supporting this hypothesis is Ellie’s reported 
audible joint sounds, which is sometimes reported in those with patellofemoral 
pain. [159] It is thought this noise is the result of the aberrant patella motion 
though the trochlear groove of the femur during flexion and extension of the 
knee, and may reflect the integrity of articular cartilage. [253] It has been 
suggested that audible grinding noises and/or palpable vibrations may 
indicate the presence of early osteoarthritic features of the patellofemoral joint 
on MRI in women without tibiofemoral joint changes. [254] 
 
The secondary hypothesis of fat pad irritation was supported by the location 
and description of symptoms (anterior knee, inferior to the patella), and by the 
provocation of pain during dynamic activities, such as knee extension during 
stair ascent.  
 
3. It is interesting that cold environments aggravated Ellie’s symptoms, 
yet she indicated that she used ice for pain relief, which could appear a 
little contradictory. Are you able to make any comment on this? Has 
this been a consideration in determining your hypothesis regarding the 
dominant ‘Pain Type’? 
 
Answer to Reasoning Question:  
The pain aggravation induced by cold ambient temperatures is not consistent 
with our hypothesis of a nociceptive ‘Pain Type’, but the relief of pain with ice 
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could possibly be consistent with nociceptive pain. A study of patients with 
patellofemoral pain has reported that those with cold sensitivity indicate higher 
pain severity, tolerate less physical activity, and demonstrate less 
improvement to lower limb stretching, vastus medialis training and patellar 
taping treatment [255]. Ellie’s presentation did not align well with those 
reported findings. Perhaps in cold environments, she might have adopted 
more flexed lower limb postures, which she had reported were provocative of 
her knee pain. However, this was not explored with her at the time and so this 
is purely conjecture. Regarding her use of ice to modulate patellofemoral pain, 
this could be subserved by a peripheral inhibitory mechanism through cooling 
effects on nociceptors and small afferent fibre function. 
 
Pain is seldom the result of solely peripheral or solely central pathophysiology 
but is more likely a combination thereof. So it is conceivable that while Ellie’s 
predominant pain presentation was nociceptive in nature, she could 
concurrently have had some central nervous system changes (sensitisation) 
due to the long term nature of her condition.  
 
7.1.4 Clinical Reasoning Commentary  
It is a common clinical reasoning error for the practitioner to only consider the 
‘positive’ or supportive clinical findings in the patient examination, and to fail to 
give similar consideration to absent or non-supportive findings in determining 
likely hypotheses. This was not the case in the clinician’s response to the 
question of which clinical features supported the primary diagnostic 
hypothesis of persistent patellofemoral pain where the absence of clinical 
features indicative of some alternative or competing hypotheses (such as 
knee ligamentous pathology) was given due weighting in their reasoning 
process. This suggests that the clinician is actively and simultaneously 
considering multiple diagnostic hypotheses (tissue/structural; and/or physical 
impairments) and ordering these based on the presence and absence of 
features typically to be expected in the associated clinical patterns. Pain Type 
cannot be measured clinically and needs to be a hypothesis based on pain 
science and current understanding of expected clinical patterns. While clinical 
118 
patterns are helpful, they are often not fully validated, features can overlap 
with other patterns and patients will not necessarily present with every 
feature. This is nicely illustrated in the reasoning here, where features of a 
nociceptive dominant pattern are recognised along with features of central 
nervous system sensitisation. 
 
7.2 Physical examination  
 
7.2.1 Observation  
 
On observation of the lower limb in bipedal stance, the hips were internally 
rotated, and the feet were pronated, left greater than right. The knees were in 
hyperextension and appeared normal, with no apparent swelling. Based on 
the pronated foot posture and knee hyperextension, the Beighton 
Hypermobility Scale was applied [256], with Ellie scoring 6/9 with bilateral 
hyperextension of the 5th metacarpophanageal joints, elbows and knees. This 
score indicates the presence of generalized joint laxity [256, 257]. Single leg 
stance resulted in 3/10 retropatellar pain in the left knee only. Performing a 
small single knee bend on the left leg resulted in 4/10 peripatellar pain, 
described as an ‘ache’, at approximately 30 degrees of flexion.  
 
7.2.2 Functional tests  
 
Each functional test was performed either until the onset of pain or 
performance of 25 pain-free repetitions. These tests included squats (i.e., full 
deep squat/full knee flexion, onto the balls of the feet, touching the floor with 
hands either side of the ankles) where Ellie achieved 6/25 repetitions; step-
ups onto a 25cm step at the speed of a metronome set to 96 beats/minute 
(7/25 repetitions on the left, 18/25 on the right); and step-downs from a 25cm 
step (2/25 repetitions on the left, 3/25 on the right).   
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On active range of motion testing with overpressure at end-range, there was 
full pain-free active range of motion of both knees.  
 
7.2.3 Knee tests  
 
The patella borders were tender to palpation both medially and laterally on the 
left, with no swelling or joint effusion present. The Hoffa test was conducted to 
test for fat pad irritation [258]. The test is designed to irritate the fat pad by 
applying firm pressure via the thumb inferior to the patella outside the margin 
of the patellar tendon with the knee in 30 degrees of knee flexion, and then in 
full knee extension (hyperextension). The test is regarded as positive for 
impingement if pain is produced during the last 10 degrees of extension 
indicating involvement of the fat pad in the presenting symptoms [259], 
although little is known about the Hoffa test’s diagnostic properties [260]. The 
test was repeated on both the medial and lateral sides of both knees but did 
not reproduce Ellie’s symptoms. Further testing designed to irritate the fat pad 
was undertaken, which involved isometric quadriceps contraction in full 
extension and passive extension overpressure, again with no symptoms 
reproduced [258]. There was also no pain elicited on firm palpation of the 
proximal, mid or distal portions of the patella tendon.  
 
Valgus and varus ligamentous tests of the medial and lateral collateral 
ligaments respectively, anterior drawer test and Lachman’s test, posterior 
drawer test and sag sign, and McMurray’s and Apley’s tests were all negative 
for both knees, indicating that the ligamentous structures and menisci were 
not likely to be the source of symptoms. The patellar apprehension sign for 
instability was also negative. Manual compression of the patella into the 
trochlear groove at both 0 degrees and 20 degrees of knee flexion was 
positive for symptom reproduction for the left knee only. Clarke’s test was 
performed with Ellie lying in supine, with both knees supported in slight flexion 
[261]. The patella was pressed distally (with the therapist’s hand on the 
superior border of the patella) and she was instructed to gradually perform an 
isometric contraction of the quadriceps muscle [262]. This test is thought to 
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actively compress and stress the articular surfaces of both the patella and the 
femoral trochlear groove. Reproduction of symptoms is regarded as a positive 
test and suggestive of a patellofemoral joint disorder, and whilst Ellie tested 
positive for both knees, this test’s diagnostic utility is questionable [263]. 
Similarly, no assessment of patella translation mobility was conducted as the 
ability of patella mobility to assist in diagnosis is marginal [264] 
 
7.2.4 Foot tests  
 
Foot posture index [265], navicular drop [74], and midfoot mobility 
measurements [76] were recorded. For the foot posture index, the left foot 
scored +7 and the right +8, indicating a pronated foot posture bilaterally [207]. 
Navicular drop is measured by the change in height of the navicular tuberosity 
relative to the floor between a subtalar neutral posture and a relaxed stance 
foot posture. Ellie’s navicular drop was 7mm on the left and 9mm on the right. 
Midfoot mobility is measured by recording the difference between the midfoot 
width in weight bearing (WB) and non-weight bearing (NWB) and is expressed 
as midfoot width (MFW) difference (DiffMFW=WB–NWB). Ellie’s midfoot width 
measurements in weight bearing were 87.7mm on the left and 87.6mm on the 
right, and in non-weight bearing were 75.6mm on the left and 76.4mm on the 
right. Thus, the DiffMFW was 12.1mm and 11.2mm on the left and right 
respectively. Ellie’s change in midfoot width was more than the 11mm 
previously reported to be associated with a greater benefit from foot orthoses 
intervention [95, 142]. 
 
7.2.5 Treatment Direction Test (TDT)  
 
Given the findings on observation, foot posture and mobility testing, a 
Treatment Direction Test (TDT) was next applied. The TDT has been 
previously reported [164], however, in brief, it involves applying a physical 
manipulation (e.g., anti-pronation taping in this case) during the client-specific 
impairment measure (e.g., pain-free step-ups on a 25cm step with Ellie). 
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According to Vicenzino [164], if a significant improvement in the client-specific 
impairment measure is observed (i.e., ≥75% number of pain-free step-ups), 
then treatment of the foot with orthoses and exercises would have a high 
likelihood of success. Ellie achieved nine pain-free step-ups on the left (i.e., 
her most problematic knee) before the onset of her knee pain. After applying 
the anti-pronation tape (Figure 7.2), Ellie was able to achieve 14 pain-free 
step-ups on the left, suggesting a high probability of a successful outcome 
with foot orthoses for Ellie. 
 
   
Figure 7.2 Anti–pronation taping  
(Left) low Dye technique (just the foot taped); (Right) augmented low Dye 
technique (taping up the lower leg) 
 
7.2.6 Ankle range of motion 
 
Reduced ankle dorsiflexion range has been previously associated with lower 
limb pathologies, including an association with aberrant hip patho-mechanics 
in a single leg squat task in those with patellofemoral pain. [266-269] Ellie’s 
bent-knee ankle dorsiflexion range was measured using a modified knee-to-
wall test [212] , (146mm left and 128mm right) and straight-knee ankle 
dorsiflexion using an inclinometer placed mid tibia (48° left and 45° right) 
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7.2.7 Hip muscle strength tests  
 
Deficits in hip muscle function have been associated with altered movement 
patterns of the lower limb [170, 235, 270]. Recent studies have identified 
reduced hip muscle strength, particularly of the hip abductors and external 
rotators, in people with patellofemoral pain as compared to an asymptomatic 
group [213, 214, 271]. On the basis of this evidence, maximal voluntary 
isometric hip strength measurements of hip abduction, adduction and external 
rotation were recorded (in supine lying) using a hand-held dynamometer that 
was fixated by a belt (Table 7.1).  
 
Table 7. 1 Maximal voluntary isometric hip muscle strength scores at baseline 
Hip muscle group 
0 weeks 
Left Right 
Abduction (N) 71.1 70.2 
Adduction (N) 70.7 61.13 
External Rotation (N) 67.2 64.7 
 
7.2.8 Reasoning Questions  
 
4. Can you explain how the physical examination findings 
supported/refuted your primary diagnostic hypothesis of persistent 
patellofemoral pain, and your secondary hypothesis of fat pad 
irritation? How did your treatment hypothesis of foot orthoses fit with 
these findings? 
 
Answer to Reasoning Question 
 
On physical examination, Ellie presented with hyperextended knees and 
internally rotated femurs in standing. On observation of the knees, there was 
no evident swelling or enlargement of the fat pad. Ellie tested negative for fat 
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pad irritation on palpation and on pain reproduction techniques (Hoffa test, 
isometric quadriceps contraction in full extension and extension overpressure) 
suggesting the fat pad was not the primary source of pain. Tests were also 
negative for other local knee pathologies (i.e., ligamentous, tendon etc). Most 
importantly, Ellie’s symptoms were reproduced with techniques that loaded 
and stressed the patellofemoral joint (squats, step up/down, and single leg 
squats). Ellie also had marked tenderness on the medial and lateral borders 
of the patellae, and symptom reproduction on Clarke’s test. 
 
When physical examination findings were taken into consideration with her 
patient interview, and importantly the exclusion of other differential diagnoses, 
the overall findings were indicative of Ellie having bilateral persistent 
patellofemoral pain. Based on the findings of pronated foot posture on the foot 
posture index, DiffMFW ≥11mm, and a positive response to the TDT, it was 
decided that foot orthoses would be the initial treatment in managing Ellie’s 
patellofemoral pain. 
 
5. You performed a comprehensive assessment of foot biomechanics in 
this patient. Is this an assessment approach you take with all of the 
patients in your clinic with patellofemoral/knee pain or were there 
features in the history and physical examination that led you to pursue 
that direction, rather than perhaps another approach? 
 
Answer to Reasoning Question 
 
The focus on the foot assessment was based on Ellie’s report that her most 
provocative activity was stair climbing, a weight bearing under load task, 
combined with the initial observation of her marked pronated foot posture. 
Physical examination of stair walking confirmed it provoked her pain and 
correcting her foot posture with anti-pronation taping allowed the patient to 
perform substantially more steps. These findings led to further examination of 
foot posture with the foot posture index and measures of midfoot height and 
weight, which confirmed her feet to be more pronated than normal. If it had 
not been possible to reproduce Ellie’s pain on stair walking and if there had 
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been no observable pronation of her feet, then the assessment would likely 
have focussed more on the knee and the hip. 
 
 7.2.9 Clinical Reasoning Commentary  
These responses demonstrate how the clinician has come to diagnostic and 
treatment decisions based on a combination of knowledge/evidence derived 
from prior experience with similar clinical presentations and also scientific 
evidence obtained from the published research. Hypotheses tentatively 
formulated during the patient interview have now been tested in the physical 
examination to determine whether expected clinical findings are indeed 
present, based on this previously acquired experiential and empirical data. 
Impairments were specifically tested to determine their relevance to key 
presenting symptoms (such as the correction of foot pronation on the knee 
pain experienced during stair walking) and were not simply assumed to be 
supportive of the primary structural hypothesis (persistent patellofemoral 
pain). Similarly, it was not assumed that competing hypotheses (e.g., fat pad 
irritation, ligament pathology) were not to be accepted in conjunction with, or 
instead of the primary hypothesis, but were each specifically physically tested 
to ensure their exclusion at this time was appropriate. In the ‘Hypothesis 
Category’ framework presented in Chapter 1, assessment and trial correction 
of foot posture represents reasoning about potential ‘Contributing Factors’, as 
might the assessment of femoral posture and hip strength where trial 
intervention may similarly have had a positive effect. Treatment decisions 
were therefore based on supportive derived clinical findings and applied 
scientific evidence built during both the patient interview and the physical 
examination, as well as the absence of any convincing supportive evidence 
for competing hypotheses.  
 
7.3 Treatment  
 
Ellie was provided with comprehensive information and education about 
patellofemoral pain. In particular, she was given an in-depth explanation of the 
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proposed mechanisms by which excessive foot pronation might impact upon 
patellofemoral mechanics [226]. In brief, Ellie was made aware of the effect of 
excessive foot pronation in inducing greater lower limb internal rotation and 
the flow-on effect on patellofemoral joint stress. She was further informed of 
the emerging evidence which suggests that a change of ≥11mm in midfoot 
width (from non-weight bearing to weight bearing) is associated with a 
successful outcome with the use of foot orthoses, and that her positive 
response to the anti-pronation taping technique indicated a higher probability 
of a successful outcome with this approach to treatment.  
 
The foot orthoses were subsequently fitted as previously described [272]. In 
short, the fundamental aim of the fitting was to ensure the foot orthoses were 
comfortable in order to maximise compliance, with an overall aim of improving 
pain-free function. The foot orthoses fitted were commercially available, 
prefabricated orthotics (Vasyli International) made from ethylene-vinyl acetate 
with a manufacturer specified six-degree varus wedge and arch support. Ellie 
was fitted with a full-length foot orthosis of the lowest density (Shore A 52°) to 
her work footwear (sports running shoes), that were subsequently heat 
moulded to optimise comfort (Figure 7.3). She was instructed to wear her 
work shoes during the day and at work, with to remove the orthoses if they 
began to feel uncomfortable.  
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Figure 7.3 Full length foot orthoses 
 
7.3.1 Appointment 2 (three days after initial appointment)  
 
Ellie returned three days later for a review of her foot orthoses and to be 
taught a home exercise program. She reported that she had noticed a 
reduction in the severity of pain in both knees, and that symptoms took longer 
to commence while she was working. There were no adverse effects at her 
foot-to-orthoses interface beyond a mild general ache. Ellie’s work and casual 
footwear were reviewed and were all found to have minimal heel counter 
stiffness, midfoot sole sagittal stiffness (bending the midfoot in the sagittal 
plane), and midfoot sole frontal stability (torsional movement or twisting of the 
midfoot section by counter-rotating the rearfoot and forefoot components). 
She was asked to seek more stable footwear that would meet the 
requirements for her work but also complement the application of the foot 
orthoses.  
 
Ellie was supplied with a second set of full-length foot orthoses of medium 
density (Shore A 60°) that were heat moulded to optimise comfort. She was 
instructed to swap the foot orthoses into whatever footwear she would be 
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wearing. This change was done on the basis of tolerability to the initial lower 
density orthosis and a desire to provide an orthosis that would likely have a 
longer life. 
  
Ellie was then taught a home exercise program consisting of anti-pronation 
foot exercises and calf stretches with the knee extended. The arch forming 
exercises commenced in partial weight bearing (seated) with the knees flexed 
and bare feet flat on the floor. To help facilitate the exercise, a piece of paper 
or non-adhesive tape was placed under the distal end of the first metatarsal 
and Ellie was instructed to maintain firm pressure on the paper/tape (in order 
to prevent the paper from being slid out from under the foot by the clinician) 
whilst keeping her toes relaxed. She was also instructed on the technique of 
supinating the rearfoot, which was initially assisted with manual facilitation 
(using finger pressure under the arch) (Figure 7.4). This was sustained for ten 
seconds and then repeated on the opposite foot. Ellie was asked to repeat the 
foot supination task five times for each foot, twice daily. As she became more 
proficient at performing this exercise, Ellie was to progress practicing this in 
bipedal stance.  
 
Finally, Ellie was asked to perform straight-knee calf stretches for 30 seconds, 
three times, twice daily, either by a lunge stretch against a wall or over the 
edge of a step whilst keeping the rearfoot in neutral supination/pronation as 
per the arch forming exercise. The lunge stretch against the wall involved 
facing the wall in step-stance with both hands on the wall and both feet flat on 
the floor aligned perpendicular to the wall.  The lunge calf stretch was 
performed to a comfortable but firm stretch felt in the back of the calf. 
Alternatively, Ellie could lower the heel down over the edge of a step whilst 
maintaining a straight knee.  
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Figure 7.4 Anti-pronation foot exercise 
 
7.3.2 Appointment 3 (11 dyas after initial appointment)  
 
Ellie reported a notable bilateral improvement in her knee pain since the last 
visit. She found the foot orthoses did not fit all of her footwear, but when she 
was unable to fit the orthoses, she instead focused on the anti-pronation foot 
exercises and holding this position momentarily at various times during 
standing, especially at work. No physical re-examination was conducted at 
this time. The anti-pronation foot exercises were reviewed and progressed 
from sitting to bipedal stance to bilateral isometric heel raise holds (i.e., 
holding heels just off the floor) whilst maintaining the rearfoot in a neutral 
position. Ellie was still yet to seek more supportive footwear. She was to 
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continue to use the foot orthoses where able, particularly at work, but was to 
remove them if they were uncomfortable or not fitting the footwear properly, 
and to rather focus on the anti-pronation foot exercises with increasing 
periods of incorporating this posture during standing throughout the day. 
 
 7.3.3 Appointment 4 (27 days after initial appointment)  
 
Ellie returned to report significantly less knee pain, especially at work and 
while ascending stairs after work, which was previously the most aggravating 
activity and time of day. She reported that she had decided to stop wearing 
the foot orthoses during the previous week, because she had difficulty fitting 
them to her footwear selection and preferred to do the anti-pronation foot 
exercises. She had been focusing on the exercises consistently throughout 
the day and particularly at work. The anti-pronation foot exercises were 
progressed from bipedal standing with increasing duration of isometric holds 
to bipedal dynamic heel raises whilst maintaining a more subtalar neutral 
position.  
 
 7.3.4 Appointment 5 (48 days after initial appointment)  
 
Ellie returned to report she was only experiencing slight twinges in her left 
knee at work (0.5/10). She now reported feeling no symptoms walking 
upstairs and only an ‘awareness’ of symptoms in her left knee at other times. 
Importantly, her knee was not painful after work. The anti-pronation foot 
exercises were progressed from bipedal dynamic heel raises to single calf 
raises whilst maintaining a subtalar neutral position. Ellie was to perform 
these throughout the day as she remembered, especially at work. As Ellie 
was making substantial improvements, no physical re-examination or 
assessment was conducted. Ellie felt comfortable to now self-manage with 
anti-pronation exercises and return for a review and re-assessment in 7 
weeks.  
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7.3.5 Appointment 6 (16 weeks after initial appointment 
 
Ellie was reviewed at 16 weeks and reported she was ‘much better’ on a 
seven-point global rating of change scale (much better, better, a little better, 
no change, a little worse, worse, much worse). On a scale of 0% (not 
recovered) to 100% (totally recovered), Ellie rated her knees as 100% totally 
recovered from her presenting knee pain. On the day of assessment, Ellie 
rated her knees as being 100% normal on a scale of 0% to 100% (100% 
normal being defined as having ‘no problems at all with your knee’). She no 
longer felt any pain in cold environments. On the Kujala Anterior Knee Pain 
Scale she scored 100/100 and the only activity rated on the PSFS (0= able to 
do for as long as I wish, 10 = unable to do) was climbing stairs (0.5/10), as 
Ellie had experienced a one-off slight twinge ascending stairs after work the 
week prior. She had now returned to doing moderate physical activity for 30 
minutes, five times a week.  
 
On retesting of the pain-free functional task of squatting, Ellie was able to 
complete 25/25; on step-ups onto a 25cm step, Ellie was able to complete 
25/25 on the left and 22/25 on the right with slight pain (1/10), at the speed of 
a metronome set at 96 beats/minute; and on step-downs Ellie completed 
25/25 on both the left and the right knee. Ellie’s maximal voluntary isometric 
hip strength measurements of hip abduction, adduction and external rotation 
were re-measured (Table 7.2), showing a bilateral increase in external 
rotation maximum isometric force (11% and 22% on left and right 
respectively) and an increase in adduction force on the right (21%).  
 
Table 7. 2 Maximal voluntary isometric hip muscle strength scores at 0, 16 
weeks. 
Hip muscle group 
0 weeks 16 weeks 
Left Right Left Right 
Abduction (N) 71.1 70.2 * * 
Adduction (N) 70.7 61.13 71.2 74.1 
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External Rotation (N) 67.2 64.7 74.8 78.7 
* unable to test maximally as back pain was present during abduction. Back 
pain had commenced in preceding week as a result of a fall. 
 
Interestingly, Ellie reported she felt that she subconsciously held the foot in a 
more neutral position that was now her new ‘normal’ foot posture, and a 
pronated foot posture now felt very awkward. On measurement of her 
navicular drop, it was 2mm on the left and 1mm on the right (compared with 
initial measurements of 7mm and 9mm respectively). Ellie had continued to 
perform the single heel calf raises when she remembered to do so at work 
and during the day, as well as maintaining a neutral foot posture during 
activities of daily living, noting that this did not require much mental focus to 
achieve. Ellie was encouraged to keep up with the exercises she was 
currently doing and keep incorporating them into her activities of daily living.  
 
7.3.6 Appointment 7 (32 weeks after initial appointment) 
 
When Ellie was reviewed approximately eight months after treatment had 
commenced, she reported that she was still much better on a seven-point 
global rating of change scale and 100% recovered from her knee pain. Her 
knee pain did not limit any activity of her choice on the PSFS and she still 
scored 100/100 on the Kujala Anterior Knee Pain Scale. On the pain-free 
functional task tests, Ellie scored 25/25 repetitions for squats, step-ups and 
step-downs.  
 
On measurement of her navicular drop, it was 0mm on both the left and right. 
On measurement of change in midfoot width moving from non-weight bearing 
to weight bearing, Ellie’s midfoot difference was now 6.6mm on the left 
(previously 12.1mm at initial presentation) and 7.3mm on the right (previously 
11.2mm). These measures were considered consistent with a less pronated 
foot posture type. Interestingly, the hip muscle strength had also increased 
(ranging from 8 to 33%) from the first session (Table 7.3). 
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Table 7.3 Maximal voluntary isometric hip muscle strength scores at 0, 16 and 
32 weeks 
Hip muscle group 
0 weeks 16 weeks 32 weeks 
Left Right Left Right Left Right 
Abduction (N) 71.1 70.2 * * 79.4 75.7 
Adduction (N) 70.7 61.13 71.2 74.1 79.9 79.2 
External Rotation 
(N) 
67.2 64.7 74.8 78.7 89.2 78.6 
* unable to test maximally as back pain was present during abduction. Back 
pain had commenced in preceding week as a result of a fall. 
 
7.3.7 Reasoning Questions 
 
6. Reassessment revealed hip muscle strength had increased despite 
specific exercises for those muscles not being part of the treatment 
programme. Can you please propose the mechanism behind this 
increase in strength and how it may have contributed to the decrease 
in knee pain? 
  
Answer to Reasoning Question 
 
Improved hip muscle strength was not expected because the treatment was 
entirely focused at the foot. The mechanism by which this happened is likely 
multifaceted. One such mechanism might have involved the foot exercises 
and orthoses inducing changes at the foot, which countered the excessive 
foot pronation and internal rotation of the lower limb during weight bearing 
activities. The foot exercises were designed to control the amount of pronation 
the foot underwent in weight bearing. This was confirmed with a marked 
reduction in midfoot width mobility after commencing the exercises (e.g., 
12.1mm to 6.6mm on the left foot; 11.2mm to 7.3mm on the right foot). This 
reduction in foot pronation would plausibly reduce the amount of internal 
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rotation occurring in the lower limb, notably causing a reduction in the internal 
rotation and adduction of the hip during the stance phase of gait. It can be 
hypothesised that the hip abductor and external rotator muscles would be 
working at a disadvantage during the stance phase of gait with the foot 
pronated excessively, with concomitant increased internal hip rotation and hip 
adduction. The changes in foot posture observed in this case might have 
improved the mechanical efficiency of force production of the hip abductor 
and external rotator muscles by reducing the amount of lower limb internal 
rotation during loading in single limb stance (e.g., during gait or negotiating 
stairs). With improved lower limb function and reduced pain, Ellie could 
feasibly have moved more freely and often, leading to strength adaptations of 
the hip muscles. Studies have shown that isolated exercises targeting the hip 
abductors and external rotators have had a positive effect on patellofemoral 
pain [98, 105, 168, 180], which might have been a means by which the foot 
treatment led to the observed hip muscle strength improvements. 
 
Another mechanism might have been through unintended exercise of the hip 
muscles when Ellie performed the anti-pronation exercises of the foot. These 
exercises focussed on the coupling between the leg and foot, and not just the 
sagittal plane of the foot in isolation. That is, the exercises involved a coupling 
of external rotation of the tibia with supination of the rearfoot and 
plantarflexion of the forefoot, rather than focussing primarily only on the foot in 
the sagittal plane (e.g., as with foot shortening exercises that primarily target 
sagittal plane posture locally at the foot). In performing these exercises, Ellie 
could have used her hip external rotators, which could have led to some 
conditioning of the hip muscles and the observed strength adaptations. 
 
It is also feasible that the alteration in foot posture, and flow on effects to the 
lower limb, served to de-stress the patellofemoral joint, which was posited as 
the nociceptive source of the patellofemoral pain.  The resultant reduction in 
patellofemoral pain would likely lead to more efficient use of the thigh and hip 
muscles, which in turn might facilitate restitution of hip muscle strength.  
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It must be stated that it is difficult to explain how the foot treatment changed 
both the hip muscle strength and the patellofemoral pain, or indeed the causal 
direction of such effects, and that a combination of these proposed 
mechanisms along with others not considered may have been responsible for 
the observed effects. 
 
7. Can you please discuss the preference of Ellie to exercise rather than 
comply with the change in footwear, and how this may have influenced 
your management and the ultimate outcome? 
 
Answer to Reasoning Question 
 
Ellie had certain requirements for work footwear; she used a variety of casual 
footwear and spent time in bare feet at home. During Ellie’s initial session she 
received a detailed explanation of active retraining of foot posture and the 
biomechanical effect on patellar tracking, thus addressing a potential 
contributor to her knee pain. After discussion of these factors, and the 
possible long-term benefit of active versus passive intervention, she felt that 
an active approach with exercises was the most likely to be beneficial. Ellie 
felt the immediate change in her knee-pain symptoms with the anti-pronation 
taping at the initial appointment and the effect of the foot orthoses over the 
following sessions, all of which assisted with her engagement with the 
treatment approach and her view of progressing to active exercises. It is 
highly likely that an understanding of the potential mechanisms contributing to 
her symptoms, plus an immediate positive response to treatment contributed 
greatly to Ellie’s compliance and adherence to regularly performing the 
exercises. 
 
8. A midfoot width change ≥11mm was described as being associated 
with a successful response to treatment aimed at the foot for those with 
patellofemoral pain. Are there any other factors (such as severity of 
symptoms, chronicity, ‘Pain Type’, age of patient, psychosocial 
considerations, etc) that may need consideration in selecting your 
treatment approach in similar cases?  
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Answer to Reasoning Question 
 
Symptoms of patellofemoral pain are typically consistent between patients, 
however biomechanical, physiological and external factors contributing to the 
onset of a patient’s symptoms vary between individuals, due to the 
multifactorial nature of the condition. Patients may present with one or more 
combinations of contributing/associated factors proximally at the hip, locally at 
the knee or distally at the foot and ankle.  
 
Current evidence suggests a multimodal treatment approach has the best 
outcome for reducing patellofemoral pain, but it is not a ‘one size fits all’ 
approach. Of importance is a comprehensive and appropriate clinical 
examination, in order to tailor the multimodal program to the patient. 
Identifying key characteristics that are associated with the patient’s symptoms 
improves the optimal selection of management approach. In Ellie’s case, her 
foot mobility indicated targeting treatment to her foot. If Ellie did not present 
with such a mobile foot, then evidence suggests exercises targeted more 
proximally at the hip to improve neuromuscular activity [181] might be more 
successful. It is not unusual for these exercises to take some time to bring 
about an improvement, so in the meantime it could be advantageous to 
consider complementary treatments to reduce pain and improve the patient’s 
ability to be more active and adhere to the exercises (e.g., patellar taping, 
acupuncture, stretching).  
 
In cases where there are severe and persistent symptoms with associated 
psychosocial issues, such as such as negative fear-avoidance beliefs, 
anxiety, depression and pain catastrophising [273-275], which likely mitigate 
against a good response to mechanically-based treatments, it would be 
advisable to take a pain sciences approach to management. This approach 
would require consideration of referral to other clinicians (e.g., psychologist, 
pain specialist). Fundamentally however, the key is to tailor the treatment to 
the individual and their presenting case, and to educate them about their knee 
condition with the most up-to-date and relevant evidence available. It is 
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important to involve the patient in some informed decision-making in 
designing the treatment plan, which can then be tailored to their preferences 
and lifestyle. Crucial to a good outcome is patient confidence in the rationale 
behind the treatment plan, in order to facilitate adherence, which is vital to 
recovery.  
 
The key consideration in the treatment approach applied in Ellie’s case was 
the aim of reducing pain and educating her as early as possible to help to gain 
her confidence in the treatment approach and to facilitate greater adherence 
to treatment (e.g., active exercises). 
 
9. Given this condition has been described as self-limiting by some 
authors, do you think Ellie may have recovered without any 
intervention? What led you to hypothesise a favourable prognosis? 
 
Answer to Reasoning Question 
 
Patellofemoral pain is a common and persistent knee condition that affects 
teenagers and young adults [6, 115-117, 119, 120]. Conservative treatments 
for patellofemoral pain such as strengthening, stretching and functional 
movement retraining of quadriceps and gluteal muscles, foot orthoses, 
patellar taping and manual therapy have been reported to produce modest 
effects of short to moderate term duration [92]. Despite these interventions, a 
substantial proportion of patients still report persistent long-term symptoms 
[116], with approximately 1 in 4 reporting symptoms up to 20 years later [121].  
 
It is erroneous to consider this condition as being self-limiting, especially in 
adolescents when patellofemoral pain could be dismissed as ‘growing pains’. 
A substantial body of evidence points to the contrary, with 50% of 12-15 year 
olds reporting persistent knee pain 12 months later [276], 55% of 15-19 year 
olds reporting persistent pain two years later, [1] and more notably 78% of 
females diagnosed with patellofemoral pain during adolescence still 
experiencing pain after 14 to 20 years [115, 116, 121]. Ellie appears to be in 
this long-term, non-self-limiting category, because she was diagnosed with 
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patellofemoral pain at 13 years of age and has had persistent symptoms that 
have continued to significantly impact her life into her early twenties.  
 
Taking in consideration the evidence highlighting longer knee pain duration is 
predictive of a poor outcome [121, 138, 146], it is highly unlikely that Ellie 
would have recovered without any intervention. Whilst reducing the amount of 
knee loading activities may change a patient’s symptoms, a reintroduction of 
knee loading activities will likely result in a recurrence of the symptoms. This 
is demonstrated in Ellie’s case whereby she reported a cyclical history of 
improvement when activity was reduced (i.e., the knee was deloaded), but an 
exacerbation on attempting more activity, such as returning to hospitality work 
and spending more time on her feet. On commencing physiotherapy 
treatment, Ellie reported a significant improvement in her symptoms by 
appointment 3 (11 days). Given she had persistent symptoms for 10 years, it 
is highly unlikely this rapid improvement was a spontaneous recovery, 
especially as she remained improved 32 weeks later.  
 
A favourable prognosis was indicated as Ellie responded favourably during 
the step-up test when an anti-pronation taping technique was applied, 
demonstrating an immediate effect of foot intervention on her patellofemoral 
pain. Over the following few weeks with foot orthoses and exercises, Elle 
reported a marked improvement in her pain, which continued to be the case 
afterwards. This is consistent with a series of studies by Barton et al [77, 143] 
in which patients who demonstrated immediate improvement in a physical 
pain provocative test with an anti-pronation device applied were more likely to 
be improved weeks later [143]. In another study, Barton et al [277] showed an 
immediate increase in the number of pain-free single-leg rises and single leg 
squats able to be performed when those patients with a pronated foot type 
wore a prefabricated foot orthoses [277]. These improvements were present 
at follow-up [278], indicating it is not a short lived response. In summary, the 
temporal response profile seen with Elle was commensurate with 
expectations and those reported in the literature. Had she not improved 
sufficiently however, then management directed at the femoral posture and 
weakness may have been added. 
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7.3.9 Clinical Reasoning Commentary  
The importance of patient education and empowerment is well demonstrated 
in this case. Without a clear explanation regarding the likely cause of her knee 
pain and the reasons why it has persisted, Ellie may not have complied with 
the management program over several months and almost certainly would 
have been much less likely to have adhered to the tailored exercise program. 
Apart from the clarity and logic of the explanation provided by the clinician, the 
other key element in motivating Ellie to continue with the exercise program 
was the powerful demonstration of the effect on her knee symptoms during 
her most provocative activity (ascending stairs) of an anti-pronation 
intervention. This appears to have been the ‘cognitive clincher’ in Ellie 
understanding and believing that her persistent decade old problem could 
actually be changed for the better and that her chosen clinician could assist 
her to that end. Moreover, the relatively rapid improvement in her pain and 
function following the commencement of the exercise program provided Ellie 
with the knowledge that she had the ‘power’ to manage her symptoms herself, 
under the guidance of her clinician in whom she had confidence. Ellie 
embraced the responsibility of taking control of her own management, 
however importantly, the clinician facilitated this by allowing her to be a truly 
collaborative partner in the therapeutic alliance. 
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Chapter 8. Discussion and Conclusions 
 
The aim of this research was to explore specific ways of optimising the 
management of those with patellofemoral pain. In particular, to determine if a 
presenting patient’s characteristic could guide the clinician in matching the 
right treatment to the patient to achieve an improved success rate. This 
chapter will summarise the key findings from trial, how the findings fit within 
the body of current knowledge on PFP management and considerations on 
their clinical impact, as well as future research directions. A central 
consideration in relation to the outcomes of this research is that they may 
represent a combination of biological, articular, and neuromuscular function at 
the lower limb, as well as psychosocial aspects of a patient’s perception of 
pain and their functional ability.  
 
8.1 Brief review of the research  
8.1.1 Management of PFP 
In the management of PFP, evidence supports recommendation of either hip 
exercises or foot orthoses [181].These interventions target the proximal and 
distal parts of the lower limb, with different biomechanical approaches (i.e. hip 
exercises versus foot orthoses respectively) to address a pain distant from, 
and in between, the targeted areas. The recommendations and contrasting 
paradigms place considerable emphasis on the clinician’s reasoning skills to 
determine which treatment is best for which patient. One clinical tool that can 
assist clinicians in the decision-making process is utilizing clinical prediction 
rules. Clinical prediction rules quantify the contribution of certain patient 
characteristics, known as treatment effect modifiers, to provide the clinician 
and patient with a probability of a response to a particular treatment [279-
281].The greatest benefit of treatment effect modifiers can be with patients 
who present with a homogeneous, but multifactorial condition, such as PFP, 
and assist the clinician to classify the patient into a subgroup, based on a 
likely response to a specific treatment approach.  
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Two questions stem from the recommendation of both hip exercises and foot 
orthoses for managing PFP. Does greater midfoot width mobility modify the 
effect of foot orthoses treatment over hip exercises for PFP; and are foot 
orthoses or hip exercises a superior treatment PFP? To address these 
questions, this research project developed and implemented a a two-arm 
parallel, superiority randomised clinical trial.  
 
8.1.2 Treatment effect modification  
One aim of this research was to explore treatment effect modifiers for those 
with PFP. The systematic review undertaken in chapter 3 identified crucial 
methodological limitations within the reported evidence. Studies aiming to 
identify treatment effect modifiers failed to use a control or comparator 
treatment group and analyzed too many variables for the limiting sample size. 
These limitations increased the risk of type one error, spurious findings, and a 
greater higher likelihood the findings would not be reflected within a 
population of those with PFP. As such, current evidence did not support the 
ability to confidently predict the outcome after one specific treatment 
compared with another. In light of these limitations, preliminary evidence from 
the systematic review suggested patients with PFP with >11 mm midfoot 
width mobility moving from a non-weight to a weight bearing posture would 
benefit more from foot orthoses than those with lesser mobility [95, 142]. 
Previous identification of midfoot width mobility as a potential treatment effect 
modifier warranted further investigation.  
 
8.1.3 Hypotheses and results 
We hypothesized that (i) those with high midfoot width mobility would report 
greater benefit with foot orthoses, compared to hip exercises, and (ii) hip 
exercises would provide greater benefit compare to foot orthoses, in part due 
to direct effect upon the patellofemoral joint. Two hundred and twenty 
participants with PFP were recruited, stratified based on their midfoot width 
mobility (high ≥11mm, low, <11mm) and randomly allocated to foot orthoses 
or hip exercises (two were incorrectly included but later removed). Overall, we 
found midfoot width mobility was not associated with patient-perceived 
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improvement with foot orthoses, compared to hip exercises (interaction effect 
(P=0.19), and that foot orthoses and hip exercises have comparable 
outcomes (risk difference 0.94 (95% CI 0.72, 1.24). The results support the 
null hypotheses and are in contrast to commonly assumed clinical 
expectations.  
 
8.2 Plausible explanation for results 
The results from the clinical trial and case study shed some light onto 
plausible explanations for why midfoot width mobility was not associated with 
outcome and why contrasting treatments achieved similar outcome. 
Systematic review evidence suggested midfoot width mobility had the 
potential to be a treatment effect modifier for the prescription of foot orthoses. 
[243] This concept appeared plausible and clinically appealing, because a 
simple, quick and reliable measurement of foot motion could indicate the use 
of a device designed to regulate mobility that could provide greater benefit for 
those with greater mobility. Our study has conclusively shown that midfoot 
width mobility is not a patient characteristic that predicts those with PFP who 
would benefit from a foot orthosis and should not be used alone in the 
decision-making process. One explanation of our result could be due to the 
multifactorial nature of PFP. Factors in many domains of a biopsychosocial 
paradigm could influence a patient’s response to a specific treatment, 
including intrinsic physiological and psychological factors and how these 
connect via behaviour in the social and physical context of their extrinsic 
environment. Three considerations are noteworthy for why midfoot width 
alone was not a treatment effect modifier for the rate of successful outcome 
with foot orthoses. These considerations take into account (i) the structure 
being measured, i.e. the foot, (ii) the potential effect with sensorimotor control 
and movement patterns, and (iii) more broadly the generation of nociceptive 
input, perception of pain and functional limitations. The multitude of potential 
contributing factors warrants consideration in future trials, i.e. to control or 
explore, as potential methods for tailoring evidence-based treatments. 
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8.3 Biological variables 
Foot structure and excessive foot motion have been investigated as an 
associated factor in those with PFP [226, 241]. Previous studies have 
investigated measurements of the foot and associations with outcome with 
foot orthoses treatment. These have included joint and bone range of motion 
and foot posture  [77, 95, 142, 143, 152, 153]. In light of the results of the trial 
(chapter 6) in this research, only greater rearfoot eversion relative to floor, has 
been reported with a successful outcome [77]. Due consideration is warranted 
as this finding is from a case series study, with no comparator treatment, of 
which 7/26 (27%) had successful outcome, with potential overfitting of the 
statistical models and as such a higher risk of type one error. The lack of 
association between clinical foot measurements and outcome in people with 
PFP could represent the inadequacy of clinical and imaging measures to 
capture the complex interplay and multi-plane motion of the foot. Whilst 
measurement of midfoot width tried to represent combined joint motions; more 
than just movement of a single bone, it is still predominately only in one plane 
of motion. Previous work looked at the combined effect midfoot width and 
arch height mobility to calculate the foot mobility magnitude [76].  Post-hoc 
analysis of a large clinical trial [92], and a separate randomised clinical trial 
comparing foot orthoses to wait-and-see approach [142], found only midfoot 
width measurement was associated with success [95]. It is conceivable a 
combination of characteristics could have a better likelihood of success. 
However, it is worth considering the complex interplay of structures within the 
foot and the knee, the small joint motions and the high forces transmitted 
might make it too challenging to capture the motion with simple clinical tools. 
Ultimately the ability to capture the intricacy of the structure and function of 
the foot in a simple index, for which to direct treatment selection, may 
overlook the likely complexity of other relevant factors.  
 
Neuromuscular and biomechanical deficits have been widely reported in those 
with PFP [4]. These deficits are proposed to contribute to aberrant loading of 
the patellofemoral joint and a disruption in tissue homeostasis [2, 241]. It is 
theorized the treatments for PFP may address these underlying deficits, and 
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in turn, influence the loading and stress through the patellofemoral joint. 
Studies that have investigated these proposed theories have reported varying 
deficits [282-284] which may suggest individual motor control variations in 
response to pain [285]. Conversely, the mechanisms of effect for hip 
exercises and foot orthoses have not yet been clearly identified [286]. Results 
from current the trial found similar magnitude of improvements in hip abductor 
and external rotator muscle strength occurred for the hip exercise and the foot 
orthoses groups. It is understandable the direct effect exercises targeting hip 
musculature would improve muscle force output. It was unexpected to find 
foot orthoses having similar effects on muscle force output. 
 
The current trial did not include a control group (i.e. a wait-and-see or 
alternative conservative approach), so the magnitude of strength improvement 
relative to a control group is not known, but the results open new research 
questions [287]. It could be hypothesised that both treatments may have had 
a shared mechanism of effect (e.g. a reduction in dynamic knee valgus during 
knee-loading tasks), which could explain the similarities in outcome. It is 
conceivable foot orthoses had a direct effect on reducing pain and improve 
function [277]. It could equally be plausible for the foot orthoses to influence 
lower limb biomechanics [169, 226, 241], modify loading of the patellofemoral 
joint and improve function. Whether mechanical or non-mechanical effects, 
foot orthoses appear to improve function which may allow better muscle force 
development. Whatever the mechanism of effect, the results of our clinical 
trial suggest an indirect treatment approach focused the opposite end of the 
kinetic chain can have a similar effect as one specifically directed at the 
tissue. 
 
8.4 Psychosocial 
The predominant paradigm of pain presentation in PFP assumes in isolation a 
direct mechanistic link that higher loads on the patellofemoral joint cause 
greater stress and greater pain [241]. Growing evidence suggests a rationale 
for a modified approach around the persistent nature of PFP, one that moves 
the clinician’s focus away from a solely biomedical/tissue pathology model 
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towards a consideration of the addition of non-physical contributors [44, 242, 
288]. It is pertinent to consider for some with persistent PFP, previous injuries 
and repetitively performing knee-loading activities e.g. stairs, squatting and/or 
running, may amplify local nociceptive activity, and drive the development of 
mechanosensitivity, sensitisation of peripheral and/or central nervous 
systems, and persistent pain [289, 290]. Recent systematic review evidence 
indicates the presence and elevation of other non-physical contributors in PFP 
(i.e. a psychological profile that will have raised risk of symptom amplification 
and persistence), such as fear of movement, catastrophising and depression 
[44]. Such factors have the potential to adversely influence a patient’s view of 
their physical function and behavior around activities. For some, they may be 
substantial contributors to pain perception and persistence [44, 242, 291]. 
Results from chapter 6 found that those who received foot orthoses had 
reduced anxiety at 6 weeks compared to those who performed hip exercises. 
It is plausible that foot orthoses may have had an immediate effect on 
reducing pain [164, 277], which facilitated reduced fear, better lower limb 
movement and utilisation of muscles. With due consideration, the primary 
outcome measure of this trial was a patient-rated perception of improvement 
scale. Neurophysiological and non-physical contributors to PFP may have 
modified as a result of the treatments during the trial, adding further 
considerations to explain the similarities in outcome between the two 
treatments. Future clinical trials could aim to track both biomedical and 
psychosocial outcomes over time, as interventions which are effective at 
modifying chronic pain conditions could have important mechanisms across 
both domains. The findings from our trial are in agreement with other studies 
that have compared effective treatments, such as foot orthoses versus 
physiotherapy versus foot orthoses plus physiotherapy [92], hip-and-core 
versus knee-focused programs [94], and education versus education-and-
exercise versus education-and-gait retraining programs [292]. Trials with foot 
orthoses or strengthening at various regions had similar response rates, 
supporting validity of our findings. Trials with education that aimed improve 
understanding and modify behaviour had a similar response rate, reflecting 
that biological and psychosocial domains are inextricably linked in the 
management of musculoskeletal pain conditions. 
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8.5 Clinical predictors and treatment effect modifiers 
Clinical prediction rules offer clinicians a range of clinical benefits such as 
assisting in diagnosis, prognosis, or identifying those who respond best to 
treatment. In regard to treatment selection, prediction rules are one method of 
deriving the probability of success with a certain intervention, based on a 
patient’s presenting characteristics. However, identify responders to treatment 
the prediction rule still needs to meet all the criteria that a single effect 
modifier (e.g. in regard to this thesis; midfoot width mobility) would (e.g. tested 
in a randomised controlled trial using a proper test of interaction). Studies 
claim to have derived preliminary clinical prediction rules for managing PFP 
with hip and knee exercises, foot orthoses, and patient education [95, 293, 
294]. With regards to foot orthoses, post hoc analysis identified greater 
midfoot width mobility, older age, reduced height and worst-pain rating to be 
associated with a successful outcome with foot [95]. More recently, studies 
have attempted the same process [293, 294]. In a study comparing hip-and-
core to knee-focussed rehab, post hoc analyses to derive clinical predictions 
rules for each treatment found those individuals who had successful 
outcomes presented predominantly with neuromuscular factors (i.e. muscle 
endurance and weakness) around the hip and trunk. Methodological 
considerations aside, it is plausible the two interventions shared a common 
mechanism of activity modification via patient education whilst improving the 
overall neuromuscular capacity. One study investigated an education and 
load management program in runners with PFP, and the effect of combining it 
with exercise or gait retraining [292]. With no significant difference between 
the three groups, authors derived a clinical prediction rule for predicting a 
successful outcome with an education program. However, the issue with 
deriving clinical prediction rules, that these studies exemplify, is the over fitting 
of variables to the sample size in the analyses, the population investigated, 
and the potential for a multi-faceted interplay between patient characteristics 
and response to treatment. Post hoc analyses of single-groups cannot 
distinguish between treatment effect modifiers versus non-specific prognostic 
factors and have a much higher risk of spurious findings. As such, derivation 
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of clinical prediction rules and reported factors for PFP should ideally be 
validated in more appropriately design studies that replicate and extend on 
findings to date, in order to improve confidence that predictions will be 
reflected within true clinical populations and should be utilized in clinical 
practice.  
 
Our research looked to explore and test an evidence-reasoned hypothesis for 
a potential treatment effect modifier. Research into treatment effect modifiers 
offers great potential in healthcare, and particularly in managing multifactorial 
conditions, to guide evidence-based clinical practice. We undertook an 
approach to test the evidence of greater midfoot width mobility as a potential 
treatment effect modifier for those with PFP [95, 142]. The rational for this 
study was to optimise the tailoring of treatment to those with PFP, using foot 
mobility to determine when foot orthoses many be the optimal intervention, 
and thereby assisting clinicians in the decision-making process. In contrast to 
preliminary evidence and a plausible biomechanical and clinical rationale, we 
found greater midfoot width mobility did not have a significant interaction 
effect between foot orthoses and midfoot width mobility, when compare to hip 
exercises. In light of our research findings and the absence of other potential 
treatment effect modifiers [243], future research, and clinicians, may do well to 
tailor evidence-based treatments on aspects such as patient contextual 
factors rather than tailoring treatment to physical characteristics of a patient’s 
presentation. Clinicians often muse in the decision-making process, on 
multiple considerations, for the most appropriate treatment for those with PFP. 
International consensus recommends hip exercises and foot orthoses in the 
management of those with PFP. [181] Results from our trial found comparable 
success with hip exercises or foot orthoses across three key outcome 
measures of patient-perceived improvement, pain and self-reported functional 
ability. Until further evidence is provided to help guide treatment selection, 
clinicians may well be best suited to provide good training, technique and 
patient engagement to optimise compliance on the chosen treatment. In 
consideration of our results compared to other studies that utilised wait-and-
see cohorts [93, 142], our results support that foot orthoses and hip exercises, 
as applied in chapter 6, can offer benefits to those with PFP, compared to wait 
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and see, and can readily be replicated in clinical practice. An obvious path for 
future research would be to combine both foot orthoses and hip exercises, 
with consideration given to the inclusions of quadricep strengthening 
exercises, to see if there is any summative effect for success rates. 
 
8.6 Clinical implications 
One critical consideration is what size of interaction between a patient 
characteristic (i.e. midfoot width mobility) and a treatment (i.e. foot orthoses or 
hip exercises) would be needed to be useful for guiding clinicians and patients 
in shared decision making [136]. In our study, results across a range of 
secondary outcome measures do not support midfoot width mobility, as a cut-
off (≥11mm) or as a continuous measurement, as a treatment effect modifier 
for prescribing foot orthoses over hip exercises.  Although there appeared to 
be small p-values favoring hip exercises versus foot orthoses at 12 weeks on 
three subscales of a single questionnaire, the clinical significance of these 
findings remains questionable as there was no evidence of any differences 
between groups with respect to the other 22 secondary outcome measures 
(Appendix 17). 
 
A case study was undertaken, in parallel with the trial, as an exemplar of a 
clinical case. The case was a 23yr old female with 10yr history of PFP was 
presented in chapter 7. The treatment approach of addressing foot-posture 
factors was selected off symptoms reported from a combination of pain 
provocation on stairs identified in the patient interview, physical examination 
of >11 mm midfoot width mobility from non-weight bearing to weight bearing, 
and a beneficial response to a treatment direction test where anti-pronation 
tape was able to reduce the patient’s pain and increase capacity to tolerate 
ascending stairs [164, 295]. 
 
The patient noted an immediate improvement with foot orthoses and foot 
exercises, and by the second week was progressed to only foot exercises, 
that were increased in difficulty over time. The patient reported a marked 
improvement in her symptoms, and eventually full resolution over the ensuing 
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3 months. This case study demonstrated a clinically reasoned treatment 
approach as an example of how to apply the research in clinical practice. The 
positive response to the treatment direction test and progression of exercises 
raises some pertinent considerations and questions. Our understanding and 
management of PFP has historically evolved from biomechanical and tissue 
stress paradigms, and the mechanical effects of the intervention. Yet the 
presentation of PFP, and outcomes often utilised encompass all perspectives 
of a biopsychosocial paradigm. Could a patient’s response to a treatment 
direction test suitably capture a biological and psychosocial response to a 
treatment? Could treatment direction test be a suitable approach to inform 
clinicians in the selection of an appropriate treatment i.e. foot orthoses if a 
positive response as outline above for those with PFP? For example, a 
response to the treatment direction test could be the result of an effect on the 
biological and/ or neurosensory systems, be in alignment with a patient’s 
beliefs or preferences, all of which could then drive the patient-therapist 
education and alliance. Overall, case study raises important considerations for 
further research.  
 
Results of this trial are consistent with current evidence that hip exercises or 
foot orthoses are effective in reducing pain and improving functional outcomes 
in the short term. Each treatment has specific considerations that both the 
clinician and patient need to reflect upon during the shared-decision making 
process. Considerations such as patient preference and cost. For example, 
the hip exercises require diligence, patient engagement and a more active 
investment of time and effort. Foot orthoses are a more passive approach that 
require a financial cost in acquiring the orthoses, plus potential suitable 
footwear, and diligence in wearing them plus the accompanying exercises. 
Given comparable benefits between both treatments, an appropriate would be 
to adopt a shared decision-making process between the clinician and patient 
where treatment options of either foot orthoses or hip exercises are discussed 
and decided upon. 
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8.7 Implications for future research 
Our study supports previous evidence that foot orthoses are an excellent 
treatment option for those with PFP but it remains unknown which patient 
would benefit most from foot orthoses [181]. Preliminary evidence from a 
small case series study reported foot orthoses benefit those with reduced 
ankle dorsiflexion and report an immediate reduction in pain doing a functional 
task (i.e. step-ups) when a foot orthoses is in place [277]. A plausible 
selection approach for foot orthoses could be the use of treatment-direction 
tests, using their immediate response to intervention(s) to infer prognosis for 
one intervention tested or prescription to select between interventions if two or 
more interventions are tested) [164].  This would help to capture informed 
patient engagement in the decision-making process and may help to optimise 
success rates. Future studies could investigate treatment that have an 
immediate reduction in pain doing a physical task as a tailoring approach to 
identify those who might benefit most from foot orthoses. It could be plausible 
to allocate treatment based on an initial response to a particular treatment and 
then randomised to an additional intervention, such as hip exercises and/ or 
education and activity modification.  
 
It is worthwhile investigating if a combined approach of utilising both foot 
orthoses and hip exercise is more effective. The two treatments investigated 
in this research offer comparable benefits but address PFP from opposing 
ends. No studies have investigated a combined hip and foot focused program, 
to other interventions or a wait-and-see approach. Previously studies have 
reported comparable success rates, depending on the definition of success, 
with a hip-and-core focused program [94],  foot orthoses[142], a McConnell 
approach focused on the knee, or a combination of both foot orthoses and 
knee focused program [92]. One approach could be a stepwise care approach 
to the management of PFP that includes an educational and activity 
modification aspect, progressing as required to more active exercises and 
psychology-informed rehabilitation based on the patient’s contextual factors. 
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Results of the current trial found a lack of statistical differences between foot 
orthoses and hip exercises across a variety of domains of outcome measures. 
It is possible that the interventions with foot orthoses and hip exercises may 
have a shared mechanism of biomechanical / motor control effect, or share a 
combination of net effects across biomechanical, neurophysiological and 
psychosocial domains in the management of PFP. The body of literature 
around the aetiology and understanding of PFP has been focussed on 
biomechanical hypotheses for mechanisms of effect [241]. However, the 
mechanism(s) of effect of treatments for managing PFP remain relatively 
unknown. It was gratifying to observe the success rates of participants with 
PFP, irrespective of their foot mobility and proximal or distal intervention. This 
observation strengths the point that decisions about whether effects of 
treatment are meaningful or large enough to make the costs, inconvenience 
or harm worthwhile are best made by patients, not by clinicians or researchers 
[296]. Although applying the intervention protocols could achieve a lot to 
reduce the burden of this recalcitrant problem affecting up to 29% of society, it 
is also hoped that future research will offer new directions that further optimise 
outcomes. Future studies could look to utilise a ‘benefit-harm trade-off 
method’, for assessing clinically important effects of intervention [297]. This 
approach presents the involved patients with estimates of the benefits and 
harms associated with a certain intervention; to which they then to comment 
on whether they would choose the intervention (i.e. has meaningful benefit). 
Cost, time, the amount of benefit from combining effective treatments, 
individual patient profile and most importantly patient preferences may all be 
important considerations for future research to achieve these aims.   
 
8.8 Limitations and considerations  
While the trial was designed to be as clinically feasible and realistic as 
possible, replicating previously effective protocols, certain considerations 
need to be taken into account with regards to the clinical implications of this 
research. The hip exercise protocol required the participant to attend three 
sessions a week of face to face supervised exercise with a physiotherapist. 
This allowed monitoring of adherence and ensured compliance with the 
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exercises, however time and financial costs of this may present a barrier for 
patients. The hip protocol was only four weeks in duration and while this high 
stimulus will induce large neural adaptations in the short term [298] further 
progressions of exercises may be required to build greater capacity, assist a 
return to full functional demands and potentially greater success rates.  
 
With a sample of 218 participants we found no significant difference between 
groups in the primary outcome, or of any real significance across multiple 
secondary outcome measures. Whilst the hip exercises primarily targeted the 
hip abductor, external rotator and extensor muscle groups, we only measured 
the hip abductor and external rotator muscle strength, as these are the one 
highlighted to have deficits in those with PFP. It is possible that a difference 
between treatment groups may have been found, but it is questionable if the 
difference would have any clinical relevance in light of no difference in other 
outcome measures. The secondary analysis of midfoot width as a continuous 
measure found no association between midfoot width mobility and treatment 
outcome. It could be proposed that the sample size in chapter 6 may have 
been insufficient to detect important differences in treatment effect. Further 
questions could be raised on the powering of the study for 50% difference in 
treatment success between foot orthoses and hip exercises. Given the fact 
that key comparisons did not approach statistical significance, it seems 
unlikely that a greater sample size would result in different findings. 
 
The absence of a control group limits some comparison of results as natural 
resolution of symptoms or placebo effect cannot be excluded. Results from 
this trial found foot orthoses or hip exercises offer similar success rates (48% 
(48/100) vs 50% (48/96) respectively). It is unlikely that 48-50% would have 
improved with a wait-and-see or usual care approach. Previous research 
showed a success rate of  47% (9/10)  with foot orthoses but a wait-and-see 
approach reported only 5% (1/19) success rates [142], while another study 
reported a 42%(26/62) success rate with exercise therapy, and only 
35%(21/60) success rates with usual care (i.e. education and advice of 
cessation of provoking activites) [93].Given the average duration of PFP in the 
sample in chapter 6 was 53.8 (SD 61.2) months, there is a strong body of 
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evidence to extrapolate that both arms of the current trial achieved in the 
region of 13-45% over usual care or wait-and-see approaches.  
 
A recent mixed methods study incorporating level one evidence with expert 
clinical reasoning reported tailoring treatment is one of four recommendations 
in effective management of PFP [86]. A key consideration is to tailor 
treatments to the individual and not the condition. This is a complex problem 
when dealing with multifactorial conditions. Patients with different intrinsic and 
extrinsic characteristics may respond differently to any particular treatment. 
This project demonstrated that midfoot width mobility does not predict 
response with foot orthoses or hip exercises, and that foot orthoses and hip 
exercises offer comparable benefits. If the problems presented in tailoring 
treatment can be solved, solutions might need to shift from focus on 
biomechanical factors to also actively engaging patients in the informed 
decision-making processes for treatment selection. Some patients may prefer 
a management approach that is less time and effort intensive, such as foot 
orthoses. Some may prefer to undertake an active management approach 
doing hip exercises, which requires dedicated time and effort to complete the 
exercises. Some may experience an immediate modification in symptoms and 
improved function with foot orthoses [164, 277] that could then encourage 
confidence and self-efficacy for addition of active exercises as well. 
Optimising treatment could be based as much on the patient’s thoughts, 
presenting and explaining the evidence to the patient and enable a shared 
decision-making process, as the effects on proximal and distal function of the 
lower limb.  
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Appendix 1 Search strategy and results 	
 Search terms MEDLINE EMBASE CINAHL SPORTDiscus 
Web of 
Science 
Scopus 
1 Arthralgia 13099 46401 1310 64 4495 42568 
2 
Knee Joint OR Knee OR 
Patella 137304 181740 30204 39252 118874 180553 
3 #1 AND #2 2020 4157 250 16 219 4496 
4 anterior knee pain 3296 4931 392 666 3142 4570 
5 
femoropatell* OR femoro-
patell* OR retropatell* OR 
”patellofemoral pain 
syndrome” OR 
”patellofemoral pain” 2043 1636 1145 1224 2185 2787 
6 
”lateral compression 
syndrome” OR ”lateral facet 
syndrome” OR ”lateral 
pressure syndrome” OR 
”facet syndrome” 138 239 25 21 118 237 
7 
chondromalac* or 
chondropath* 1252 230 141 411 1185 6225 
8 #3 OR #4 OR #5 OR #6 OR #7 7675 10261 3230 2025 5963 16470 
9 Success* 866281 327494 90406 76371 1123969 349693 
10 Factor* 4528431 3032546 669098 106100 3446802 7141735 
11 Predict* 1214973 421916 137305 43884 1894723 2982535 
12 Charact* 2401783 169595 137915 55024 3992407 6553192 
13 Prognos* 652826 54789 57054 4194 443798 827108 
14 
#9 OR #10 OR #11 OR #12 OR 
#13 7835734 3756532 888981 248457 9141006 16466975 
15 #8 AND #14 2636 1665 600 491 1774 6013 
16 Limit to human only studies 2196 1555 600 491 1774 5013 		 	
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Appendix 2 Details and patient characteristics evaluated in 
retrieved studies 
Number Patient 
Characteristic 
Specified 
treatment studies 
(n) 
Prognostic studies 
(n) 
Successful 
outcome to a 
specified 
treatment 
Poor  outcome, 
regardless of 
treatment 
1.  
Age 7 [95, 141, 152, 
155, 299-301] 
7 [146, 147, 302-
306] 
>25 yrs to foot 
orthoses treatment 
[95] 
Older [303] 
2.  
Sex 7 [95, 141, 152, 
155, 299-301] 
7 [146, 147, 302, 
303, 305-307] 
 At 3 months: Female 
[146] 
3.  
Knee pain 
duration 
6 [95, 152, 155, 
299-301] 
7 [146, 147, 302, 
303, 305-307] 
 At 6 weeks: Longer 
duration [305] 
At 3 months: >6 
months, >4 months 
[146],  
At 12 months: 
Longer duration 
[305, 307]  
4.  
Q- Angle 4 [141, 152, 155, 
300] 
4 [121, 146, 303, 
308, 309] 
Larger Q angle to 
patella taping 
treatment [141] 
 
5.  
Body mass 
index 
5 [95, 112, 141, 
155, 301] 
3 [147, 303, 305, 
306] 
Lower BMI to 
patella taping 
treatment[141] 
 
6.  
Weight 5 [95, 112, 141, 
155, 299] 
3 [302, 303, 306]   
7.  
Height 5 [95, 112, 141, 
155, 299] 
3 [302, 303, 306]   
8.  
Sports 
participation 
2 [299, 301]  4 [147, 302, 303, 
307] 
  
9.  
Navicular Drop 5 [144, 152, 155, 
299, 300] 
 <3mm to foot 
orthoses treatment 
[152], >3mm to 
lumbopelvic 
manipulation [300] 
 
10.  
Baseline worst 
pain score 
2 [95, 299] 3 [147, 148, 305] <53.25mm (VAS) 
to foot orthoses 
treatment [95] 
 
11.  
Hamstring 
muscle length 
3 [152, 155, 300] 1 [307]   
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12.  
Anterior Knee 
Pain Scale 
(Kujala) 
1 [95] 3 [148, 305]  Low baseline score 
[305] 
13.  Step-downs 1 [299] 3 [148, 305, 307]   
14.  
Bilateral 
symptoms 
2 [95, 300] 2 [147, 307]  Bilateral symptoms 
[147] 
15.  
Effusion 1 [300] 3 [121, 146, 147, 
309] 
 Self-reported 
swelling [147] 
16.  Tibial torsion 3 [152, 155, 300]    
17.  Craig’s test 3 [152, 155, 300]    
18.  Obers test  3 [152, 155, 300]    
19.  Thomas test 3 [152, 155, 300]    
20.  
Ankle 
dorsiflexion 
(Bent knee) 
3 [144, 152, 300, 
310] 
 <41.3deg to foot 
orthoses treatment 
[299], >16deg to 
lumbopelvic 
manipulation [300] 
 
21.  
Arch height 
weight bearing 
2 [95, 112] 1 [305]   
22.  
X-ray: Lateral 
Patellofemoral 
Angle 
 
2 [141, 155] 1 [303] Smaller lateral 
patellofemoral 
angle to patella 
taping 
treatment[141] 
 
23.  
X-ray: Sulcus 
angle 
1 [155] 2 [121, 303, 309]   
24.  
Functional index 
questionnaire 
1 [95] 2 [305, 307]   
25.  
Pain when 
ascending stairs 
(VAS) 
 3 [148, 307]    
26.  
Pain when 
descending 
stairs (VAS) 
 3 [148, 307]   
27.  Grating  3 [146, 147, 307]   
28.  
Hypermobile 
patella 
 3 [121, 146, 303, 
309] 
 Hypermobile Patella 
[146] 
29.  
Baseline usual 
pain score 
2 [95, 299]  <22/100mm usual 
pain to foot 
orthoses treatment 
[299] 
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30.  
Ankle 
dorsiflexion 
(Straight knee) 
2 [152]    
31.  
Rearfoot in 
subtalar neutral 
2 [152, 300]    
32.  
Forefoot to 
rearfoot 
alignment 
2 [152, 300]  ≥2deg valgus 
forefoot alignment 
to foot orthoses 
treatment [152]  
 
33.  
Relaxed 
calcaneal stance 
2 [152, 300]    
34.  
Tibial 
varus/valgus 
2 [152, 300]    
35.  
Hip extension 
strength – 
Dynamometer 
2 [144, 155, 310]    
36.  
Hip abduction 
strength- 
Dynamometer 
2 [144, 155, 310]    
37.  
Knee extension 
strength- 
Dynamometer 
2 [144, 155, 310]    
38.  
Midfoot width 
weight bearing 
2 [95, 112]    
39.  
Midfoot width 
non-weight 
bearing 
2 [95, 112]    
40.  
Midfoot width 
difference 
2 [95, 112]  >10.96mm [95] 
and >11.25mm 
[112] to foot 
orthoses treatment 
 
41.  
Arch height non-
weight bearing 
2 [95, 112]    
42.  
Arch height 
difference 
2 [95, 112]    
43.  Arch height ratio  2 [95, 112]    
44.  Left knee pain 2 [155, 300]    
45.  Right knee pain 2 [155, 300]    
46.  
First metatarsal 
phalangeal 
extension ROM 
2 [152, 300]  <78deg to foot 
orthoses treatment 
[152] 
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47.  
PFP affects 
ability to squat 
2 [144, 300, 310]  Squatting reported 
as most painful 
activity to 
lumbopelvic 
manipulation [300]  
 
48.  
Hip internal 
rotation ROM 
2 [144, 300, 310]  >14deg side to 
side difference 
[300] 
 
49.  
Stiff after 
prolonged sitting 
2 [144, 300, 310]  No stiffness with 
sitting >20mins to 
lumbopelvic 
manipulation 
treatment [300] 
 
50.  
Beighton 
Hypermobility 
Scale 
1 [155] 1 [303]   
51.  
X-ray Patella 
congruence 
angle  
1 [155] 1 [121]   
52.  
Leg Length 
discrepancy 
1 [152] 1 [303]   
53.  
X-ray: Lateral 
Patellofemoral  
Displacement 
1 [141] 1 [303]   
54.  Clicking 1 [300] 1 [307]   
55.  Step-ups 1 [299] 1 [148]   
56.  Patella alta  2 [121, 146, 309]   
57.  
Vastus Medialis 
Atrophy 
 2 [121, 146, 309]   
58.  
Peripatellar 
tenderness 
 2 [121, 146, 307]   
59.  Pain at rest  2 [148, 307]    
60.  Triple hop (cm)  2 [148, 307]   
61.  
Pain when 
Squatting/ 
kneeling (VAS) 
 2 [148, 307]   
62.  
Pain during 
prolonged sitting 
(VAS) 
 2 [148, 307]   
63.  
Pain during daily 
activities (VAS) 
 2 [148, 307]   
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64.  
Triple hop limb 
symmetry index 
 2 [148, 307]   
65.  
Single limb hop 
symmetry index 
 2 [148, 307]   
66.  Pain at rest  2 [148, 307]   
67.  
Quadriceps 
muscle torque at 
60deg/s 
(concentric) 
 2 [148, 307]   
68.  
Frequency of 
pain (how often) 
 2 [148, 307]  Higher frequency 
[148] 
69.  
Patella grind test 
(Clarke sign) 
 2 [146, 302]   
70.  Patellar glide 1 [300] 1 [307]   
71.  
Patellar 
orientation  
1 [152]    
72.  Pelvic obliquity 1[300]    
73.  McConnell test 1 [300]    
74.  Patellar tilt 1 [300]    
75.  
Patella tilt angle 
difference 
1[311]  Greater patella tilt 
angle difference 
[311] 
 
76.  
Peak Medial-
lateral foot 
loading during 
drop jump 
1 [153]  Immediate 
decrease in medial 
– lateral peak foot 
force after fitting 
orthoses [153] 
 
77.  
Peak Medial-
lateral foot 
loading during 
drop jump 
1 [153]    
78.  
Peak Medial-
lateral foot 
loading during 
drop jump 
1 [153] 
 
   
79.  
Peak Medial-
lateral foot 
loading during 
drop jump 
1 [153]    
80.  Ely Test 1 [155]    
81.  
Femoral Slump 
test 
1 [155]    
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82.  
History of low 
back pain 
1 [155]    
83.  Leg Dominance 1 [155]    
84.  
Bilateral 
difference  in hip 
extension angle 
1 [155]  After 6 sessions 
(2weeks): ≥3deg 
difference [155] 
 
85.  
Significant 
immediate 
efficacy  
1 [155]  After 6 sessions 
(2weeks): positive 
significant 
immediate 
response [155] 
 
86.  
forefoot relative 
to rearfoot 
dorsiflexion 
1 [77]    
87.  
Forefoot relative 
to rearfoot 
Abduction 
1 [77]    
88.  
Rearfoot relative 
to laboratory 
floor eversion 
1 [77]  Greater peak 
rearfoot eversion 
with foot orthoses 
treatment [77] 
 
89.  
Rearfoot relative 
to tibia eversion  
1 [77]    
90.  
Previous knee 
pain history 
1 [300]    
91.  Knee locking 1 [300]    
92.  Knee giving way 1 [300]    
93.  
PFP affects 
ability to run 
1 [300]    
94.  
PFP affects 
ability to lift 
1 [300]    
95.  
PFP affects 
ability to go up 
stairs 
1 [300]    
96.  
PFP affects 
ability to go 
downstairs 
1 [300]    
97.  Crepitus 1 [300]    
98.  Stiffness 1 [300]    
99.  Hip flexion 
strength – 
1 [300]    
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Manual muscle 
test 
100.  
Hip extension 
strength– 
Manual muscle 
test 
1 [300]    
101.  
Hip abduction 
strength– 
Manual muscle 
test 
1 [300]    
102.  
Hamstrings 
strength– 
Manual muscle 
test 
1 [300]    
103.  
Quadriceps 
strength – 
Manual muscle 
test 
1 [300]    
104.  
Sitting flexion 
test 
1 [300]    
105.  Stork test. 1 [300]    
106.  
Hip external 
rotation 
strength- 
Dynamometer 
1 [144]    
107.  Foot length 1 [112]    
108.  Single leg rises 1 [299]    
109.  
Footwear motion 
control 
characteristics 
1 [299]  >5.0 (weighted 
mean) to foot 
orthoses treatment 
[299] 
 
110.  
Foot posture 
index 
1 [299]    
111.  
Change in 
functional 
performance 
1 [299]  Reduced pain 
during single leg 
squat with foot 
orthoses in place 
[299] 
 
112.  
change in 
footwear comfort  
1 [299]    
113.  
MRI tibial 
tubercle lateral 
deviation 
 1 [304]   
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114.  
MRI Patellar 
cartilage surface 
 1 [304]   
115.  
MRI Trochlear 
cartilage surface  
 1 [304]  Evidence of 
chondromalacia 
patella [304] 
116.  Patella Squinting  1 [303]   
117.  
Rearfoot 
eversion – 
Squatting test 
 1 [303]   
118.  
Knee range of 
motion 
 1 [303]   
119.  
Knee 
hyperextension 
 1 [303]   
120.  
Insall-Salvati 
Index 
 1 [303]   
121.  
Blackburne-Peel 
index 
 1 [303]   
122.  
Patellofemoral 
Index 
 1 [303]   
123.  
Knee angle (X-
ray) 
 1 [303]   
124.  
Tight lateral 
retinaculum 
 1 [146]   
125.  
MRI Cross-
sectional area 
VMO (patella) 
 1 [148]   
126.  
MRI Cross-
sectional area 
VL (patella) 
 1 [148]   
127.  
MRI Cross-
sectional area 
VM & VI (thigh) 
 1 [148]   
128.  
MRI Cross-
sectional area 
VL (thigh) 
 1 [148]   
129.  
MRI Cross-
sectional area 
Rectus femoris 
(thigh) 
 1 [148]   
130.  
MRI Cross-
sectional area 
 1 [148]  Smaller quadriceps 
muscle size [148] 
192 
total quadriceps 
(thigh) 
131.  
Quadriceps 
muscle torque at 
60deg/s 
(eccentric) 
 1 [148]  larger eccentric 
peak torque at 
60deg/sec [148] 
132.  
Quadriceps 
muscle torque at 
240deg/s 
(concentric) 
 1 [148]   
133.  
Quadriceps 
muscle torque at 
240deg/s 
(eccentric) 
 1 [148]   
134.  
Retro-patellar 
cartilage 
damage 
 1 [308]   
135.  
Age at symptom 
onset  
 1 [308]   
136.  
Feeling of giving 
way 
 1 [307]   
137.  
Length 
quadriceps 
 1 [307]   
138.  
Length m. 
gastrocnemius 
 1 [307]   
139.  
Step test 
ascending 
(Maximum 
height pain free) 
 1 [307]   
140.  
Step test 
descending 
(Maximum 
height pain free) 
 1 [307]   
141.  
Unilateral squat 
test (°pain free)  
 1 [307]   
142.  
Pain during triple 
jump test 
 1 [307]   
143.  
Reflex response 
time VMO 
 1 [307]  Slower reflex 
response time [307] 
144.  
Reflex response 
time VL 
 1 [307]   
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145.  
Quadriceps 
muscle torque at 
180deg/s, 
 1 [307]   
146.  
Quadriceps 
muscle torque at 
300deg/s 
 1 [307]   
147.  
Hamstring 
muscle torque at 
60deg/s 
 1 [307]   
148.  
Hamstring 
muscle torque at 
180deg/s 
 1 [307]   
149.  
Hamstring 
muscle torque at 
300deg/s 
 1 [307]   
150.  Pain during work  1 [307]   
151.  
Pain during 
walking 
 1 [307]   
152.  
Presence of 
crepitations 
 1 [307]   
153.  
Pain during 
ascending stairs 
 1 [307]   
154.  
Pain during 
descending 
stairs 
 1 [307]   
155.  
Pain during 
running 
 1 [307]   
156.  
Pain during 
jumping 
 1 [307]   
157.  
Pain during 
sports activities 
 1 [307]   
158.  Nightly pain  1 [307]   
159.  
Pain during 
squatting 
 1 [307]   
160.  
Movie sign 
symptoms 
 1 [307]   
161.  
Pain daily 
activity 
 1 [307]   
162.  
Pain during 
isokinetic testing 
 1 [307]   
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163.  
Pain with patella 
apprehension 
test 
 1 [302]   
164.  
Isometric 
quadriceps 
muscle strength 
side-to-side 
difference  
 1 [302]  Larger side to side 
isometric quadriceps 
muscle strength 
difference [302] 
165.  
X-ray 
malalignment  
 1 [302]   
166.  
Pain score 
(VAS) during 
functional test 
 1 [155]   
167.  
Pressure pain 
threshold 
localized 
 1 [312]   
168.  
Pressure pain 
threshold distal 
 1 [312]   
169.  
Education level  1[147]  Low/middle 
education level [147] 
170.  
Comorbidity 
skeletal system 
 1[147]   
171.  
Non-skeletal 
comorbidity 
 1[147]   
172.  Poor health  1[147]  Poor health [147] 
173.  
History of knee 
symptoms 
 1[147]   
174.  
Recurrence of 
symptoms 
 1[147]   
175.  
Self-reported 
warm knee 
 1[147]   
176.  
Locking of the 
knee (Lysholm) 
 1[147]   
177.  
Instability of the 
knee (Lysholm) 
 1[147]   
178.  
WOMAC 
function 
 1[147]   
179.  WOMAC Pain  1[147]   
180.  
WOMAC 
Stiffness 
 1[147]   
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Appendix 3 Study quality of all included studies assessed 
using the Epidemiological Appraisal Instrument 	
QUESTIONS Ba
rt
on
 2
01
1a
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Bl
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19
96
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st
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M
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01
2 
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i 1
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m
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8  
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01
2 
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5 
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le
ff 
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a 
Ra
th
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ff 
20
15
b 
Su
tli
ve
 2
00
4 
Vi
ce
nz
in
o 
20
10
 
W
itv
ro
uw
 2
00
2 
W
itt
st
ei
n 
20
09
 Studies 
Scoring 
"Yes" 
(n(%)) 
Q1. Reported study aim/                                                 2 (92%) 
Q2. Treatment clearly described                                                 4 (84%) 
Q3. Main outcome measure 
described 
                                                88% 
Q4. Study Design described                                                 80% 
Q5. Source of subject population 
clearly described  
                                                16% 
Q6. Eligibility criteria for subject 
selection clearly described 
                                                88% 
Q7. Participation rates reported                                                 32% 
Q8. Participant characteristics 
described                                                 80% 
Q9. Participants characteristics 
who are lost after entry or 
decline described  
                                                72% 
Q10. Important adverse effects 
reported                   *                             4% 
Q11. Intrinsic patient 
characteristics described                                                  52% 
Q12. Extrinsic factors described                                                  20% 
Q13. Statistical methods clearly 
described                                                 88% 
Q14. Main findings of study 
clearly described                                                 100% 
Q15. Reported variability in the 
data                                                 88% 
Q16. Reported statistical 
parameters                                                 88% 
Q17. Sample Size calculations                                                 28% 
Q18. Comparability of 
case/control groups 
*	 *	 *	                                           32% 
Q19. Adequate participation 
rates 
                                                32% 
Q20. Study subjects from 
different groups recruited over 
the same time period 
                                                8% 
Q21. Subject loses taken into 
account                                                 76% 
Q23. Randomisation of study 
subjects *	 *	 *	     *	 *	     *   *     *	 *	 *	 *	   *	 *	 *	 *	 *	 20% 
Q24. Blinding of subjects and 
examiners to randomisation *	 *	 *	 *	   *	 *	     *   *     *	 *	 *	 *	   *	 *	 *	 *	 *	 0% 
Q29. Blinded observers     *                                           36% 
Q30. Subjects blinded     *                                           8% 
Q31. Main outcomes measures 
reliable               
                                 16% 
Q32. Main outcome measures 
valid                                                 24% 
Q33. Assessment method of 
outcome variables standard 
across groups  
                                                96% 
Q34. Observations taken at 
same time point                                                 20% 
Q35. Prior history collected and 
included in analysis                                                 48% 
Q36. Adequate adjustment for 
covariates and confounders in 
terms of intrinsic variables in the 
analyses? 
                                                36% 
Q37. Adequate adjustment for 
covariates and confounders in 
terms of extrinsic variables in 
the analyses? 
                                                8% 
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Q38. Sufficient follow-up time to 
detect a relationship between 
treatment and outcome? 
                                                100% 
Q39. Do the analyses adjust for 
different lengths of follow-up of 
subjects? 
                                                84% 
Q41. Reported data for 
subgroups of subjects                                                 80% 
Q42. Generalizability of results 
to study populations                                                 60% 
Q43. Generalizability of results 
to other populations                                                 60% 
Average quality score (0-2) 
1.
18
 
1.
00
 
1.
13
 
1.
36
 
0.
95
 
1.
31
 
1.
20
 
1.
11
 
0.
68
 
1.
35
 
1.
35
 
1.
11
 
1.
32
 
1.
32
 
1.
11
 
0.
43
 
1.
06
 
1.
49
 
1.
73
 
1.
54
 
1.
26
 
1.
17
 
1.
11
 
1.
03
 
  
 
Black shading (2) = “Yes”; Grey shading (1)= “Partial”; White (0) = “No” or “Unable to determine”; 
‘shaded with a * ’= “Not applicable”, items removed from scoring and not included in calculations. 
 
Question 22, 25, 26, 27, 28 & 40 were removed as they are not applicable to intervention studies 
Inter-rater agreement between the quality assessors was 87%  
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Appendix 4 Quality appraisal using a checklist for 
prescriptive, derivation-based clinical prediction rules 
(QUADCPR) 
Questions Bar
ton 
201
1a 
Bar
ton 
201
1b 
Cro
well 
201
2 
Hu
ang 
201
5 
Iver
son 
200
8 
La
n 
20
10 
Lank
horst 
2015 
Mill
s 
201
2 
Pen
g 
201
5 
Rat
hlef
f 
201
5 
Su
tliv
e 
20
04 
Vice
nzin
o 
201
0 
1. Setting and location 
reflective  
            
2. Inclusion and 
exclusion criteria 
            
3. Sample 
characteristics  
            
4. Prospective and 
consecutive sampling 
            
5. Outcome 
measure(s) defined 
            
6. Outcome measure 
reliability, validity and 
sensitivity to change 
            
7. Blinded outcome 
measure(s)  
            
8. Outcome measure 
defined (positive/ 
negative)  
            
9. Logical rationale for 
predictor test  
            
10. Predictor test was 
performed pre-
treatment 
            
11. Predictor test and 
measures were 
explained in detail 
            
12. Predictor tests/ 
measures performed 
in a clinically 
consistent, 
acceptable, and 
appropriate method 
            
13. Examining 
clinicians blinded to 
the outcome 
measures  
            
14. Treating clinicians 
blinded to outcome 
measures 
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15. Reliable predictor 
tests and measures 
used (>0.60 Kappa 
and or 0.70 ICC)  
            
16. Appropriate time 
intervals  
            
17. Equivocal or 
indeterminable results 
were reported 
            
18. Adequate sample 
powering (10 subjects 
in the limiting sample 
size for each potential 
predictor variable) 
*footnote 
            
19. First order 
interactions were 
assessed and 
reported 
            
20. The statistical 
significance of the 
model or "fit" was 
reported 
            
21. Confidence 
intervals of the 
regression analyses 
reported  
            
22. Irrelevant 
predictors removed 
prior to multivariate 
modeling  
            
23. Statistical results 
of the clinical 
prediction rule were 
reported using 95% CI  
            
24. Treatment/ 
intervention 
procedures are 
explained in detail 
            
25. Treatment/ 
intervention(s) were 
performed in a 
clinically consistent, 
acceptable, and 
appropriate method 
            
26. Comparator 
treatment/ intervention 
procedures are 
explained in detail 
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27. Comparator 
treatment/ 
intervention(s) were 
performed in a 
clinically consistent, 
acceptable, and 
appropriate method 
            
 
Black shading = "Yes", Grey shading = "Unclear", White (no shading) = "No" 
Inter-rater agreement between the quality assessors was 92% across all 13 
papers. 
*footnote: Modified in accordance with the TRIPOD statement [134] 
recommendation for a minimum of 10 subjects in the limiting sample size (i.e. 
those who experienced the least frequent outcome) for each potential 
predictor variable.
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Appendix 5 Patient characteristics associated with a poor outcome (prognosis) 
Author Sample 
size (n) 
Variables 
assessed 
(n) 
Outcome 
measures 
Univariate (p) 
or  
Multivariate 
(p)  
Follow 
up 
Prognostic variables for a poor 
outcome 
Explained 
Variance (R2) 
Covariate Intervention(s) Trial Type 
Blond 
and 
Hansen 
1998 
[146] 
250 12 Pain resolution Univariate 
(p<0.05) 
5.7 yrs  Hypermobile patella 
>4month duration of symptoms 
Female 
- None 
specified 
Advised to wear knee 
brace and VMO exercises: 
open and closed kinetic 
chain (Phase 1: non-
loaded, phase 2: loaded 
exercises, phase 3: return 
to main athletic activity) 
 
Retrospective 
case study 
Collins et 
al 2010 
[138] 
179  11 1. Pain (VAS) 
2. Kujala Scale  
3. Functional 
Index 
Questionnaire 
 
Univariate 
(p<0.01) then 
multivariate 
(p<0.01) 
6 wks 
 
1. High pain severity  
2. Longer duration of 
symptoms, lower baseline 
Kujala score 
3.Longer duration of 
symptoms, lower baseline 
Functional Index Questionnaire 
score 
1. R2 = 23%  
2. R2 = 40.1% 
3. R2 = 38.6% 
Treatment 
group 
Flat inserts - versus - foot 
orthoses – versus - physio 
exercises (patellar 
mobilization, patellar 
taping, VMO retraining, 
Hip ER retaining and hip 
and hamstring stretches) 
– versus - foot orthoses 
and physio exercises 
 
Randomized 
Controlled 
Trial 
12 wks 1. Nil 
2. Lower baseline Kujala score 
3. Lower baseline kujala score 
1. - 
2. R2 = 28% 
3. R2 = 22% 
52 wks 1.Nil 
2. Long duration of symptoms, 
lower baseline Kujala 
3. Long duration of symptoms 
1. - 
2. R2 = 29.5% 
3. R2 = 26.6% 
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Kannus 
and 
Nittymaki 
1994 
[149] 
49 22 1. Pain (VAS) 
2. Lysholm 
scale 
3. Tegner 
scale 
Univariate 
(p<0.05) then 
multivariate 
(p<0.05) 
6 wks 
 
1. Older age 
2. Older age 
3. Older age  
- None 
specified 
Rest, quadriceps strength,  
quadriceps stretch, cold 
pack (10mins) non-
steroidal anti-inflammatory 
medication and intra-
articular injections (n=33, 
5x - 1x/week) of 
physiologic saline (n=17) 
or glucosamine (n=16) 
Prospective 
cohort study 
26 wks 1. Nil 
2. Older age 
3. Older age 
Karlsson 
et al 
1996 
[308] 
48 3 Patellofemoral 
joint evaluation 
scale  
Univariate 
(p≤0.001) 
11 yrs No variables found - None 
specified 
Quadriceps isometric 
activation. Straight leg 
rises with angle weights 
and inner range quad with 
ankle weights (30-0°) 
Retrospective 
case-control 
study 
Kastelein 
et al 
2015 
[147] 
48 21 GROC - 7 
point  
 
Univariate 
(p<0.20) then 
multivariate 
(p<0.10)  
52 wks 
 
Low/middle education level  
Poor health 
Bilateral symptoms 
Self-report of a swollen knee 
- None 
specified 
None Prospective 
cohort study 
Kettunen 
et al 
2012 
[306] 
56 6 Kujala Knee 
Pain score 
Univariate (p 
value not 
specified) 
5 yrs No variables found - None 
specified 
Arthroscopic surgery – 
versus - home exercise 
program (8weeks) 
 
Randomized 
Controlled 
Trial 
Natri et 
al 1998 
[150] 
49 11 1. Pain severity 
(VAS) 
2. Lysholm 
scale 
3. Tegner 
Scale 
Univariate 
(p<0.05) then 
multivariate 
(p<0.05) 
7 yrs Greater side to side isometric 
quadriceps muscle strength 
difference 
- None 
specified 
Rest, quadriceps strength 
, quadriceps stretch, Non-
steroidal anti-inflammatory 
medication  & intra-
articular injections (n=33, 
5x - 1x/week) of 
physiologic saline (n=17) 
or glucosamine (n=16) 
7 year 
Prospective 
cohort study  
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Nimon et 
al 1998 
[121] 
63 6 1. Pain resent 
2. Pain severity  
3. Analgesic 
use 
4. Pain 
frequency 
5. Sport 
restriction 
6. Pain 
associated 
activities 
5. Other 
symptoms  
Univariate (p 
not specified)  
16 yrs No variables found - None 
specified 
Physiotherapy and laster 
immobilization 
Prospective 
cohort study 
Pattyn et 
al 2012 
[148] 
40 21 1. Kujala Knee 
pain Scale 
2. GROC – 5-
point Likert 
scale 
 
Univariate 
(p<0.05) 
7 wks Higher frequency of pain at 
baseline 
Smaller quadriceps muscle 
size 
Greater average eccentric 
peak torque at 60°/sec 
R2 = 0.46 None 
specified 
Mobilization, 
neuromuscular 
coordination exercises, 
stabilization exercises, 
strengthening exercises, 
stretching, cardiovascular 
and home exercise 
program of neuromuscular 
coordination exercises  
Prospective 
cohort study 
Rathleff 
et al 
2015 [ 
39 2 1. PPT 
localised  
2. PPT distal 
3. GROC – 7-
point Likert 
scale 
Univariate 
(p<0.05) 
12 and  
52 wks 
No variables found - None 
specified 
Patient education – versus 
- patient education and 
exercises therapy 
Randomized 
controlled 
trial 
Wittstein 
et al 
30 4 PT 
Responders: 
resolution of 
 8 wks Evidence of chondromalacia 
patella on MR imaging 
Tibial tubercle deviation 
- None 
specified 
Strengthening, stretching, 
footwear modification and 
Retrospective 
case-control 
204 
2009 
[151] 
symptoms to 
the point that 
they required 
no further 
treatment 
PT Non-
responders: 
continued to 
have PFP 
severe enough 
that they 
sought further 
treatment 
>14.6mm  
 
Non-steroidal anti-
inflammatory medication 
(comparative) 
study 
Witvrouw 
et al 
2002 
[145] 
30 39 
 
1. Kujala Knee 
Pain Scale 
2. Manual test 
(Q-angle, 
muscle length, 
patellar glide) 
3. Subjective 
assessments 
4. Functional 
assessments 
 5 wks Slower reflex response time 
(VMO) 
Longer duration of symptoms 
 
- None 
specified 
No sports participation, no 
medication prescribed, no 
brace or tape, stretching 
exercises, strength 
exercises (Seated leg 
press, double or single 
one-third knee bend, 
stationary bike (10-15min 
@ 100W), rowing 
machine, step up and 
down (at pain free height), 
progressive jumping 
(3x1min)) and home 
exercise program to 
maintain strength 
Prospective 
cohort study 
12 wks Slower reflex response time 
(VMO) 
Longer duration of symptoms 
 
GROC = global rating of change, PPT= pressure pain threshold, VMO = Vastus medialis obliquus, VAS = visual analogue scale, 
*foot note: all variables are listed in appendix 2 
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Appendix 6 Patient characteristics associated with a successful outcome from a specific treatment  
Author  Intervention Comparator Outcome 
measure 
Sample 
(n) 
Success 
(n) 
Predictors to a successful outcome  Significance 
level (p) 
Positive Likelihood 
Ratio (95% CI) 
Odds Ratio 
(95% CI) 
Barton 
2011a 
[143] 
Foot 
orthoses 
Nil 5-pt GROC 60 14 Footwear motion control properties (weighted mean) 
>5.0 
Usual pain <22.0/100mm (VAS) 
Ankle Dorsiflexion (knee flexed) <41.3° 
Reduced pain during single leg squat 
0.05 1.9 (1.1–3.1)  
2.5 (1.3–4.8)  
1.5 (0.71–3.3)  
3.0 (1.8–4.9)  
 
Barton 
2011b 
[77] 
Foot 
orthoses 
Nil 5-pt GROC 26 7 Greater rearfoot eversion relative to the laboratory 
floor  
0.05 - - 
Crowell & 
Wofford 
2012 
[144] 
Lumbo-
pelvic 
manipulation 
Nil 11-pt NPRS  
15-pt 
GROC. 
44 25 Hip IR side to side difference >14° 
Ankle dorsiflexion (knee flexed) >16° 
Navicular drop >3mm 
No self-reported stiffness sitting >20 min  
Squatting (most painful activity) 
0.05 0.76 (0.05, 11.39)  
0.93 (0.78, 1.11)  
1.52 (0.54, 4.31)  
0.74 (0.46, 1.19)  
0.82 (0.49, 1.37)  
 
Huang 
2015 
[155] 
Femoral 
nerve 
mobilization 
Nil 10cm VAS  
15-pt GROC 
51 28 Significant immediate efficacy 
Bilateral difference in hip extension angle of femoral 
slump test (>3°) 
0.05 NA 
5.11 (1.28-20.30) 
 
Iverson 
2008 
[154] 
Lumbo-
pelvic 
manipulation 
Nil 11-pt NPRS 
15-pt 
GROC. 
49 22 Hip IR side to side difference >14° 
Ankle dorsiflexion (knee flexed) >16° 
Navicular drop >3mm 
No self-reported stiffness sitting >20 min  
Squatting (most painful activity) 
0.05 4.9 (1.2, 20.8)  
2.0 (1.0, 3.9)  
1.91 (1.0, 3.6)  
2.0 (1.1, 3.4)  
2.3 (1.1, 4.7)  
 
Lan 2010 
[141] 
Patella 
taping 
Nil 100mm VAS 100 66 Smaller Lateral Patellofemoral Angle 
Larger Q Angle 
Lower BMI 
0.05 - 0.81 (0.70-
0.95) 
1.14 (1.03-
1.26)  
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0.85 (0.75-
0.98)  
Lankhorst 
2015 
[156] 
Exercise 
therapy (ET)  
Usual care 
(UC) 
Kujala scale 
11-pt NPRS 
131 At 3mth 
26(ET) 
21(UC) 
 
At 12 mth 
36(ET) 
30(UC) 
Nil significant a 0.01 - - 
Mills 2012 
[142] 
Foot 
orthoses  
Wait-and-
see 
6-pt GROC 40 9(FO) 
1(W-S) 
Foot orthoses: Mid-foot width difference >11.25mm b 0.05 3.9 (1.07-14.1)  
Peng 
2015 
[138] 
Leg press 
and 
stretching 
Nil 10cm VAS 43 24 Difference in patella tilt angle between maximal 
quadriceps contraction and quadriceps relaxed 
(measured on axial CT)  
0.05 - 0.84 
Rathleff 
2015b 
[153] 
Foot 
orthoses 
Nil PFP 
Severity 
Scale 
23 12 Immediate decrease in the medial-to-lateral peak force 
after fitting the orthoses during drop jump task 
 
0.05 - - 
Sutlive 
2004 
[152] 
Foot 
orthoses 
and activity 
modification 
Nil 15-pt GROC 50 27 Forefoot alignment ≥2° valgus 
Great toe extension <78° 
Navicular drop test ≤3mm  
Uncertain 4.0 (0.7–21.9) 
4.0 (0.7–21.9) 
2.3 (1.3–4.3) 
- 
Vicenzino 
2010 
[140] 
Foot 
orthoses 
 5-pt Likert 
GROC 
42 17 Age >25 years 
Mid-foot width difference >10.96mm 
Height <165cm 
Worst pain <53.25/ 100mm (VAS) 
0.05 1.9 (1.1 to 3.1) 
3.0 (0.91 to 9.6)  
4.9 (1.2 to 20.9)  
1.5 (0.74 to 2.9)  
 
- 
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GROC = global rating of change, PPT= pressure pain threshold, VMO = Vastus medialis obliquus, VAS = visual analogue scale, 
NPRS = Numerical Pain Rating Scale, a: Analysis of interaction used was a classification and regression tree approach, b: Analysis 
of interaction used was a liner regression modeling.  	 	
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Appendix 7 Derived Clinical Prediction Rules for a specific treatment  
Study Intervention Follow-
up 
(weeks
) 
Predictors within the rule  n of 
predictors 
Success/ 
non-
success 
(n) 
Sensitivity (95%CI) Specificity 
(95%CI) 
Positive Likelihood 
Ratio (95% CI) 
Posttest 
Success 
(%) 
Barton 2011a 
[143] 
Foot orthoses 12 Footwear motion control properties >5.0 
Usual pain <22.0/100mm (VAS) 
Ankle Dorsiflexion (knee flexed) <41.3° 
Reduced pain during single leg squat 
≥1 
≥2 
≥3 
All 4 
11/25 
11/16 
7/2 
0/0 
1.00 (0.74-1.00) 
1.00 (0.74-1.00) 
0.64 (0.35-0.85) 
0 
0.26 (0.14 - 0.42) 
0.54 (0.38 - 0.70) 
0.94 (0.81 - 0.98) 
0 
1.3 (1.1 - 1.6) 
2.2 (1.5 - 3.1) 
11.1 (2.7 - 46.9) 
0 
24 
41 
78 
0 
Crowell & 
Wofford 2012 
[144] 
Lumbo-pelvic 
manipulation 
1 Hip IR side to side difference >14° 
Ankle dorsiflexion (knee flexed) >16° 
Navicular drop >3mm 
No self-reported stiffness sitting >20 min 
Squatting (most painful activity) 
≥2 
≥3 
≥4 
≥5 
- 
- 
- 
- 
0.72 (0.54–0.90) 
0.45 (0.23–0.67) 
0.16 (0.02–0.30) 
0.02 (0–0.07) 
0.11 (0–0.24) 
0.33 (0.14–0.52) 
0.84 (0.68–1.01) 
0.95 (0.85–1.0) 
0.8 (0.6–1.1) 
0.7 (0.4–1.2) 
1.0 (0.3–4.0) 
0.4 (0–10.5) 
- 
- 
- 
- 
Iverson 2008 
[154] 
Lumbo-pelvic 
manipulation 
1 Hip IR side to side difference >14° 
Ankle dorsiflexion (knee flexed) >16° 
Navicular drop >3mm 
No self-reported stiffness sitting >20 min 
Squatting (most painful activity) 
≥1 
≥2 
≥3 
≥4 
all 5 
0/11 
5/11 
8/1 
5/0 
2/0 
0.91 (0.71, 0.99) 
0.91 (0.71, 0.99) 
0.68 (0.45, 0.86) 
0.32 (0.15, 0.55) 
0.09 (0.02, 0.31) 
0.15 (0.04, 0.35) 
0.56 (0.35, 0.75) 
0.96 (0.81, 1.00)  
1.00 (0.84, 1.00) 
1.00 (0.84, 1.00) 
1.1 (0.87, 1.3) 
2.05 (1.3, 2.9) 
18.4 (3.6, 105.3) 
Infinite (0.90, infinite) 
Infinite (0.31, infinite)  
47 
63 
94 
100 
100 
Vicenzino 2010 
[140] 
Foot orthoses 12 Age >25 years 
Mid-foot width difference >10.96mm 
Height <165cm 
Worst pain <53.25/ 100mm (VAS) 
≥1 
≥2 
≥3 
All 4 
17/16 
12/8 
6/1 
0/0 
1 (0.77 to 1.0) 
0.71 (0.44 to 0.89) 
0.35 (0.15 to 0.61) 
- 
0.36 (0.19 to 0.57) 
0.68 (0.46 to 0.84) 
0.96 (0.78 to 0.99) 
- 
1.6 (1.2 to 2.1) 
2.2 (1.1 to 4.2) 
8.8 (1.2 to 66.9) 
- 
52.7 
59.5 
85.4 
- 
IR = internal rotation; (VAS) = visual analogue scale 	 	
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Appendix 8 Prognostic factors and potential treatment effect modifiers identified in this review 
 Modifiable with non-operative treatment Potentially modifiable Unable to modify with non-operative 
treatment 
Factors associated with a poor outcome  
Prognosis Clinically measurable  Swelling of knee (self-reported) [147] 
Lower Kujala score [137] 
Higher frequency of pain [148] 
Bilateral symptoms [147] 
Lower eccentric knee strength [148] 
Larger asymmetry in side-to-side isometric quads strength [150] 
Low/middle education [147] 
Poor health [147] 
Longer duration [137, 145, 146])] 
Older age [149] 
Female gender [146] 
Patellar hypermobility [146] 
 
Not standard clinical 
measurement  
Smaller quads cross sectional area [148] Slower VMO reflex response 
[145] 
 
Tibial tubercle lateral deviation >14.6mm[151] 
Chondromalacia patella [151] 
Factors reported to be associated with a successful outcome to a specific treatment  
Foot orthoses Clinically measurable  Midfoot width difference > 11mm [140, 142] 
Ankle dorsiflexion (knee flexed) <41° [143] 
Usual pain < 22/100mm (VAS) [143] 
Worst pain <53/100mm (VAS) [140] 
Reduced pain during single leg squat with orthoses fitted[143] 
Footwear motion control properties (weighted mean) <5[143] 
- Height < 165cm [140] 
Age > 25 yrs [140] 
 Not standard clinical 
measurement 
Greater rearfoot eversion relative to floor [77] 
Reduced medial-lateral peak force during drop-jump [153] 
  
Patellar 
Taping  
Clinically measurable  Lower Body Mass Index [141] 
 
 Larger Q-angle [141]  
 
Not standard clinical 
measurement 
 Smaller lateral 
patellofemoral angle [141] 
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Leg press & 
stretching 
lower limb 
muscles 
Not standard clinical 
measurement 
 Difference in patellar tilt 
angle between maximum 
quadriceps contraction and 
quadriceps relaxed [138] 
- 
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Appendix 9 Hip exercise descriptors  
 Hip abduction  
(side lying) (Fig 3A) 
Hip external rotation  
(Fig 3B) 
Hip abduction  
(standing) (Fig 3C)  
Hip extension  
(Fig 3D) 
Load magnitude Approximately 10-
12RM 
Approximately 10-
12RM 
Approximately 10-
12RM 
Approximately 10-
12RM 
Number of repetitions 10 10 10 10 
Number of sets 3 3 3 3 
Rest in-between set 
(s) 
Approx. 90s Approx. 90s Approx. 90s Approx. 90s 
Number of exercise 
interventions (per 
week) 
3/week 3/week 3/week 3/week 
Duration of the 
experimental period 
(weeks) 
4 weeks 4 weeks 4 weeks 4 weeks 
Fractional and 
temporal distribution 
of the contraction 
2s concentric 
1s isometric 
2s concentric 
2s concentric 
1s isometric 
2s concentric 
2s concentric 
1s isometric 
2s concentric 
2s concentric 
1s isometric 
2s concentric 
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modes per repetition 
and duration (s) of 
one repetition 
    
Rest in-between 
repetitions (s) 
1s 1s 1s 1s 
Time under tension (s) 5s/ rep 
50s/ set 
150s/ exercise 
session 
1800s/ total 
intervention 
5s/ rep 
50s/ set 
150s/ exercise 
session 
1800s/ total 
intervention 
5s/ rep 
50s/ set 
150s/ exercise 
session 
1800s/ total 
intervention 
5s/ rep 
50s/ set 
150s/ exercise 
session 
1800s/ total 
intervention 
Volitional muscular 
failure 
No No No No 
Perceived exertion 
(/11) (appendix 1) 
5-7/11  
(‘Hard’ to ‘very hard’) 
5-7/11 
(‘Hard’ to ‘very hard’) 
5-7/11 
(‘Hard’ to ‘very hard’) 
5-7/11 
(‘Hard’ to ‘very hard’) 
Range of motion 
(degrees) 
0° to approx. 30° 0° to approx. half of 
available external 
rotation range° 
0° to approx. 30° 45° hip flexion to 
approx 0°  
214 
Recovery time in-
between exercise 
sessions ((hr) 
48hr 48hr 48hr 48hr 
Anatomical definition 
of the exercise 
(exercise form) 
Side lying with the 
symptomatic leg top-
most. Elastic band is 
placed around the 
ankle of the 
symptomatic leg and 
attached to the end of 
plinth. Participants 
abduct the leg up to 
30° hip abduction and 
return back from the 
bed.  
 
With the participant 
supine, and hips in 
30° flexion over a 
wedge. Elastic band is 
placed around the 
ankle of the 
symptomatic leg and 
held by the therapist. 
Participants externally 
rotate the hip against 
resistance to mid-
range of available 
external rotation.  
The participant will 
stand with the elastic 
band looped around 
both ankles, superior 
to lateral malleoli. 
Prior to the exercise, 
the target hip will be in 
slight internal rotation 
(to minimize incorrect 
compensatory action 
of external rotation 
during abduction). Hip 
abduction will then be 
performed to 
approximately 45°. 
The participant will 
stand with target hip in 
45°hip flexion. One 
end of the elastic 
band fixated (or held 
by the therapist) at 
knee height and 
looped around the 
back of the knee. The 
hip is then extended 
whilst maintaining a 
neutral lumbo-pelvic 
position.  
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Appendix 10 SPIRIT figure. Schedule of enrolment, interventions and assessments 
  TRIAL PERIOD 
 
Enrolment Allocation Intervention period Follow 
up 
Close out 
 
May 2014- 
November 
2016 
May 2014- 
November 
2016 
Week 
1 
Week 
2 
Week 
3 
Week 
4 
Week 
5 
Week 
6 
Week  
6 
August 
2014 – Feb 
2017 
ENROLMENT           
Eligibility screening X          
Informed Consent X          
Allocation  X         
INTERVENTION           
Foot orthoses   X X X X X X   
Hip exercises   X X X X     
ASSESSMENT           
Diagnosis X          
Midfoot width mobility X          
Demographics   X         
Global rating of 
change 
        X X 
Rate of recovery         X X 
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Patient acceptable 
symptom state 
        X X 
Numerical pain rating  X       X X 
PSFS  X       X X 
Kujala   X       X X 
KOOS  X       X X 
HADS  X       X X 
Euro-QoL   X       X X 
TSK  X       X X 
PCS  X       X X 
Functional tests: step 
up, step down, squat 
 X       X X 
Navicular height  X        X 
Midfoot height mobility  X        X 
Isometric hip strength 
testing 
 X       X X 
Range of motion 
measures 
 X       X X 
Kujala – Kujala patellofemoral pain scale; PSFS – Patient specific functional scale; KOOS - Knee injury and osteoarthritis outcome 
scale; HADS – Hospital anxiety and depression scale; TSK – Tampa scale for kinesophobia; PCS - Pain catastrophising scale  	
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Appendix 12 Participant information sheet 
			
Sports Injury Rehabilitation & Prevention for Health research 
unit (SIRPH) 
School of Health and Rehabilitation Sciences 
Division of Physiotherapy 
The University of 
Queensland 
Brisbane Qld 4072 
Australia 
Telephone (07) 3365 2008 
International +61 7 3365 
2275 
Facsimile (07) 3365 2775 
  
  
 
 
PARTICIPANT INFORMATION SHEET 
 
TITLE:  Comparing foot orthoses and hip exercises for 
patellofemoral pain:  
   predicting those who will benefit most from foot orthoses. 
	
	
LAY	TITLE:	 Predicting	which	people	with	knee	pain	improve	more	
by	using	foot	orthoses.	
	
INVESTIGATORS:	 Mr	Mark	Matthews		
	 Dr	Andrew	Claus	 	
	 Professor	Bill	Vicenzino		 	 	 Associate	Professor	Kay	Crossley	 	
	 	 	 Professor	Tom	McPoil	
	 	 	 Associate	Professor	Robert	Nee		You	have	been	invited	to	participate	in	this	trial	of	interventions	for	knee	pain.	It	is	important	for	you	to	read	and	understand	the	following	information	about	the	trial,	which	contains	details	about	your	role	and	rights	in	the	trial.		
1.  Purpose of study 	This	study	will	examine	current	treatments	that	are	commonly	used	to	treat	people,	similar	to	you	with	pain	around	the	front	of	the	knee.	The	treatments	are	foot	orthoses	and	hip	exercises.	Previous	studies	have	shown	that	these	treatments	reduce	pain	and	improve	the	ability	to	do	move	about	and	exercise.	There	have	been	no	studies	that	have	directly	compared	the	two	treatments	against	each	other.	The	main	purpose	of	this	study	is	to	compare	the	two	treatments	in	the	same	study.	The	study	will	also	evaluate	if	there	are	any	measures	of	your	foot	or	hip	taken	before	you	start	the	treatments	that	predict	how	your	knee	responds	to	treatment.				
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2.	 Description	and	duration	of	the	study			If	you	are	willing	to	participate,	you	will	be	required	to	attend	a	preliminary	session	at	the	School	of	Physiotherapy	at	the	University	of	Queensland	for	a	screening	exam	to	ensure	that	it	is	safe	and	appropriate	to	treat	you	with	either	of	the	two	treatments	(foot	orthoses	or	hip	exercises).	In	addition	to	this	you	will	undergo	a	number	of	tests	(e.g.,	physical	measures	and	functional	movement	analysis	involving	tasks	like	walking	up	and	down	a	step)	and	completion	of	questionnaires.	These	tests	are	commonly	used	in	physiotherapy	clinics	and	if	it	brings	on	it	should	usually	be	mild	and	short	lasting	(i.e.,	settle	within	minutes	of	doing	the	test).	Functional	movement	analysis	will	involve	measuring	knee	and	thigh	posture	from	a	digital	video	recording	of	a	single	leg	small	squat	(approximately	one	third	squat).	The	questionnaires	will	cover	a	wide	range	of	factors	related	to	your	knee	pain.	For	example,	the	questionnaires	will	get	your	description	of	the	pain	and	how	it	impacts	on	you,	your	physical	activity	levels	and	other	pain	related	impacts.		Prior	to	commencing	the	trial,	you	will	be	randomly	assigned	to	one	of	the	two	treatments.	That	is,	much	like	a	flip	of	a	coin,	you	will	have	a	50/50	chance	of	being	treated	either	by	foot	orthoses	or	hip	exercises.	The	study	investigators	who	will	be	working	with	you	will	not	know	what	you	are	going	to	be	assigned	before	you	know	yourself.	Most	importantly	nor	will	they	be	able	to	change	your	treatment	once	you	have	been	assigned.	So	before	you	agree	to	enroll	in	the	study,	it	is	extremely	important	that	you	are	comfortable	with	being	treated	with	either	the	foot	orthoses	or	the	hip	exercises.	Remember,	both	treatments	have	been	shown	to	help	relieve	pain	and	improve	movement,	but	we	do	not	know	which	one	of	these	treatments	is	better.	It	is	important	for	you	to	understand	that	once	you	have	been	assigned	to	either	foot	orthoses	or	hip	exercise,	there	will	be	no	possibility	of	this	being	changed	by	yourself	or	the	investigators.	It	is	also	important	to	avoid	other	treatments	for	your	knee	during	the	12	week	study	period.		You	will	be	assigned	to	either	of	the	two	following	treatments:	
	
	
1. Foot	orthoses	
	Foot	orthoses	are	a	device	that	is	inserted	inside	of	your	footwear.	An	experienced	and	trained	physiotherapist	will	fit	these	into	your	footwear.	The	orthoses	will	be	fitted	and	modified	to	ensure	that	they	fit	you	well.	It	is	essential	that	the	orthoses	are	comfortable	for	you	to	wear.	You	will	also	do	a	simple	home	exercise	program	of	daily	calf	stretching	and	foot	exercises,	which	will	be	taught	to	you	by	the	physiotherapist.	You	will	be	required	to	attend	6	physiotherapy	sessions	(each	will	take	approximately	30-45	minutes)	over	a	time	frame	of	6	weeks.	As	well	as	fitting	the	orthoses	and	teaching	you	the	exercises	during	these	sessions,	the	physiotherapist	will	also	monitor	your	treatment	and	make	modifications	as	required.		
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2. Hip	exercises	
	The	hip	exercises	have	previously	been	shown	to	help	pain	at	the	front	of	the	knee.	The	exercises	will	strengthen	muscles	around	the	hip	that	have	been	shown	in	previous	studies	on	knee	pain	to	be	weak.	The	strengthening	exercises	will	use	strong	elastic	bands	under	the	direct	instruction	and	supervision	of	an	experienced	and	trained	physiotherapist	in	the	clinic,	That	is,	you	will	not	have	to	do	a	home	exercise	program.	As	your	hip	muscles	strengthen,	stronger	elastic	bands	will	be	used	to	progressively	increase	muscle	strength,	so	that	you	gain	maximum	benefit	from	these	exercises.	The	exercise	program	will	require	you	to	attend	3	exercises	sessions	(each	will	take	approximately	30-45	minutes)	per	week	for	4	weeks.	That	is,	you	will	be	required	to	attend	a	physiotherapy	clinic	for	a	total	of	12	sessions	over	4	consecutive	weeks.			In	addition	to	the	treatments	at	the	physiotherapy	clinics,	you	will	be	required	to	attend	two	follow-up	testing	sessions	at	the	School	of	physiotherapy	at	the	University	of	Queensland.	At	these	testing	sessions	you	will	undergo	the	tests	mentioned	above	as	well	as	some	questions	regarding	how	your	condition	has	changed	since	treatment.	These	sessions	will	occur	6	and	12	weeks	after	starting	treatment.			This	current	informed	consent	process	seeks	your	involvement	in	the	12	week	study	described	herein	as	well	as	an	option	to	be	followed	up	over	an	extended	period.	There	is	some	evidence	that	patients	with	pain	at	the	front	of	the	knee	continue	to	experience	symptoms	well	into	the	future.	So	in	addition	to	following	you	up	at	12	weeks	to	determine	the	effects	of	the	two	treatments	in	the	short	term,	we	would	like	to	follow	you	up	long	term,	over	an	extended	period	of	10	years.	If	you	do	not	wish	to	be	followed	up	over	this	extended	period,	please	mark	where	indicated	on	the	consent	form.		This	is	entirely	at	your	discretion	and	will	not	impact	upon	your	involvement	in	this	12	week	study.		You	are	free	to	change	your	mind	and	withdraw	your	consent	at	any	time	without	any	consequences.				You	will	not	have	to	pay	for	your	treatments	(physiotherapy	sessions	or	foot	orthoses	etc),	because	we	will	pay	the	therapists	directly	once	they	have	completed	all	of	your	treatment	sessions.			
4.	 Location	of	the	study	
	Baseline	measurements	will	be	conducted	at	the	School	of	Health	and	Rehabilitative	Science,	Division	of	Physiotherapy	at	the	St	Lucia	campus	of	The	University	of	Queensland.	We	will	provide	you	with	parking	vouchers	if	you	come	to	St	Lucia	in	a	car	or	we	will	be	able	to	provide	up	to	$20	to	cover	some	of	the	costs	for	bus	or	taxi	for	travel	to	and	from	St	Lucia	campus	of	The	University	of	Queensland.			
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Treatment	sessions	will	be	conducted	locally	at	participating	physiotherapy	clinics.	The	physiotherapy	clinics	are	spread	around	the	greater	Brisbane	area	so	that	it	should	be	reasonably	easy	to	attend	a	clinic	that	is	near	your	work	or	residence,	thereby	reducing	any	time	required	to	get	to	and	from	the	clinics.		
	
	
5.	 Benefits	and	risks	
	
	It	is	important	to	understand	this	treatment	trial	may	or	may	not	be	of	benefit	to	you	and	your	symptoms.	While	treatments	used	in	this	study	have	been	shown	to	improve	pain	and	movement	for	the	majority	of	patients,	it	is	important	to	understand	that	not	all	patients	would	have	improved.			It	is	very	important	to	be	aware	of	the	very	low	risk	of	being	involved	in	this	trial.	A	small	number	of	people	involved	in	previous	studies	have	experienced	some	discomfort	at	foot	or	at	the	hip.	They	did	not	experience	any	worsening	of	their	knee	symptoms	because	of	the	treatment.			The	risk	involved	if	you	do	the	hip	strength	treatment	is	that	you	may	feel	some	delayed	muscle	soreness.	This	sometimes	happens	when	you	are	doing	a	new	exercise	and	the	muscle	aches	the	next	day.	You	have	probably	felt	this	after	a	long	walk	or	climbing	a	lot	of	stairs.	It	is	a	low	temporary	stiffness	and	or	muscle	ache	that	can	last	1-2days	and	should	not	limit	you	in	anyway.	The	elastic	bands	used	in	the	trial	may	contain	latex	products	so	please	inform	your	physiotherapist	if	you	have	any	known	allergies.		If	you	receive	the	foot	orthoses,	they	will	be	fitted	to	you	with	the	main	goal	of	being	comfortable.	However	there	is	a	small	chance	you	may	feel	some	rubbing	and	discomfort	on	your	foot	and	toes	with	a	chance	of	a	small	blister.	This	usually	happens	at	the	very	start	of	wearing	orthoses	and	can	be	improved	with	small	adjustments	made	by	the	physiotherapist	at	one	of	the	six	treatment	sessions.		Generally	these	minor	discomforts	do	not	stop	you	from	continuing	to	participate	in	the	trial.	If	you	do	experience	any	discomfort,	please	report	it	immediately	to	your	treating	physiotherapist	who	will	advise	you	on	what	to	do.	Your	treating	physiotherapist	will	let	us	know	about	any	complications	you	report	to	them.	In	addition	to	contacting	your	physiotherapist	during	the	four	or	six	week	treatment	period	please	contact	a	member	of	the	research	team	(details	below)	for	any	complications	or	adverse	reaction	at	any	stage	during	the	12	weeks	of	the	study	or	thereafter.		Feedback	on	individual	assessment	results	will	be	provided	on	request	and	a	summary	of	the	overall	outcomes	of	the	study	will	be	available	at	the	completion	of	the	research	project.	Should	you	have	any	questions	regarding	the	nature	of	the	research,	please	feel	free	to	contact	Professor	Bill	Vicenzino	(b.vicenzino@uq.edu.au	or	3365	2781)	who	will	be	happy	to	provide	you	with	more	information.	
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	Your	privacy	while	participating	in	this	study	will	be	maintained	at	all	times.	Any	publications	or	presentations	will	not	identify	you	or	any	individual	in	the	study.,	We	will	use	a	numerical	code,	not	your	name,	in	our	databases.	All	information	provided	by	yourself	and	data	collected	will	be	kept	securely	in	a	locked	filing	cabinet	and	password	protected	computer	files	at	the	School	of	Health	and	Rehabilitative	Sciences,	Division	of	Physiotherapy	at	the	University	of	Queensland.		All	information	will	only	be	accessed	by	the	research	team	at	the	School	of	Health	and	Rehabilitative	Sciences,	University	of	Queensland.		This	study	has	been	cleared	by	one	of	the	human	ethics	committees	of	the	University	of	Queensland	in	accordance	with	the	National	Health	and	Medical	Research	Council’s	guidelines.	Whilst	you	are	free	to	discuss	your	participation	in	this	study	with	the	project	staff,	if	you	would	rather	speak	to	an	officer	of	the	University	not	involved	in	the	study,	you	may	contact	Michael	Tsu,	the	Ethics	Officer	on	3365	3924.		Whilst	we	have	invited	you	to	be	involved	in	this	trial,	your	participation	in	this	trial	is	completely	at	your	discretion.	Your	involvement	is	completely	voluntary	and	you	are	free	to	withdraw	from	the	trial	at	any	stage	without	providing	a	reason,	without	any	penalty,	and	this	will	not	affect	in	any	way	future	management	of	your	condition.			Thank	you	for	your	interest	in	this	research	project.		Professor	Bill	Vicenzino		Ph:	07	3365	2781	Email:	b.vicenzino@uq.edu.au			Dr	Andrew	Claus	 	Ph:	(07)	3365	2095	Email:	a.claus1@uq.edu.au		
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Appendix 13 Consent form 
 
 
  
 
 
 
 
 
Sports Injury Rehabilitation & Prevention for Health research unit (SIRPH) 
School of Health and Rehabilitation Sciences 
Division of Physiotherapy 
The University of Queensland 
Brisbane Qld 4072 Australia 
Telephone (07) 3365 2008 
International +61 7 3365 2275 
Facsimile (07) 3365 2775  
 
CONSENT FORM 
 
TITLE:  Comparing foot orthoses and hip exercises for patellofemoral pain:  
   predicting those who will benefit most from foot orthoses. 
 
LAY TITLE: Predicting which people with knee pain may improve their symptoms by 
using foot orthoses. 
 
INVESTIGATORS: Mark Matthews – PhD Candidate, University of Queensland 
 Dr Andrew Claus – University of Queensland 
 Professor Bill Vicenzino – University of Queensland 
   Associate Professor Kay Crossley – University of Queensland 
   Professor Tom McPoil - Regis University, USA 
   Associate Professor Robert Nee - A.T Still University, USA 
     
 
1. I, _________________________________________________(PLEASE PRINT YOUR NAME) hereby 
consent to take part in this research project. 
2. I understand that this project is a trial of two treatments. 
3. The details of the treatments have been explained to me, including the frequency and duration of the 
treatment sessions,as well as an indication of any discomfort or possible risks that may occur.  
4. I understand that my involvement in this project requires me to attend regular physiotherapy sessions, 
and may require me to comply with a prescribed home exercise program.  
5. I understand that measurements will be taken prior to commencing and also after completing the 
intervention protocol. These will include questionnaires, repeated movements (i.e. Step-ups), joint 
movement, foot posture, muscle length and muscle strength measurements.  
6. I acknowledge that I have read the information sheet provided, and that I have had the project, so far as it 
affects me, fully explained to my satisfaction by the investigators. I freely consent to my participation in 
the project. 
7. I understand I will be randomly assigned to an intervention protocol, which cannot be changed. I also 
acknowledge that the treatment will involve some of the following: hip or foot exercises, and foot orthoses.  
8. I am informed that the results of any tests involving me will be published so as to not reveal my identity, 
and that my privacy will be maintained at all times. 
9. I understand that I am free to withdraw from the project at any stage without penalty and that this will 
not affect in any way the ongoing management of my condition. 
10. I understand that the trial has a follow-up period after completion of the treatment. Please select ( [X] )  
one of the two follow up options below to indicate the follow up period you consent to: 
[ ] I wish to participate in ONLY the 12 week trial 
[ ] I wish to participate in the 12 week trial AND consent to being followed up over a 10 year period 
 
 
Signed: __________________________  Name: ________________________ Date: ______________ 
  (participant)    (Print) 
 
Signed: __________________________  Name: ________________________ Date: ______________ 
    (witness)    (Print) 
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Appendix 14 FOHX trial Statistical Analysis plan  
 
Study: Foot Orthoses versus Hip eXercises for patellofemoral pain 
1. EXECUTIVE SUMMARY  
Trial registration:  
Australian New Zealand Clinical Trial Registry : ACTRN12614000260628  
 
Background: 
Current best practice guidelines for optimally managing patellofemoral pain 
lists tailoring of treatment to the individual as first of four over-arching 
principles. [86] Foot orthoses and hip exercises are two such targeted 
treatments with supporting level II evidence (at least one RCT), but they have 
not been directly compared head to head in a trial. Preliminary evidence 
suggests that a more mobile foot (measured as midfoot width change from 
non-weight bearing to weight bearing) is predictive of superior outcomes with 
foot orthoses.  [140, 142] 
The FOHX trial is a randomised controlled trial that directly compares the 
efficacy of foot orthoses versus hip exercises, as well as investigating the 
utility of a midfoot width mobility measure to predict success with foot 
orthoses.  
Primary objectives: 
1. To determine if those with greater midfoot width mobility are more likely to 
report better outcomes from foot orthoses when compared to hip exercises  
2. To conduct a head to head comparison between foot orthoses and hip 
exercises in the treatment of patellofemoral pain.  
Possible treatment effect modifier 
A reliable method of measuring midfoot width in weight bearing and non-
weight bearing postures will be used to calculate the index of midfoot width 
mobility. [76] Preliminary studies have shown that a midfoot width mobility 
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index of approximately 11mm is a cut point, above which there is a far higher 
probability of success with foot orthoses. [140, 142]  
An investigator will take this measurement before participants are allocated to 
a treatment. Participants will be stratified on this index (‘high’ ≥11mm midfoot 
width mobility; ‘low’ <11mm) to ensure there are approximately equal amounts 
of those in high subgroup in each of the treatment groups. 
The investigator responsible for screening participants for study inclusion and 
collecting outcome measures, as well as the treating physiotherapists, will be 
blind to the midfoot width mobility measurements.  
Primary outcome 
The primary outcome measure will be a 7-point global rating of change scale, 
with following categories: much better, better, a little better, no change, a little 
worse, worse, and much worse. The scale categories will be dichotomized for 
analysis, with much better and better representing a success with treatment. 
Participants will be assessed at 6 and 12 weeks follow up, with 12 weeks 
being the primary endpoint.  
2. INTRODUCTION 
Current best practice guidelines for managing PFP suggests tailoring 
treatment to the individual as the first of four over-arching principles to 
optimize treatment outcome. [86] One method to do this is by using clinically 
assessable patient characteristics to match the right treatment to the right 
patient.  
 
Distal to the patellofemoral joint, greater mobility of the midfoot width has 
previously been suggested as a patient characteristic associated with better 
outcomes to foot orthoses. [140, 142] Proximal to the patellofemoral joint, 
weaknesses in the hip abductor and external rotator muscle groups have 
been associated with PFP. [213] Hip muscle strengthening exercises targeting 
these muscle groups have been shown to be efficacious [180, 310][310] but to 
date no characteristic has been reported to suggest those that would have 
better outcome over other treatments. 
 
The FOHX trial: Foot Orthoses versus Hip eXercises for PFP is a randomised 
controlled trial comparing the efficacy of two common forms of treatment for 
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PFP at 12 weeks, and if a foot mobility measure will identify those who will be 
successfully treated with a foot orthosis. 
 
3 STUDY OBJECTIVES 
3.1 Primary objectives 
The primary objectives are to: 
3.1.1 Determine if greater mobility of the midfoot width (≥11 mm) is associated 
with better self-reported outcome with foot orthoses compared to hip 
exercises at 12 weeks.  
[Note: midfoot determined to be at half the total foot length; mobility 
determined as the difference in midfoot width between 50% weight bearing 
(i.e. bipedal stance) and non-weight bearing] 
3.1.2 Assess the efficacy of foot orthoses compared to hip exercises on self-
reported global perceived effect of treatment pain at 12 weeks 
3.2 Secondary objectives 
 
The secondary objectives are to: 
3.2.1 To explore the moderation of the treatment group-outcome relationship 
by midfoot mobility, where midfoot mobility is included in the model as a 
continuous variable 
3.2.2. Determine the effects of foot orthoses compared to hip strengthening 
exercises on a range of secondary outcomes (pain (usual and worst pain), 
self-reported knee pain scores, self-reported functional and physical activity, 
functional tasks (step up, step down, squats), health-related quality of life and 
psychological well-being domains (fear of movement, anxiety and depression, 
and pain catastrophising), at 6 and 12 weeks. 
 
3.2.3 Identify patient characteristics that could identify those who will be likely 
benefit from hip strengthening exercises compared to foot orthoses; at 6 and 
12weeks. 
 
4. STUDY DESIGN 
4.1 Experimental design and procedures  
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The trial is a two-arm parallel-group randomised controlled trial in which 
participants will be randomly assigned to the foot orthoses or hip exercises 
treatment group. The trial and measurements taken are designed to be 
clinically relevant/applicable so as to help inform clinicians on optimizing 
treatment outcomes. 
 
An off-site clinical trials centre will provide the randomisation sequence. 
Concealed randomisation will occur after the completion of the baseline 
assessment. 
 
Midfoot width mobility of the target knee (left or right, as some are bilateral, so 
we treat the most symptomatic) will be measured as a potential treatment 
effect modifier. An independent investigator who is not involved in participants 
screening for study inclusion, or any other baseline or any outcome measures 
will be measuring midfoot width mobility. Midfoot width mobility is defined as 
the difference in width of the midfoot between the bipedal stance position 
(50% body weight) and the non-weight bearing sitting position (0% body 
weight, as in feet not in contact with floor). Based on preliminary evidence that 
suggests midfoot width mobility of ≥11mm seems to predict success with foot 
orthoses, we will stratify participant into ‘high’ (≥11mm) and ‘low’ (<11mm)’ 
subgroups. 
 
The trial will be conducted across two sites; Brisbane, Australia and Aalborg, 
Denmark.  
4.2 Study population 
Participants will be recruited from advertisements and undergo a screening 
procedure to ensure they meet the following selection criteria. 
4.2.1 Inclusion criteria: 
• Aged from 18 to 40years at the time of study inclusion  
• Reporting a history of anterior, retro or peri-patellar knee pain of 
non-traumatic origin  
• Greater than 6 weeks duration of symptoms  
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• Self-reported worst pain over the previous week will be required to 
be greater than 3/10 on a numerical pain scale (0 = no pain, 10 = 
worst pain imaginable) 
• Self-reported symptoms provoked by at ≥2 of the following 
activities: squatting, running, prolonged sitting, stair ascending or 
descending. 
• On physical examination, pain should be provoked by clinical 
palpation of the patella borders, stepping down from a 25 cm step, 
during a double-leg squat and present on clinical compression of 
the patella into the trochlear groove. 
• Have basic comprehension of written and spoken English 
(Brisbane, Australia) or Danish (Aalborg, Denmark) 
• Provide informed consent  
 
4.2.2 Exclusion criteria:  
• Prior treatment for PFP that included targeted hip exercises or foot 
orthoses.  
• Concomitant injuries or pathologies affecting other knee structures 
(e.g. ligamentous, meniscal, tendon, iliotibial band, pes anserinus) 
• A history of knee surgery, patellofemoral dislocation or subluxation, 
Osgood-Schlatter’s disease, Siding-Larsen-Johanssen syndrome,  
• On physical examination a positive patellar apprehension test, 
evidence of knee joint effusion, a foot condition that may preclude the 
use of foot orthoses, pain in and/or referred from the hip, pelvis or 
lumbar spine 
• Current use of anti-inflammatory or corticosteroid medication 
• Pregnant at the time of study inclusion  
 
4.3 Study blinding 
Participants will not be informed of the primary objective of the study 
pertaining to midfoot width mobility as a possible treatment effect modifier. 
Participants will be blind to the physical measurements taken at baseline and 
follow-up, including midfoot width measurements.  
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Treating physiotherapists will be blind to the baseline and follow-up 
questionnaires and physical measurements taken, including midfoot width 
measurements. The physiotherapists will be aware that there are the two 
treatment arms of the study, so blinding to treatment will not occur. 
The investigator responsible for screening participants for study inclusions, 
collecting all baseline data (demographic and physical measurements, and 
baseline questionnaires) and outcome measures will be blind to treatment 
allocation and midfoot width mobility measurements.  
The investigator responsible for collecting midfoot measurements will be blind 
to all baseline data and outcome measures.  
 
5. INTERVENTIONS 
All participants will receive an education sheet about PFP, how their allocated 
treatment is associated with addressing the condition and the advice to keep 
active as long as symptoms cease as soon as activity ceases and there are 
no residual symptoms immediately after exercise or later. 
5.1 Foot orthoses 
Participants in the foot orthoses group will be prescribed foot orthoses 
following a protocol established in a previous randomised control trial. [92] 
Registered physiotherapists will be provided with a range of commercially 
available prefabricated foot orthoses (Vionic Group LLC, Labrador, Australia). 
Physiotherapists will follow a standardised systematic fitting procedure that 
prioritises comfort of the orthoses, with the scope during the fitting procedure 
to re-review the length, size and hardness of the device and various 
modifications until the participant deems the device fits comfortably.  
Participants will also be asked to perform a home foot and ankle exercise 
program, to be repeated twice per day consisting of i) stretches for the triceps 
surae/tendo-achilles complex (3 x 30 sec weight-bearing), and ii) foot 
exercises for active anti-pronation. Participants will attend a total of six 30min 
sessions over six weeks.  
5.2 Hip exercises 
Participants in the hip exercise group will receive a hip muscle strengthening 
exercise program that has previously been reported. [180] Participants will 
complete a 30min exercise session with the physiotherapist, consisting of four 
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exercises to be done bilaterally. The four exercises will be: hip abduction in 
side-lying, hip external rotation in supine with the hips in 30degrees of flexion, 
hip abduction in standing and hip extension in standing. Resistance will be 
provided by Theraband™ elastic bands of predetermined lengths and 
strengths (red, green, blue, black, grey). These exercises are prescribed 
routinely in clinical practice. Participants will attend three sessions per week 
for four weeks. There are exercises to be conducted at home. 
 
5.3 Intervention recording  
• In the hip exercise group the physiotherapist will record such 
information as: number of exercises, repetitions and sets per exercise, 
strength and pre-determined length of Theraband™ used per exercise, 
level of difficulty on a scale of perceived exertion.  
• In the foot orthoses group the physiotherapist will record the size and 
type of orthoses used, any modifications to the orthoses, comfort rating 
on a scale of 0-10 (0 ‘too uncomfortable to wear’; 10 ‘very 
comfortable’), and exercises taught (calf stretching, arch forming. 
• Adherence to treatment will be calculated using a treatment diary 
completed by the treating physiotherapists.  
 
6. OUTCOMES 
One primary outcome, a number of secondary outcomes be collected at two 
follow up sessions at 6 and 12 weeks, by an investigator blinded to treatment 
allocation and midfoot width measurement.  
6.1 Primary outcome 
The primary outcome measure will be a global rating of change scale for 
participants to rate their perception of the overall effect of their treatment.  The 
scale will consist of a 7-point vertical scale (much better, better, a little better, 
no change, a little worse, worse, much worse).  
 
6.2 Secondary outcomes 
• Single assessment numerical evaluations: Participants will be asked to 
rate their symptoms with a numerical evaluations (0-100): 
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• Self reported rate of recovery: participants will self-report a percentage 
on how they feel they have recovered from their knee pain on a scale 
where 0% is ‘not at all’ and 100% is ‘totally recovered’. 
• Self reported scale of normality: participants will be asked to rate their 
knee on the day of assessment as a percentage of normal on a scale 
of 0% to 100% (no problems at all).  
• Usual pain in the last seven days: participants will self-report their 
worst pain experience in the last seven days using a 11-point 
numerical rating scale (0 to 10), where 0 is ‘no pain’ and 10 is ‘worst 
pain imaginable’, This will be measured at baseline, 6 and 12 week 
follow up. An improvement of two or more on the NPS indicates 
clinically meaningful change. 
• Worst pain in the last seven days: participants will self-report their 
worst pain experience in the last seven days using an 11-point 
numerical rating scale (0 to 10), where 0 is ‘no pain’ and 10 is ‘worst 
pain imaginable’. This will be measured at baseline, 6 and 12 week 
follow up. An improvement of two or more on the NPS indicates 
clinically meaningful change. 
• Knee pain score: participants will complete the Kujala patellofemoral 
scale which comprises of 13 items, each weigh differently, to give a 
total score out of 100 (0 represents total incapacity, 100 represents full 
pain free function). 
• Physical activity (level): physical activity will be self-reported using the 
International Physical Activity Questionnaire-Short Form [11]. 
Participants will be classified into one of the three activity levels (low, 
moderate or high). For secondary analysis Physical activity (level) will 
then be dichotomised as having low physical activity (yes/no). 
• Knee injury scale: participants will complete the Knee injury and 
Osteoarthritis Outcome Scale (KOOS) that comprises of five separate 
subscales (pain, symptoms, activities of daily living function, sporting 
and recreation function and quality of life) designed to assess the 
patient’s opinion of their knee and symptoms. Each subscale is scored 
separately.  
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• Health-related problems and quality of life: will be measured using the 
Euro-Qol-5 Dimensions instrument that comprises of five questions 
about mobility, usual activities, self care, pain and discomfort, and 
anxiety and depression. 
Fear of movement: will be measured using the 13-item Tampa scale of 
kinesiophobia.  
• Health-related anxiety and depression: will be measured using the 14-
item Hospital Anxiety and Depression Scale 
• Pain catastrophising: will be measured using the 13-item pain 
catastrophising scale that comprises of three subscale scores for 
ruminations, magnification and helplessness respectively. 
• Functional abilities: participants will complete three physical tasks 
(step-up and step-down respectively on a 25cm step, and full depth 
squats) to first onset of pain, increase in existing symptoms or a 
maximum of 25 repetitions.  
• Participant acceptable symptom state: participants will be asked to 
respond yes or no to a question:  “Is your current condition 
satisfactory, when you take your general functioning and your current 
pain into consideration?” 
• Participant perception of success: Participants will be asked to answer 
yes or no to (a) Overall, if they agreed their treatment has been 
successful, and (b) if they would recommend the same treatment to a 
good friend.  
• Participant satisfaction: participant’s statisfaction will be assessed on a 
five-point satisfaction scale (very satisfied, somewhat satisfied, neither 
satisfied not dissatisfied, somewhat dissatisfied, very dissatisfied). 
Participants will be asked how they felt overall about (a) their 
treatment, and (b) if they had to live with their current symptoms.  
7. STUDY SAFETY 
A safety committee will be established when the need arises. It is not 
anticipated that a safety committee will need to convene much or at all, 
because the treatments have been previously studied with no reported 
serious adverse events, are common to everyday practice for this condition 
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and there is low perceived risk to participants. Participants and the treating 
physiotherapists are instructed to report any adverse effects. Adverse effects 
reported by participants or documented by the physiotherapists during the 
treatment phases of the trial will be managed and reported (to ethics and 
relevant institutional unit) as per appropriate policies and procedures at the 
relevant site.  
8. SAMPLE SIZE  
Sample size was based on proportions of patients rating themselves as 
“better” or “much better” on the Global Rating of Change (GROC) score in the 
foot orthoses and hip exercise treatment groups. A sample of 30 participants 
(15 per group) provides 80% power using a two-sided significance level of 
0.05 to detect a difference between the proportions of participants with 
improvement of 30% in the hip exercises group compared to 80% in the foot 
orthoses group. Of primary interest is the detection of an interaction between 
randomised treatment group and foot mobility group, where foot mobility is 
dichotomised as high (≥11mm) versus low mobility (<11mm). To ensure 
adequate power to detect an interaction effect of 50% (the difference in the 
difference in outcomes between the randomised groups in the high versus low 
mobility groups), assuming 20% of participants would be in the high mobility 
group, we inflated the sample size to 94 per group. [222] To allow loss to 
follow-up of up to 15%, the final sample size was 220 participants (110 per 
group).  
We decided to power the study on an interaction effect of 50% on the basis of 
our previous findings that have indicated a strong effect of foot orthoses in 
patients with PFP who had a midfoot mobility ≥11mm. [142] In that study we 
found 78% (7/9) of those with high midfoot mobility responded to an orthosis 
compared to only 20% (2/10) assigned to a control group. [142] The success 
rate had improved substantially from 47% (9/19) in the group assigned foot 
orthoses. [142] 
 
9. DATA ANALYSIS  
9.1 Data collection quality 
To ensure all data collected during the trial maintains quality, the following 
procedures will be employed: 
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• All investigators will have standardized data collection forms with pre-
determined set-up and verbal instructions to give, and will ensure all 
applicable outcomes at each assessment time point have been 
appropriately completed. 
• All relevant participant variable and outcome data collected during the 
trial will be entered into a password protected online database 
(OpenClinica™) that is maintained by an external offsite party.  The 
database will incorporate range limits for each variable entered to 
minimize input error. Once data from all participants have been 
entered, the database will be locked and data extracted in file formats 
appropriate to statistical analysis package(s) used.  
To maintain investigator blinding, participants’ data will be coded and 
documents that can disclose treatment allocation and midfoot width mobility 
measurements will be stored in locked filing cabinet accessible only to the 
appropriate investigator. Related online files will be password protected  
9.2 Data analysis principles 
All analysis of data will be conducted on a intention-to-treat basis. All 
statistical tests will be at a significance level of p<0.05 with no adjustment for 
number of comparisons.  
9.3 Blinding of data 
All data will be entered in a coded fashion and all analyses will be undertaken 
in a blind method. The statistician will be blind to group allocation by coding 
the treatment and the participants. Revealing of the coding to treatment 
allocation will only occur once the final statistical analyses have been 
conducted.  
9.5 Missing data handling  
Once all data has been collected, missing data will be reviewed. Should the 
proportion of missing data be greater than 5%, multiple imputed methods will 
be applied where necessary prior the analysis of the primary trial objectives.    
9.6 Statistical analysis  
A biostatistician blinded to treatment group allocation will conduct the trial 
analyses. All participants who have missing data and did not fully comply with 
the treatment protocol will be included in analyses. Demographic 
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characteristics will be inspected to assess baseline comparability of treatment 
groups and compare those participants who remain in the study and those 
who withdraw. If the proportion of missing data for endpoints exceeds 5%, 
multiple imputation methodology will be applied. To test the hypothesis of 
interaction between randomised group and foot mobility, terms for randomised 
group and foot mobility group, together with an interaction between the two, 
will be included in models. For the primary outcome (dichotomised GROC) 
and other binary secondary outcomes, binary regression models with a 
logarithmic link will be fit. Odds ratios will be presented, as will risk differences 
calculated from marginal probabilities. [311] For continuous outcomes, linear 
regression models will be fit, and assumptions assessed using standard 
diagnostic plots. To test for an overall treatment effect, the regression models 
described above will be interrogated to yield a marginal treatment effect 
estimate and 95% confidence interval. Similar models will be fit to determine 
the effects of treatment on secondary outcomes.  
We will also undertake a secondary analysis to further explore the relationship 
between foot mobility and the effect of treatment, whereby foot mobility will be 
included in the model as a continuous variable, together with an interaction 
term with randomised group. Relationships will be investigated using 
fractional polynomials. [223] Further exploratory analyses to assess effect 
modification will be conducted including interaction terms between treatment 
group and potential effect modifiers.  
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Appendix 15 Baseline demographics by randomised 
treatment group.  
 
Foot Mobility 
Strata Total Hip Exercises Foot Orthoses 
Site     
Both (n (%)) High 49 (22.5) 25 (22.9) 24 (22.0) 
 Low 169 (77.5) 84 (77.1) 85 (78.0) 
 All 218 109 109 
     
Australia (n (%)) High  28 (12.8) 14 (12.8) 14 (12.8) 
 Low  110 (50.1) 55 (50.1) 55 (50.1) 
 All 138 (63.3) 69  (63.3) 69 (63.3) 
           
Denmark (n (%)) High 21 (9.6) 11 (10.1) 10 (9.2) 
 Low 59  (27.1) 29 (26.6) 30 (27.5) 
 All 80 (36.7) 40 (36.7) 40 (36.7) 
     
Sex High  32 (65.3) 16 (64.0) 16 (66.7) 
Female (n (%)) Low 119 (70.4) 54 (64.3) 65 (76.5) 
 All 151 (69.3) 70 (64.2) 81 (74.3) 
     
Bilateral symptoms High 37 (78.7) 17 (73.9) 20 (83.3) 
Yes (n (%)) Low 109 (66.1) 52 (63.4) 57 (68.7) 
 All 146 (68.9) 69 (65.7) 77 (72.0) 
     
Study Knee (most problematic) High  30 (63.8) 16 (69.6) 14 (58.3) 
Right (n (%)) Low  81 (49.4) 43 (52.4) 38 (46.3) 
 All 111 (52.6) 59 (56.2) 52 (49.1) 
 
    
Age (years mean (SD)) High  27.8 (5.8) 29.2 (4.9) 26.4 (6.3) 
 
Low 28.2 (6.1) 28.0 (6.3) 28.3 (5.9) 
 All 28.1 (6.0) 28.3 (6.0) 27.9 (6.0) 
 
    
Height (cm mean (SD)) High  170.0 (10.5) 169.1 (10.1) 170.9 (11.1) 
 
Low 171.5 (9.3) 172.1 (9.7) 171.0 (8.9) 
 All 171.2 (9.6) 171.4 (9.8) 171.0 (9.4) 
 
    
Weight (kg mean (SD)) High  76.0 (14.9) 80.7 (15.5) 71.0 (12.7) 
 
Low  73.3 (17.0) 73.7 (17.0) 72.9 (17.1) 
 All 73.9 (16.5) 75.3 (16.9) 72.5 (16.2) 
     
BMI (kg/m2 mean (SD)) High  26.3 (4.8) 28.3 (5.3) 24.3 (3.4) 
 
Low  24.8 (4.8) 24.7 (4.5) 24.9 (5.1) 
 All 25.1 (4.8) 25.5 (4.9) 24.7 (4.8) 
 
    
Duration of Symptoms  High  62.6 (69.0) 67.6 (67.0) 57.7 (72.1) 
(months mean (SD)) Low  51.3 (58.8) 47.9 (60.1) 54.8 (57.7) 
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 All 53.8 (61.2) 52.3 (61.9) 55.4 (60.8) 
 
    
Self-reported measures     
     
Worst Pain  High  6.4 (2.0) 6.4 (2.4) 6.2 (1.9) 
(NRS mean (SD)) Low  6.25 (2.0) 6.2 (2.0) 6.1 (2.3) 
 All 6.3 (2.0) 6.3 (2.0) 6.3 (2.0) 
     
Tampa High  39.3 (6.7) 39.3 (6.5) 39.2 (7.0) 
(mean (SD)) Low  39.5 (5.5) 38.9 (5.4) 40.0 (5.5) 
 All 39.4 (5.7) 39.0 (5.6) 39.9 (5.8) 
     
HADS Anxiety High  6.4 (3.1) 6.2 (3.1) 6.2 (3.4) 
(mean (SD)) Low  5.8 (3.9) 5.6 (3.8) 6.0 (3.9) 
 All 5.9 (3.7) 5.8 (3.6) 6.0 (3.8) 
     
HADS Depression High  2.9 (2.5) 3.0 (2.7) 2.8 (2.2) 
(mean (SD)) Low  3.0 (2.6) 3.0 (2.7) 3.0 (2.6) 
 All 3.0 (2.6) 3.0 (2.7) 3.0 (2.5) 
     
Pain Catastrophising Scale High  13.4 (8.3) 12.6 (7.5) 13.7 (9.5) 
(mean (SD)) Low  12.5 (9.5) 11.9 (8.5) 13.0 (10.5) 
 All 12.7 (9.3) 12.2 (8.2) 13.3 (10.2) 
     
Percentage of normal  High  59.7 (19.1) 54.0 (25.5) 55.6 (24.2) 
(0-100% mean (SD)) Low  59.6 (21.5) 55.8 (25.8) 52.1 (28.0) 
 All 59.6 (20.9) 60.3 (20.3) 58.8 (21.6) 
     
KOOS (mean (SD)) High  65.6 (16.0) 66.1 (15.8) 65.2 (16.4) 
 Symptoms Low  68.1 (15.3) 69.3 (16.2) 66.9 (14.4) 
  All 67.6 (15.4) 68.6 (16.1) 66.5 (14.8) 
     
Pain High  69.1 (12.1) 67.2 (12.4) 70.9 (11.7) 
 Low  69.0 (12.9) 69.5 (13.0) 68.5 (12.9) 
 All 69.0 (12.7) 69.0 (12.9) 69.0 (12.6) 
     
 Activities of daily living High  78.9 (13.4) 79.4 (14.5) 78.4 (12.5) 
 Low  79.3 (13.0) 79.7 (12.7) 78.9 (13.4) 
  All 79.2 (13.1) 79.6 (13.1) 78.8 (13.1) 
     
Sporting and recreation High  52.5 (22.9) 49.2 (23.4) 55.8 (22.3) 
 Low  52.4 (21.6) 55.5 (20.9) 49.2 (22.0) 
  All 52.2 (21.6) 54.1 (21.5) 50.7 (22.1) 
     
Quality of Life High  48.4 (16.7) 48.4 (13.9) 48.4 (19.4) 
 Low  44.9 (15.8) 45.9 (16.9) 43.9 (14.6) 
 All 45.7 (16.0) 46.5 (16.3) 44.69 (15.8) 
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KOOS Patellofemoral High  52.9 (19.1) 51.1 (19.0) 54.9 (19.5) 
(mean (SD)) Low  52.3 (16.1) 52.5 (15.2) 50.0 (17.7) 
 All 52.3 (16.1) 52.2 (16.1) 51.0 (18.1) 
     
Physical measurements     
     
Functional tests study knee High  13.5 (8.3) 13.6 (8.4) 13.5 (8.4) 
 Step-up (n mean (SD)) Low  13.1 (8.6) 13.1 (8.6) 13.2 (8.6) 
 All 13.2 (8.5) 13.2 (8.5)  13.3 (8.6) 
     
Step-down (n mean (SD)) High  8.7 (8.5) 8.4 (8.6) 9.0 (8.6) 
 Low  7.7 (7.5) 7.5 (7.3) 8.0 (7.7) 
 All 7.9 (7.7) 7.7 (7.6) 8.2 (7.9) 
     
Squats (n mean (SD)) High  9.9 (7.3) 10.7 (7.5) 9.0 (7.1) 
 Low  9.2 (7.7) 8.5 (7.5) 9.9 (7.9) 
 All 9.4 (7.6) 9.0 (7.5) 9.7 (7.7) 
     
Beighton Joint Mobility  High  2.3 (2.3)  1.9 (2.4) 2.6 (2.3) 
(mean (SD)) Low  2.2 (2.3) 1.9 (2.3) 2.4 (2.2) 
 All 2.2 (2.3) 1.9 (2.3) 2.5 (2.2) 
     
Hip Strength study knee  High  1.39 (0.33) 1.35 (0.29) 1.44 (0.38) 
 Abduction  Low  1.43 (0.41) 1.47 (0.42) 1.39 (0.39) 
(Nmkg-1 mean (SD)) All 1.42 (0.39) 1.44 (0.40) 1.40 (0.39) 
     
Adduction  High  1.45 (0.40) 1.44 (0.43) 1.46 (0.37) 
(Nmkg-1 mean (SD)) Low  1.43 (0.47) 1.49 (0.49) 1.38 (0.44) 
 All 1.44 (0.45) 1.48 (0.48) 1.40 (0.43) 
     
External rotation  High  0.48 (0.12) 0.49 (0.13) 0.47 (0.11) 
(Nmkg-1 mean (SD)) Low  0.45 (0.12) 0.46 (0.12) 0.44 (0.13) 
 All 0.46 (0.12) 0.46 (0.12) 0.45 (0.12) 
     
Hip ROM study knee High  25.3 (7.6) 23.4 (8.4) 26.2 (8.3) 
 Internal rotation  Low  26.9 (8.0) 26.5 (7.6) 27.3 (8.3) 
    (degrees mean (SD)) All 26.5 (7.9) 26.0 (7.5) 27.0 (8.3) 
     
External rotation High  32.8 (7.7) 32.0 (9.8) 32.2 (8.2) 
   (degrees mean (SD)) Low  32.8 (7.4) 33.1 (8.0) 32.5 (6.8) 
 All 32.7 (7.4) 33.1 (7.8) 32.4 (7.1) 
     
Midfoot width Mobility study side High  12.6 (1.5) 12.7 (1.4) 12.5 (1.7) 
(mean (SD)) Low  7.4 (2.3) 7.9 (2.0) 6.9 (2.6) 
 All 8.5 (3.1) 9.0 (2.7) 8.1 (3.4) 
     
Foot Posture Index study side High  6.0 (4.0) 6.0 (4.6) 5.8 (3.5) 
(mean (SD)) Low  3.3 (4.0) 3.6 (3.9) 2.9 (4.1) 
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 All 3.9 (4.2) 4.2 (4.2) 3.6 (4.2) 
     
Navicular Drop study side High  8.3 (4.3) 8.4 (4.9) 8.0 (3.8) 
(mm mean (SD)) Low  5.5 (3.8) 5.6 (3.5) 5.3 (4.1) 
 All 6.1 (4.1) 6.3 (4.0) 5.9 (4.1) 
     
Ankle Dorsiflexion study side High  126.0 (35.9) 116.2 (32.3) 135.8 (37.4) 
 Bent knee Low  118.1 (33.4) 112.1 121.4 (31.0) 
    (mm mean (SD)) All 119.9 (34.1) 115.2 (34.7) 124.6 (32.9) 
     
Straight knee High  36.9 (5.4) 35.0 (5.1) 38.7 (5.2) 
   (degrees mean (SD)) Low  37.0 (5.5) 36.2 (5.8) 37.9 (5.1) 
 All 37.0 (5.5) 35.9 (5.7) 38.1 (5.1) 
     
BMI: Body Mass Index; NRS: Numerical pain Rating Scale 
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Appendix 16 Secondary analysis including midfoot width 
mobility as a continuous interval measure.  
 
Relative risk of Global rating of Change associated with a one-unit increase in 
midfoot width mobility in each treatment group at each time point. P-value for 
the three-way interaction between time, treatment group and midfoot width 
mobility was 0.097. 
 
 Hip exercises Foot orthoses 
Treatment-by-
MFW interaction 
Time RR (95% CI) P-value RR (95% CI) P-value P-value 
6 1.00 (0.92, 1.08) 0.956 0.97 (0.91, 1.05) 0.477  
12 0.93 (0.88, 0.99) 0.025 0.99 (0.93, 1.05) 0.715  
     0.66 
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Appendix 17 Secondary outcomes for Foot orthoses versus 
Hip exercises, for each visit and each foot-mobility subgroup  
 
Time 
(wk) 
Strata 
Hip 
Exercises 
Count  
(successful/t
otal)(%) 
Foot 
orthoses 
Count 
(successful/t
otal)(%) 
Foot orthoses - Hip exercises 
Treatment 
by strata 
interaction 
RR (95% CI) P-value 
P value 
Global rating of change outcome based on treatment allocation and stratification on midfoot 
width mobility at 6 weeks 
 
6 
 
High 10/21 (47.62) 6/23 (26.09) 0.52 (0.23, 1.20) 0.12 
 
6 Low 35/75 (46.67) 35/78 (44.87) 0.95 (0.68, 1.34) 0.78  
6 All 45/96 (46.88) 
41/101 
(40.59) 
0.87 (0.63, 1.19) 0.37 
 
       
“Is your current condition satisfactory?” (y/n) 
6 High 10/21 (47.62) 15/23 (65.22) 1.26 (0.78, 2.06) 0.35  
6 Low 47/75 (62.67) 47/77 (61.04) 1.01 (0.80, 1.27) 0.95  
6 All 57/96 (59.38) 
62/100 
(62.00) 
1.05 (0.85, 1.29) 0.66 
 
12 High 11/20 (55.00) 14/21 (66.67) 1.17 (0.72, 1.88) 0.53  
12 Low 47/72 (65.28) 48/78 (61.54) 0.96 (0.78, 1.19) 0.72  
12 All 58/92 (63.04) 62/99 (62.63) 1.00 (0.82, 1.21) 0.97  
12      0.41 
       
“Overall, has treatment been successful?” (y/n)  
6 High 12/21 (57.14) 15/23 (65.22) 1.09 (0.66, 1.80) 0.72  
6 Low 49/74 (66.22) 48/74 (64.86) 1.01 (0.80, 1.28) 0.94  
6 All 61/95 (64.21) 63/97 (64.95) 1.02 (0.82, 1.27) 0.83  
12 High 12/20 (60.00) 10/20 (50.00) 0.81 (0.46, 1.45) 0.48  
12 Low 42/71 (59.15) 46/77 (59.74) 1.00 (0.77, 1.29) 0.99  
12 All 54/91 (59.34) 56/97 (57.73) 0.96 (0.75, 1.21) 0.72  
12      0.77 
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EQ-5D – Mobility (no problem/ problems)  
6 High 4/21 (19.05) 5/23 (21.74) 1.11 (0.37, 3.35) 0.85  
6 Low 16/73 (21.92) 24/76 (31.58) 1.29 (0.76, 2.17) 0.35  
6 All 20/94 (21.28) 29/99 (29.29) 1.25 (0.78, 2.01) 0.36  
12 High 2/20 (10.00) 2/21 (9.52) 0.97 (0.15, 6.14) 0.97  
12 Low 11/72 (15.28) 23/79 (29.11) 1.73 (0.92, 3.24) 0.089  
12 All 
13/92 (14.13) 
25/100 
(25.00) 
1.62 (0.89, 2.92) 0.11 
 
12      0.81 
       
EQ-5D: Usual activities (no problem/ problems)  
6 High 7/21 (33.33) 12/23 (52.17) 1.52 (0.80, 2.86) 0.20  
6 Low 26/73 (35.62) 30/76 (39.47) 1.13 (0.75, 1.70) 0.57  
6 All 33/94 (35.11) 42/99 (42.42) 1.23 (0.88, 1.73) 0.23  
12 High 7/20 (35.00) 6/21 (28.57) 0.81 (0.38, 1.74) 0.59  
12 Low 18/72 (25.00) 27/79 (34.18) 1.40 (0.86, 2.26) 0.17  
12 All 
25/92 (27.17) 
33/100 
(33.00) 1.19 (0.79, 1.78) 0.40 
 
12      0.44 
       
EQ-5D: Pain/ discomfort (no problem/ problems)  
6 High 17/21 (80.95) 19/23 (82.61) 1.00 (0.76, 1.30) 0.98  
6 Low 49/73 (67.12) 58/76 (76.32) 1.14 (0.93, 1.41) 0.21  
6 All 66/94 (70.21) 77/99 (77.78) 1.10 (0.93, 1.30) 0.28  
12 High 14/20 (70.00) 14/21 (66.67) 1.05 (0.67, 1.62) 0.84  
12 Low 51/72 (70.83) 51/79 (64.56) 0.93 (0.74, 1.16) 0.51  
12 All 
65/92 (70.65) 65/100 
(65.00) 0.96 (0.79, 1.17) 0.67 
 
12      0.43 
       
EQ-5D: Anxiety/ Depression (no problem/ problems)  
6 High 4/20 (20.00) 2/23 (8.70) 0.35 (0.08, 1.62) 0.18  
6 Low 11/73 (15.07) 12/76 (15.79) 1.01 (0.50, 2.06) 0.98  
6 All 15/93 (16.13) 14/99 (14.14) 0.81 (0.43, 1.53) 0.51  
12 High 3/20 (15.00) 2/21 (9.52) 0.45 (0.09, 2.17) 0.32  
12 Low 10/72 (13.89) 10/78 (12.82) 0.74 (0.35, 1.57) 0.43  
12 All 13/92 (14.13) 12/99 (12.12) 0.66 (0.33, 1.32) 0.24  
12      0.21 
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Hip 
Exercises 
mean(SD) 
Foot 
orthoses 
mean(SD) 
Foot orthoses - Hip exercises  
Coefficient (95% 
CI) 
P-value 
Rating knee as % of normal (0-100%) 
6 High 
67.1 (18.4) 67.3 (21.1) 
-1.66 (-12.98, 
9.67) 0.77 
 
6 Low 
73.5 (18.3) 67.5 (18.8) 
-4.89 (-10.73, 
0.95) 0.10 
 
6 All 72.2 (18.4) 67.4 (19.3) -4.16 (-9.46, 1.14) 0.12  
12 High 
71.8 (22.7) 73.8 (21.5) 
-0.89 (-13.96, 
12.19) 0.89 
 
12 Low 75.9 (18.5) 73.0 (18.9) -2.75 (-8.56, 3.05) 0.35  
12 All 75.0 (19.4) 73.2 (19.4) -2.34 (-7.78, 3.10) 0.40  
12      0.61 
       
Recovery scale score (0-100%) 
6 High 
56.0 (26.8) 50.0 (28.9) 
-8.34 (-24.70, 
8.02) 0.32 
 
6 Low 
57.9 (29.2) 51.0 (27.7) 
-7.43 (-16.21, 
1.36) 0.098 
 
6 All 57.5 (28.6) 50.8 (27.8) 
-7.67 (-15.38, 
0.04) 0.051 
 
12 High 
51.8 (34.9) 47.1 (33.6) 
-6.28 (-26.59, 
14.03) 0.55 
 
12 Low 58.7 (31.2) 60.4 (30.3) 1.31 (-8.60, 11.22) 0.80  
12 All 57.2 (32.0) 57.6 (31.3) -0.36 (-9.32, 8.60) 0.94  
12      0.92 
       
Kujala Patellofemoral scale (0-100) 
6 High 75.9 (12.2) 77.5 (12.3) 0.90 (-4.67, 6.47) 0.75  
6 Low 77.8 (9.8) 74.9 (11.8) -1.71 (-4.70, 1.27) 0.26  
6 All 77.4 (10.3) 75.5 (11.9) -1.13 (-3.78, 1.51) 0.40  
12 High 77.5 (9.3) 79.0 (13.1) -0.02 (-5.92, 5.87) 0.99  
12 Low 79.8 (9.0) 78.5 (13.6) 0.39 (-2.84, 3.63) 0.81  
12 All 79.3 (9.0) 78.6 (13.4) 0.31 (-2.50, 3.11) 0.83  
12      0.42 
       
KOOS: Symptoms subscale 
6 High 70.4 (15.7) 69.6 (16.0) -0.83 (-5.55, 3.89) 0.73  
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6 Low 76.2 (14.1) 69.9 (15.7) -3.86 (-6.85, -0.87) 0.011*  
6 All 74.9 (14.6) 69.8 (15.7) -3.17 (-5.73, -0.62) 0.015*  
12 High 72.7 (13.6) 71.1 (16.3) -2.21 (-7.18, 2.76) 0.38  
12 Low 76.7 (14.6) 71.9 (17.5) -3.12 (-6.19, -0.04) 0.047*  
12 All 75.8 (14.4) 71.7 (17.2) -2.92 (-5.52, -0.32) 0.028*  
12      0.29 
       
KOOS: Pain subscale 
6 High 75.7 (13.8) 78.0 (11.6) -0.31 (-6.22, 5.60) 0.92  
6 Low 78.8 (10.6) 74.6 (13.2) -3.43 (-6.64, -0.21) 0.037*  
6 All 78.1 (11.4) 75.4 (12.9) -2.73 (-5.57, 0.11) 0.060  
12 High 
79.4 (12.3) 77.8 (14.8) 
-3.88 (-11.42, 
3.65) 0.31 
 
12 Low 81.1 (10.9) 76.0 (16.2) -4.15 (-8.16, -0.14) 0.042*  
12 All 80.7 (11.2) 76.4 (15.9) -4.09 (-7.63, -0.55) 0.023*  
12      0.36 
       
KOOS: Daily living subscale 
6 High 83.0 (14.7) 87.0 (10.4) 3.18 (-2.64, 9.00) 0.28  
6 Low 86.8 (9.7) 83.0 (14.9) -2.98 (-6.24, 0.28) 0.07  
6 All 86.0 (11.0) 84.0 (14.0) -1.59 (-4.45, 1.26) 0.27  
12 High 87.4 (10.9) 87.7 (11.1) 0.35 (-6.10, 6.81) 0.91  
12 Low 89.0 (9.1) 84.2 (15.8) -4.44 (-8.09, -0.80) 0.017*  
12 All 88.6 (9.5) 84.9 (14.9) -3.37 (-6.54, -0.20) 0.037*  
12      0.072 
       
KOOS: Sports & recreational subscale 
6 High 65.5 (22.9) 70.0 (22.1) 1.00 (-9.58, 11.58) 0.85  
6 Low 66.0 (20.9) 60.2 (23.7) -3.12 (-9.60, 3.36) 0.34  
6 All 65.9 (21.2) 62.5 (23.6) -2.20 (-7.74, 3.33) 0.43  
12 High 
70.0 (18.6) 71.9 (23.3) 
-3.20 (-13.84, 
7.45) 0.56 
 
12 Low 69.6 (20.7) 67.8 (22.4) 0.51 (-5.88, 6.89) 0.88  
12 All 69.7 (20.2) 68.7 (22.5) -0.31 (-5.81, 5.18) 0.91  
12      0.52 
       
KOOS: Quality of life Subscale 
6 High 
57.7 (16.6) 53.3 (19.4) 
-5.79 (-14.67, 
3.09) 0.20 
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6 Low 51.7 (17.3) 50.8 (19.9) -0.62 (-5.93, 4.69) 0.82  
6 All 53.1 (17.3) 51.4 (19.7) -1.80 (-6.35, 2.75) 0.44  
12 High 
55.9 (16.8) 58.6 (16.6) 
-0.65 (-10.45, 
9.15) 0.90 
 
12 Low 59.9 (17.3) 55.1 (19.9) -4.16 (-9.70, 1.37) 0.14  
12 All 59.1 (17.2) 55.8 (19.2) -3.35 (-8.24, 1.53) 0.18  
12      0.33 
       
Worst pain past week (NPRS; 0-10) 
6 High 5.2 (2.2) 4.9 (2.6) -0.17 (-1.53, 1.19) 0.81  
6 Low 4.4 (2.4) 4.9 (2.5) 0.35 (-0.35, 1.05) 0.33  
6 All 4.6 (2.4) 4.9 (2.5) 0.23 (-0.40, 0.86) 0.47  
12 High 4.7 (2.6) 4.6 (3.1) 0.33 (-1.28, 1.93) 0.69  
12 Low 4.0 (2.4) 4.6 (2.9) 0.64 (-0.17, 1.45) 0.12  
12 All 4.1 (2.5) 4.6 (2.9) 0.57 (-0.16, 1.30) 0.13  
12      0.50 
       
Average pain past week (NPRS; 0-10) 
6 High 3.5 (1.8) 2.7 (1.6) -0.43 (-1.38, 0.52) 0.38  
6 Low 2.8 (1.9) 3.1 (2.0) 0.21 (-0.36, 0.77) 0.47  
6 All 2.9 (1.9) 3.0 (1.9) 0.06 (-0.43, 0.55) 0.80  
12 High 2.9 (1.8) 3.0 (2.2) 0.43 (-0.79, 1.65) 0.49  
12 Low 2.5 (1.8) 2.9 (2.2) 0.40 (-0.20, 1.00) 0.19  
12 All 2.6 (1.8) 2.9 (2.2) 0.40 (-0.13, 0.94) 0.14  
12      0.26 
       
Step-up most-problematic knee (Pain free reps: 0-25) 
6 High 21.1 (6.2) 18.1 (8.0) -2.06 (-6.12, 2.00) 0.32  
6 Low 19.3 (7.3) 16.7 (7.8) -2.42 (-4.74, -0.10) 0.040*  
6 All 19.7 (7.1) 17.0 (7.8) -2.34 (-4.38, -0.30) 0.025*  
12 High 20.2 (7.2) 18.9 (8.0) -1.31 (-5.48, 2.86) 0.54  
12 Low 18.0 (8.3) 17.2 (8.6) -0.90 (-3.56, 1.76) 0.51  
12 All 18.5 (8.1) 17.6 (8.5) -0.99 (-3.28, 1.29) 0.39  
12      0.88 
       
Step-down most-problematic knee (Pain free reps: 0-25) 
6 High 15.1 (9.6) 10.2 (10.4) -5.23 (-9.97, -0.48) 0.031*  
6 Low 14.5 (9.2) 12.5 (8.7) -1.82 (-4.35, 0.70) 0.16  
6 All 14.6 (9.2) 12.0 (9.0) -2.58 (-4.82, -0.34) 0.024*  
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12 High 14.2 (9.1) 15.4 (10.0) 0.35 (-4.69, 5.40) 0.89  
12 Low 14.1 (9.2) 12.7 (9.4) -1.42 (-4.35, 1.51) 0.34  
12 All 14.1 (9.2) 13.3 (9.6) -1.03 (-3.59, 1.52) 0.43  
12      0.22 
       
Squats (Pain free reps: 0-25) 
6 High 13.9 (8.3) 12.4 (9.6) -0.60 (-4.58, 3.39) 0.77  
6 Low 15.8 (9.1) 12.2 (8.5) -3.71 (-6.22, -1.20) 0.004*  
6 All 15.4 (8.9) 12.2 (8.7) -3.00 (-5.18, -0.82) 0.007*  
12 High 17.5 (8.4) 13.8 (8.6) -3.29 (-7.88, 1.30) 0.16  
12 Low 15.2 (9.0) 13.1 (9.0) -2.73 (-5.43, -0.03) 0.047*  
12 All 15.7 (8.9) 13.3 (8.9) -2.86 (-5.14, -0.59) 0.014*  
12      0.19 
       
Hip Abduction strength (Nmkg-1) 
6 High 1.44 (0.33) 1.45 (0.37) -0.05 (-0.17, 0.06)        0.37  
6 Low 1.53 (0.38) 1.44 (0.38) -0.04 (-0.10, 0.03)        0.25  
6 All 1.51 (0.37) 1.44 (0.37) -0.04 (-0.10, 0.01)        0.15  
12 High 1.46 (0.25) 1.49 (0.35) -0.02 (-0.15, 0.10)        0.71  
12 Low 1.54 (0.39) 1.43 (0.34) -0.03 (-0.10, 0.04)        0.35  
12 All 1.52 (0.36) 1.44 (0.34) -0.03 (-0.09, 0.03)        0.32  
12              0.81 
       
Hip Adduction strength (Nmkg-1) 
6 High 1.57 (0.53) 1.46 (0.42) -0.12 (-0.25, 0.02)        0.10  
6 Low 1.49 (0.48) 1.38 (0.39) -0.02 (-0.09, 0.05)        0.55  
6 All 1.51 (0.49) 1.40 (0.39) -0.04 (-0.10, 0.02)        0.18  
12 High 1.52 (0.57) 1.51 (0.44) -0.04 (-0.21, 0.13)        0.67  
12 Low 1.49 (0.45) 1.37 (0.40) -0.01 (-0.08, 0.06)        0.79  
12 All 1.50 (0.48) 1.40 (0.41) -0.01 (-0.08, 0.05)        0.65  
12      0.22 
       
Hip External rotation strength (Nmkg-1) 
6 High 
0.53 (0.18) 0.46 (0.10) -0.06 (-0.12, -0.01) 
       
0.028 
 
6 Low 
0.51 (0.13) 0.47 (0.14) -0.04 (-0.06, -0.01) 
       
0.013 
 
6 All 
0.52 (0.14) 0.47 (0.13) -0.04 (-0.07, -0.02) 
       
0.001* 
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12 High 0.51 (0.15) 0.49 (0.12) -0.01 (-0.06, 0.04)        0.70  
12 Low 0.52 (0.10) 0.48 (0.14) -0.01 (-0.04, 0.02)        0.36  
12 All 0.51 (0.12) 0.48 (0.13) -0.01 (-0.04, 0.01)        0.33  
12      0.41 
       
Tampa Scale of Kinesiophobia score 
6 High 36.1 (7.6) 37.8 (6.8) 1.83 (-1.35, 5.01) 0.26  
6 Low 36.3 (7.2) 37.7 (6.1) 0.55 (-1.17, 2.27) 0.53  
6 All 36.3 (7.3) 37.8 (6.2) 0.84 (-0.68, 2.35) 0.28  
12 High 35.6 (7.7) 34.2 (6.9) -0.17 (-3.67, 3.33) 0.93  
12 Low 35.5 (7.5) 36.2 (6.5) 0.09 (-1.74, 1.93) 0.92  
12 All 35.6 (7.5) 35.8 (6.6) 0.04 (-1.55, 1.63) 0.96  
12      0.49 
       
Hospital Anxiety and Depression Scale: Anxiety subscale 
6 High 5.5 (3.2) 4.3 (3.0) -1.08 (-2.81, 0.65) 0.22  
6 Low 5.3 (3.6) 4.9 (3.3) -0.86 (-1.58, -0.13) 0.020*  
6 All 5.3 (3.5) 4.8 (3.3) -0.91 (-1.60, -0.22) 0.010*  
12 High 4.7 (3.2) 4.0 (3.7) -0.45 (-2.18, 1.28) 0.61  
12 Low 4.8 (3.8) 4.6 (3.5) -0.65 (-1.50, 0.20) 0.13  
12 All 4.8 (3.7) 4.5 (3.5) -0.61 (-1.38, 0.16) 0.12  
12      0.81 
       
Hospital Anxiety and Depression Scale: Depression subscale 
6 High 2.5 (2.1) 2.2 (2.7) 0.06 (-1.09, 1.21) 0.92  
6 Low 2.5 (2.3) 2.6 (2.6) 0.04 (-0.56, 0.63) 0.91  
6 All 2.5 (2.3) 2.5 (2.6) 0.04 (-0.49, 0.57) 0.88  
12 High 2.5 (2.3) 2.1 (2.4) -0.39 (-1.77, 0.98) 0.58  
12 Low 2.3 (2.4) 2.2 (2.4) -0.31 (-0.92, 0.31) 0.33  
12 All 2.4 (2.4) 2.1 (2.4) -0.33 (-0.90, 0.25) 0.26  
12      0.97 
       
Pain Catastrophising Scale (total) 
6 High 10.2 (7.8) 10.9 (11.7) 0.54 (-3.71, 4.79) 0.80  
6 Low 9.4 (8.0) 10.8 (9.0) 0.32 (-1.75, 2.38) 0.76  
6 All 9.6 (7.9) 10.8 (9.6) 0.37 (-1.49, 2.22) 0.70  
12 High 8.3 (8.2) 8.9 (10.3) 1.25 (-3.08, 5.58) 0.57  
12 Low 8.8 (9.0) 8.5 (8.1) -0.78 (-3.02, 1.46) 0.50  
12 All 8.7 (8.8) 8.6 (8.5) -0.32 (-2.31, 1.67) 0.75  
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12      0.93 
       
No model was fit for EQ-5D Personal care due to almost all participants 
reporting no problems with personal care.  
+ The model for “Pain or discomfort” failed to converge.  
* p<0.05 
EQ-5D: The personal care, problems with usual activities, pain/discomfort, 
and anxiety/depression outcomes were dichotomised due to very few 
participants reporting the most extreme values of these variables 
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Appendix 18 Treatment outcomes for hip exercises versus 
foot orthoses at 6 and 12 weeks, grouped according to 
midfoot width mobility stratification  
(treatment by foot mobility strata interaction p value = 0.53). 
Midfoot Width 
Mobility 
Hip Exercises  
(successful+/total 
(%))* 
Foot orthoses  
(successful+/total 
(%))* 
Foot orthoses vs Hip 
exercises^ 
Relative Risk 
(95% CI) 
P-value 
Week 6     
High (≥11 mm) 13/20 (65.00) 14/23 (60.87) 1.00 (0.63, 1.61) 0.99 
Low (<11 mm) 51/75 (68.00) 42/76 (55.26) 0.85 (0.66, 1.08) 0.18 
All 64/95 (67.37) 56/99 (56.57) 0.88 (0.70, 1.09) 0.23 
Week 12     
High (≥11 mm) 13/19 (68.42) 13/21 (61.90) 0.88 (0.57, 1.37) 0.58 
Low (<11 mm) 52/72 (72.22) 55/79 (69.62) 0.96 (0.79, 1.17) 0.70 
All 65/91 (71.43) 68/100 (68.00) 0.95 (0.79, 1.13) 0.55 
+ successful defined as a decrease of at least 2 units in worst pain 
experienced in the past week, and/or an increase in the Kujala patellofemoral 
scale of at least 8 units, * frequency counts are complete-cases, ^ point 
estimates (Relative Risk) are based on multiply imputed data  
 
 
 
